var title_f10_17_10512="Serum sickness urticarial";
var content_f10_17_10512=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F52352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F52352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Urticarial rash as a consequence of a serum sickness reaction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 389px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGFAPwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD54E5yCclAeAaTzyVxt59d3akjlAhliIBVjnG3J49D2qLZlIzgccn1Na6jHzSSJajnKtzjvimFy0eD2Aofc8RXcikfNgnHftVdlcKWZAAe7d/ek9wHK5CnnIzyB/WhpCWYAg4GeOlQ4ZRgEqGOC3rSKp3DsOmKQE0b7lwpYP2HrTvNcsBLkY644zURkKklRhuhpoZHJDnHHOf5UAW7Yq9ygHy+vf8AGty6ISE56Adc1g6SGmvBngDoPWtbWXMVsy5yQMZFM0hszGaTcpYnpk/WnWwMkoABAzmqcwAxghtyg8djW9pVuMRsOhAz65pExV2bViuYgGX6+tXWwI8+lNswMbmB64FLd/7Jz6gCsZO7PVpw5Y3LVk218Zzz2NdLp9yEOATyOBXJ2rsJQNo5/Sum04B5FB6nrxxXDX0PRoaxO10b5mXdJuB9a6SGFXTI/AHiuS0uHy4w2RnPHPaumtJi/TGe+ayhLuctSOuhaWDLlSclRxVqKH5cnJKjj1qqN5YkZHfnpirsTbsZ4IGfXNVcm1hY0weDlsY5qVUB5IHzAdeKSFTvB6ex6U4SH5Q/AIwPQUyr9iORzjGfXg9qajqVO/pjJpZ1yfkx/Q1CvEpXkZGeRwKB3uTycBRkMeetV2ODzgccZNPLhByCT780yQruIJwD6ip5bjU7EcwHXIx71lzXAWZQ3P1NXppQBwAOeh5rCvZDvYgFVB3HNNKwnK+hJJIdpxuIPes4DErlmzgVKtwTEOeQMn0NU5JGRC+flPrTW5mlY5zxDMIFurgs2xEJz715QpD5ZgdxOTmux8eag5tWhVjiR+g6cVxYJIz/AFr0sNC0b9zhx1Tmko9iGOTLyFMkgA4A496bGC5EbnbhSQfSlkQxyYRSo5wFpYyYsrkEHgFutbnCVmGSNykkdF6D607yz5e9vlCj7uO/tUTsVcluQBxk96HunIAGCCdwA6VDeoxCJHCBj3zg0mTyNvfrUyzxqQzoWYc5PrUcjc/N95uenSgCMRlwzZGRySTjNBB2bxgAnHPWgZ4CYJzTV3AdMgdaEBr6HGiLIzH5j09qXXZwFjjx1OcUujRloCewPGaztTlM10xc5C/KM96b2NL2jYhhUzTBSd3v7V1mnW7MYxjgVz2kW5aQylTnAxXZ6XCAArsAo7jpUSdkbYam5O5bgiIUgDIApJVIY5Ay3Sp3lRSBHzmkB86QEKflOc+lcnM76nr8mg+3s9x4yGA610FjAwVFKZPSqNhCxkDHPHUV01nLsZSsIyo49jXFVk5OxvGXItC3YwyhXVkK47HvXQac6AhV+Q8cY6VVsc3bRs2UPGCBzW5b6eq8pk5OKmCM5Sv8RIACcofoRyDVmI7HycfN6VJFZt1AAXrgf1qYxfxFfujnA71d7Gdk9h0QGwEkdKRkA5H3cjGOaIk2MCCd3Sp0ALtsHO0D5aozasU2IxkLg45qu6sxLLjNXp0PVR8rEjjsKigZS+HUgjnNFwuUpEdE5O3Pfrg0xshRjnitS6jVrcFAMjPA71jsDu28nHvimmK90VbrO0849x6ViXzgsFYYBHbnit66YNu5XA7Cuc1Ngo3LgY44pyFHcqRSNh+hyMnNUr2YjT2U/f3ZNSRSY3KwwMfmayLyc4nXf8q+lEUbWPPPF8h+3JHktgZJ9CayI0Ur8zAmrGqTfaL+dzn72KqhD24FevBWikeHWlzTbJQ23aVw3ynt0zVWTd5DeYxyO2OtLyGBJONueDVeeRmX5c9O1U9DJELMGPKKCCDxQ5Vih2gAcnH8VIVdiFY+5yKJXBfAACkf5xWYyVwWkDNjGM89hVZ3JZTwAepp8rbgCeOMZJpgG5cDj+VACKSD8uAD3NDMFb1A6YpBwQAAewOaUnJH6igDThufs1mQCQXGMetZ8IJnhwMtu785NJNIZG56DtWjpdmcrIwwCeD6U9ylqbVrbqpUjoeTgV0dtBuRNu0Dbmsa0DAbTnbnqK1bado12jpjj3rGte2h6WGlyFm3tS4JcYx0qe2g2tlhkdgB1p1nI04wBwPety1tcRd855BFcNRtHf7a62I7Qqo5XnHAroLBBK2HOG+lUo7F8bkXJOMDHaunsrAQQ7mUM4BPPrXNytsblFq5NYJ5dwV+UAjAPTNdPaj5cjI+lcrDFK7RsVKAHIU11ekoZlCEZIGMGiL1sKrCyuXCGWHK9+v0p8Cl5FLYLjPFWTasCOdvHQ1Yto181Q7AsDgmmc3MrFGeIMw+Ug45HvVR42SQLvx/tDtWrfQhWGCd4GMMffrWVPgkDd07Gm2XT1Wg18yQP83HQHvQULFd4HA/OiIfISeCc9f51LGwYDOcnnn0qkwkrFe4XMZ6hs9KzJVyxI4Ydq2XUBQApHXANZtyRllII7c1SIuZdygKNtOCe3rXOagD5XH45rorptmAR7VzOsS7IZR13DvTaHHUyyyeQxByRkDPPNYGpM0GnTzZK5HBP8q3Yk3WytwCenpmuc+Icq2Wl2kAbLsD8vrWlGLlJFVZqMGecS/6zfj7xzzTGZQepOfSnKrPwDyePpT3/dttJTgdfX3r1zwSF5DGmM9uMjp9azXy53bjkdanu5SWYEnG4ng96ZIR5g3KDgdD3rOTAhYbWAL7gcZ9aRmzkN9BTsqSzYxjsDSSAbyB90cg461IwBWPnaDjpnvTGJcgLgUbhxu59aRh6DFIBwwQOcmlwARuzgdeaaCSQp6jnirNrE0rhR696aAfZ2vmOrFTs9a6KCJVRQnGOefWm2FqQApHTnp1rTmgMUe8gEYxk+tO6Wh0Qp9WRw42D5xgn7vr71p2FsGw24kZ7+lYsLEsQep5ro9NXcq5yozWNZ2R14ePMzZsrVEII44Hauj022aUEkHHUduKzNLhU5yWDbeMc102mxMBgcVwJNs6ZuyLlvDgKucdySMjFbVpFtGXXgdKpwIdmQPwFWheCGQI/J/SraSM4pvY0La2UsSFBPYGtvT444nUgKCScA1l2DR3HIYqSO1aaeUkalmCg8Bgajl6oc3J+6zQecLEWIGB6+gpY1BAZR0OcdqpuqrC3lyBwwPSlsrkocHOOvHSs5EJO2hbnjDANz68981h3cewtnJXAHtW2ztKuVPQBjVaVcxFSh56EVFi6c3EyrMg71kXa3PHanbtrg8banlQYDJlcjGf8agiZUjIcAEcn6VUS5O+pI7fKGYlSD9Rism9AExweKuyTAxgls96zmkG98DBH41pEzsZWpOUUDoN2fqK5nV13Rsz4Ckg10uo4cSPuwOAAK5PW5GUBMZLHsachwdypbyhUjQkcMeeteZ+N9T/ALQ1x0Rvkh+Uema7PWL0adp0k7D5hkKM968slfdKzHJ3HJPua7MJDTmObHVF8CFi3cqCee471MzDj5s4FMiwznBbHr3oQADDg5+ld55pjMqMB8xyCc+mKdGNpPmD5WHHr+NGQ67QQO2MdajkwCD3FYFD9oDMD0A6d6a33dpYYB4wKbxt4HbqaXzCAqnoppANVSz88Dp0odShK5IweR6UOQT8oxikJaSTLdTzkmkAp+aQDk5710WkWm1ASDkjoKzdKg3yB3BI7V1enhlI7Bf0qtlc2pQ5mXbG32YyPbn+dQ6wVQbQSefWrL3ARiAAOetUZIWllyc4J9axV+a7PQnbl5YlexXdLu5P9K7HTIgCNwBzWRpen5ILD8RXW6ZYFdjDoSBmsK0ud2RrQh7OOpsafCEjGzG4/pXSWaAKDgjPf1qhbWwRCBhuwxW3bxk7e49PSpSsRJ3ZPBGT8/T2FSNYmZBIFIcg8itCygVyMqTxzWvDp8Yxkgg9u4NKzlsCnyGJpEEguVCrgdC3StO6hY/NnOOwHT3rYtraKNfmwWHTHrVe7mSB2jVQ241LhZamkavNLRFDTyyO24fKRhgeKuPCWcEDHpg8VDEzOS79wePWrkUkY3k5APr06VCjdBV0dyCNpInKDkdD65pk7sJAUO5GHapX+eflh1GD061XlQo2AOQMEGo5bGaauVzJvQhvlz0zVK8P7wFM7M5PrmpbraqsRyue9QPKfkBxt6haSNERXbFYgVXO3n0NZpk3ZYZBx24xV+5nBjdmTcR0FYt+/kptOPTn/GtYkNla+uAowPm9sVyV4zT3RlH3F5HtV+/uiW2g5bIUfSub1u+FraTYb5I1PTuc0kud2RUfdV2cd4yv/tF4tsp/dxcn6muYz8rZ5B6VLMWuJXlLfO7bqjXI4z17d69mnHlikjxqk3OTkxQ2QhJ3BTgCnLnnnHNM+ZQc4OO3TFPjUMudwOT6VaMzMhhaTGGUH1Y4z7VCSMjg9+lS8kId3ynvUTEoeeM8iucoYQQM4+UUj4G3CnOMjNPO3aM5GByPWp7eESg7S3AyOM8UWArE8DIH0pI0aR1Veae56Kct3/GrljFumjyAD6j+tNIEa+lQlVHU44rch2xq25s/3jWZEwRCB+XY1ahAkGOp+tEkdtLTQuxDcRnkYzyKkUHeFUEH2HSrNjD8gDZHpzmtm0skyC3QDsK46lS2h6uHpJ6yJdAtGcklRtA798111lbnyht2ggfhWLDJHCqRhtpPXBrsNJijktV8sqc9c1jBrqViE90tCxaxAY7nHetW2iChQOrHofSo7O324yTjFaltFkll45wDWjZyJF/T1UZ5xgA9KuSMwI8vqfWktIwOGGARzV2W0JlUIeNuaLdhJq+pi+ZKZCgbauMGpLVjcMNxHHANTz6dLGxLn5CuQR0z71BZx7MEjaTnHPFZKMuazOy8XG6L0NuuWViMZ7dqHURF49uVJ+VzVuOAtE5j8vO0cD09aW+j8mIfKQpPU84roULHHKd3YxJlYSBsg4+bHOBT5SYxjIAKj5jyOatx2ZuAx3EMRj2qvcwGCICTk7QM9azcCJNXsY90wwyYxnpVWSQEjkAjjFWboKhYMfm5/EVmpKg5B56k+1Z8li1LQSWQhD8vfPtXO6/d/MAMDHp0zWne3DpGzkfKDn61yGq3BuJccgH0ofuoIJyZWYFo5puv8K4rg/G9wVWKzyMv+8cg9uwr0dglvp7ksOFzn3rxzW7oXWoXL5BGdq59K2wcLzv2M8XPlp8vczhjfkcD0FDhWJZT35JpMHhR/wDqp68KSw57e9eoeUByWx0PtQhAGAB7545pybU+cZVsY+lNYZP3M+9AjIKqeo2jpgGmttxt9B3NPUkHIUHHXHNJkOwBBLE/n9a5yh1hZvdThV+71JNdVHYbFIXAAH60mhWQjt1IBDk5II7V1ltY5j8tkYMRnJpTqKCO7C4V1NTy7V4Ps94VAG088UWtyIgS5yQOK2/HVr9mnhIUA88DqK5hjuVMKOfTrTUr6o5qsHTm4vobNlcvczbQDj0Paup0qz3Sqz9+MetYfh6yEaZC5duua7jTrPZF83LH0NZ1p8qO7BUXN3Zf060TC5BAzgZ610dlArvtRdgz09qxbQMsnykKMYB71saOkj3QycAH8/rXnc+p7jw+l7lZtHu2vHYRMRnqK77QbM29mgYHd1PHerFvB8oOFz1yB/SrsAwSCPyq4xSfMjmrYhzjyvoULq8e2wsW0lhV3RL1nZhIM5PpjI9agvbFrr5ouCvIx1qzYWjLKrSH2A6cUPmuOKp+zt1OqtXj+WNm+bG4EVqKN06BgR71ykElw1yPJQFFHIrrY0LLG23BxnA9a6IO559aHI0X5LYSxKFOP1Nc5PY+XdSK/AUjDdMV0tmdow2TxwM1ZvbRLolQOoxn3rblTOaFZ03Z7HM2YNvOXkP3l28+lasxS4gWRF3jj/OKdPpjtCdyBmAxn2p1laNHCEAbGTuoSsOdSMve6lJHR48hArgg4HWs7VSsseBjIOeOxrbe3ihZmQEE5Jyc5rlNTlJmOMjjO08ZqZ6Ew953RzOsSlZ8jtxn0rJkn+c4HJ9Ksa5L8kxbjCnjOKxoJC6I7Hjb071hLRGyK2p3TvCQCcDrjisWBVeUA8IOOlaWqkRW5zyzNkisveEDNnIAz1rmkmdVNK2hl+Nb9LKwkdT8zLsWvKAynJOfQ10Pi3VPtt75aMTHEcD0J7mueVeAxIwc16uFpOENd2eVi6vPOy2Q4HcFEYI+p60p4TBPQ0w7ypOw+WmAXHv0qZcHjH6da60zlGIevyk1LHkr9yo2facHgZ6A9KkUKwy2c+1KwbGCDh1IUgetaej2xubkOANq9PXNZkZIY/7II69K6zwlZsArRjLFs9K5r9TalDmkkdTpEKxwL+73nHGDW1E6RndJwuMkt2xTrS2BiLAAAjjnpXM+PtU+w6cbOJsXE3HXkLXBJurOyPpo8uFoub6HEeLdSfVNWkcE+UCVXHcCq2hWhuLoNyI1/U1TTc8iqnzE/KOfWu+8P2caRBAoXHf1rtuoI+epwliKl+rNPRdOURqW4b+Vdbp1juhOcAggDPFVdGjDEKoHNdVptqoclsEfzrgnL2jPe5PYKxhw2e+5YJnbnFdPomktHcgyKAoyck9aura28EbOkYyBzkVTivp94bcvlMemOQKx5VF6nSq0qsbROut1U9QASOpNSRoCxHXaOD05rMsJDcw7dx355BNbVvb+WmGJyB39a2i9DzqkeV2ZHdN5EbEKX2r371QtL95WVmjABbAB6gVvNFH9lIxksMc9Kwrp4opisSgFTyamfc3w3LJWa1Oks3iRgQTl+doro7VSqoBlM5JridMcyr5ihlJxXb2hJtQu7Lkc56CtaUuY5MXT5C1CQJEUZzz271pQOcxleByDmqliQFUAgn35H4VbQ+W4bfgZwQe1dKPMnvYuuo8orz92oWRUR9uKes4bcARgd6a4Dn+6+MGrMFdGBeOSyhAcgEc964/UeCW3YdRjBrrdUJjfrke3PeuM1WT7PJLwGVhgE85rGbO6kjh/FE42TEcDHeqGmtut4ecDb82ah8XzFUdcgFyAO/41DA/k24GQGPb8KyqaG0FdEOrMXnQc7e/PBrlfF+p/2Zp7KmfNlGEOela+s3kducuwCj73NeVeINUbUtQaT/lknyoOwFGHpc87vYK9X2UNN2ZrZZs/NuPJNKc4wT/9enLgkYwD1pWAJwRg9q9VHkCBfmBAxgY5p/BOWbbgYxUfm4YE9+KekYY5IHHFOwDSykLnOPU1IeT8vT2pXRUUsudw9e1CozDKrx9aAMHyiZAB83Neo+E4QkY2rwMcV5rYpvuok4wWHevXfDPli1PAyQATnvXDXdqbPTy2ClV1Nlgoh3NhVXJP0rxbxVqDahq8833o1bav0r1TxlejT9BnbO6RxtWvFd/zNuwSeelYYWOjkzrzet8NJepp6FCZrkHA2x8/jXoen2/lW4RlAZuc1y/hS3UxIxUEn5sV3ForbhlQB2Bq8TOysaZTQVudm3ocZDAYznjmuxtIiJl29sD2FcXZSPHIuGwB1HrXc6NOk0SMDuwRu9jXHSlrY9DG038SLSywszwB18z0HNY7hPtLhThVPPpxW/a6XGl08wG4vz9PepTpUc85b7pJ5wMA0O7MKc6dPRMj0G3PmvMPu5BzXRq6oQR1PXHeqtvCkUYRF2gjnHepYs4O0nIParT5Uc9WXPK468kYW7CNdvGN1YaH5WVhlm6VsalcrHCwI3HGBjvVPR2hkm3GPk8Z9BWctXY3oe7BysamgW2OJVO3bkAGuvtA4baBkL39a5X+0BFLiEjOOSOw9K3tJ1MyzIjrggZOO9b03Fe6cmKU5e8bsSFlywAI5200Dc7buM9801b0K+GXGeRzUsI82UYAxjJx1NdN10PMaa1Y3e0YL9V2+lSb2l2spO3OMntViC3bbufuMY/CoL7IjZQrhevNHQi6bsZd6Q77GYk4xx0zXF60jFSrHHHBrfuJXa7TAP1JrF1tSSSpLADH0rLm5jrhHlPIfGJ26jaLngseB7VSur/byeg5z71N44mMOpQljnaCRXnfiTxDtBgt2xK33j1wKPZupJJGiqRpw5pFfxTrP2udreOQkDkkd65xkbYRtBAwaYpbeHU5PcmnPnbhc4xzXoQgoqyPLqVHUldj40y5UgYIzxSEAttyST09qanOWLkEDNPL7yMEAYwOKszGyq+4DHGcU9VdQxC8jFOBzGqgZweTTCzFWI4zwM+1MEOZmZfmPTrzT4ypBJ2g5qFGySAPmApxQcFwSaAMzTiy30JwGy3AxXqGhykIgXCnqcV5VC2yaEoWyDkgjivT/DpLRLgg5HPGc1w1leDPUyyVqpmfFG9P2e0gDHLku3vXnyks4C9+Oa6j4jTh9YSI9I4wABXNW0TNKjfwgjNFKNopGWPn7TESZ3nh6AKEAGMAcetddZKSpYHgjBz61y2jrlRnJJFdTbHaoHOBXNi9z38rVqaOistNDQqgK+a+CD6V1eiaabdCZHUn244ribS4k8wMckKMcHBrvtHn8y2jZmDnHfrmuana5ti3OMd9DdQImMc5GM1JGRlgBjnnPpUUBG3P8K9N3U0ryKmS4GCP4jWrPKs2WHdIn3EgAnoazbm/3u4i5YdcetUdQujLMrgHYuCQe9MVflMgBDNhtvas5SOunSSs2OFw8rAncQAQMmrli48ttpzg4HY1VRHAGUUjB4p8J8rzMBQc/wAXp61mro6HZqxeihLys75K7cjB5Fddo0DRCNpWBPbA5Ga57T3hbDSMOn3fUV0kGoRopYKoXtuHT0ralZanFipSa5UbIRplDYDKOCc4JrTsYvJRGY7s+vUVxLXczSbnkdQRwF6D3rV0a8mLfPIzKv8AeNdMZq551XDyUb3OuMgEbEHkdjVS4lHIcrnn8sVharrUiebHAmPlznqBWMmrTmcO20+vuKJ10tDOlg5yVzXvIlLRMgHrnHWud1hQcsRjIHHTn2rX0/UBchkcbHQH6GsrWZEcED7yjHI9+tQ5q10aqEoy5ZHhPxpgngsYru3BzG5Vj6A14iSSSzkndX1N4401dU0e7tpRnzUKjjOD2P518uz28kU8kEqlZYmKMPcV2YaSascmJi00xqSYTaAOM4zQx+QdAT2zTWyvtSu2VGcZHcV1HKPQEkBRgmghlPJyM5oUAlSDk4pS4XORkHrmgB642jLHAOSKYQWIUMMfypVJIwBtUUBec4APABqgBNq+px3FT+dkA7cfWiMKScjgDk03OOA2APakBhHIIdT3x9Pwr0DwrcAIjFsAjGQetcHGSq7iQTg4wfu+9bvha82Foz93OcdPyrkaurHTh58lRMg8c4PiBsElQoNY9rkXKHIPPet3xgmNSRyQQyCsBW+dW24wRz0oXQVd3qSfmegaM23JUZAx1rp7Zsg4ILdTXJaO4CIdwI7muotip6NgHt7Vy4lan0WXTvTsjWtUeTCrz6+9dl4dt2Mu13yqAFQPX3rj7GM4ICM3HAHau+8PW/2W1V2B3Ng5JriiveO7EytB6m0suwEDqB0PNZbXD3OXYhQpIGRkEClmvI97x7/m2k5UVSSaONdidG+Ykc8d6qUjjp07K7RMC0j5YfIeOvSr0b5ARs8cZ9azWlBlBDAR5B470PfGG4QQkcdc0XuiuVs2XkSGBlXG4CqChmmJIyp/GmW12l5J91l6jdjvVqFEGx8ttZsA0cysEYNPUtQqVVXKHaQT9K0bd5COSxbkgHpUlvJbrbYbuO3p9KcIVXBVywPPWmjOTvui1bTlgqjPpnsTWppoZXkGSQw4wMge9Z1nZSORtibHYg9zXU6LbGPYrAA/zNdFOJxV6iimYOpI4TH3d3U468VRS2BVgDgk5yOwrf1+FigVQcr6DpXPSrMmc/KevHGRWdRWb0NaEuaKsytEXhuTgjCndnNXOJ0HJ3Yqkitl88ueuBRHcSxKNgG5D24NYwaWhtVp8225Hq9qDbtuwHII6dK+a/ixop03xEt3Gp8q8XJx/eHX/Gvp6+k862LkDLHgjtXlvxT0j+0/DVw6rmeAGZMdeO35ZrsoT5ZJnl1qblFpnz9s+fBbGep603Zg845OOadEARwMnGcUg5B3D/61eoeXYcPlJGAe1N29iMH0NPwNu7BC/wAqfIBt6cnuRTQDY/uD0xQEQ9cjPPNKoUkLwKVF3feBOP0piFJQMF3DaeppzBAcEsD6bajABclhxjgnmpkdQi742ZsdeaRRgyoEjViPlfp/+un6dciC7VmPGcEEcYqHaQp6nBpGXeTjC8Z5rlKTsdB4mKyx20wBOOD9PWucI27tvP8AhWs8/wBo0loy481DyPaszapXdnHbbQVN8zudR4fmEkMa4+YcGu70t0aBSCN4PGRXlehzGG52ZyHHHPeu80q7yQpwDnqO1ZVoc0T08vr8jsdxoN/m4wy8E4ya7QXLPFgfMOxFed2MqRR5yM9eO9a1lqhjALZOeg9K8xy5XY9mrS9o7o0WklhuGCMWGe1SGci2Xd/rSecdlqk0rLmZyB8uQabNeiQFYwRgck1zynbY6qcHOxZle4lm3xKTtGQB3A71YDymEmRiM87fftVWxklZ1O/YGPzHp0rQg2qHMm5iQME1VOWg6ia0JrBXeZBli2Mk9AK6WKA/ZWZsOynggdKwbN0ZmypIxwa6O3uFhiHQhun5Vt6nFObTugt3XDAn5sVYjchhllIHaqxlNz8yqvT6Yp9vGQy7sjB5zTgiKkrnVeHLiRjtYqwHr2rpIsiXBx1x9K5vw7DsRmYMd3I4rpo4cDaVII7mu2lsePiLc7FmbzA0ZByemfpVS8sI54xvUZIH5VcJMUcjPuLY4DUxGVocOBye/Q8VT13MYycdUczc6WysCDkbuoqBLII5jl+YkZyfWusdY3RQh4yD61m3kUaSEoASP1NYyppanXDEya5Wc/qFuUhK4GOw6VyerwLJG6kBgylce1drfxtKpCkHJIFc7qFsApxgZ9anZlLVHyd4isP7M1u7tMfKj/IPUHkVm4xkZ9q9E+MelvbatbXoTHnDy2PTkcivPpIyuxmYdTxXq0pc0UzyasOWbQxQSwXBIIqTO1u3NN3szg7TgcHBpcbifpnp0rS5mSK42KpUAA5yB1p3HzEDAPX6VAwO0BmJ7j2qZOA287t3p1poABdhwBwAOlSoWVQM9PSmOhCBiRwccHmnphRg0Ac2R8jFSMD1600KZGGCqjrzSSIQSy/cA/KmcsuB0HrXIMkVtpVs43HBpuRkAHgd6B3pTu2Zx8tAx65SUMcKeCCDXVaJfJICc1yRyGCkY4zx6VZ026Frdq3JiJ5Bp+RpTm4Suj1XT51mjGG9q2LLZ5ylyMdq4bTL0Y7BSf4TXTWl1+73ZJBHFedXotM+mwtdVInR391G8BjUjcp7dKpwFt24nOaprIWxx0q8jmOMnqp4JxXDKJ6tJ8kTUtX2EhmDgjNaFk4YYdsLyc4zj0rHsMPGWk3HPcGrcDGMH587udo7VMNGZVZXujftgo4TgdDmtlGHkptA4GOa5/SgXOTxgZrdspFIGOAGxmutHlzb2LenKBcD5gqngjqK0ZnUzbI+o5znjiqiR75jtbB25woqzHbyxyDK5J5xTIbTdzo9EvN0YDn5ycYArafUhCR5pbgcYrF0uPZApUfvAfmJovoJJXDr2OPr9K6IyaOKUITmXm1kTK42AbRxuNSQXAuUYSZxkEbeazxbvcAERFSw6jpxWva2wtIlJGCw/Kqjd7kVFCK93cmVEgCZyRzjPFZt75v3mVkU461ZSYy43E7MnpTL8AoEBJZR1NEttDON09TJklQgjO09vQ1i6vxwjLg8Zxxir9/uVmwRkEgECsbUJWljx0I9KxfY66UVe55l8WLEah4TuJ1QtLA4fjsB/wDWrwliGVVJJyK+m9dtBPpl1buQA6bSPwr5quVSI+UYTG8W6NiDneQetd+Fd42ODHQtO6IozjPHXt6VICd3TOD61GDx6Ad8dadyrYH4ius4h8oDyZRePY0m4FsDhRx9aaWyo2j2zRgo2ScBeemeaLgTl2bB4IBxgCpVRXyTxz2FQD7mQfmPUYpEfYMAfnRewHPcsOMHnkUgXhj2NO25IzgHOfrSBWaNio4zjOa5igYrsPy85GGz0HfircdiZ7YSWxBY/eX0+lVhECFVcFzwfatHSM2t3slZo9xwMjigcbX1M1lKcSJtIPSoz82FA4HtXfXOkJe2w4XIGQ69a5i/0O6tsthmQc5pXRrKhOOttBmj33kSGKUkKeldro92TtXIIHr2rzhQcZI5HTnke9bGlar5JVHb5R0b/GlKKmrM0w+IdKSZ6bG5PU4xzntWhDMVibHKn7uea89m8SrDFsiHmOx2j0rZ0m/mmU+axPYLjA/CuCphXa579PMac/cR3lq8TIqbgrMPmIrRsrdQWDctngZ6Vy9hKQiq/BHbrmte1uW84AuQD6CuLkszpltodBp1wsczfKcY5xW3bmJuYTksQRjj8a40S4yFG5hwW6VoWly0ceVfJJAA71tDc5ZRvqjvIDt5HzE9WHXFbFtI0m07No7tXHabcNIACx56juK6nT5M8E+4B7VotzlqRsbtmnz4z8y/1rVURSqVOMDr6/hWFp7hjnfyf559a0WikecMsnyZzW9M5JrXc2Ygq2xUfdC8VBLMs0SgjCD5T+VNtpB5W3BLDqfQVTkmRAypgHd8uTW1zGMLst4jWNSEGOeR1Aqo8oklKsf4QfQ1nSXjhgBJgjrjvVFLuQ3K7myTxlqynNI6YYd7kuqowDGP+Hg5rmZi3HXJP5AV0k92rbxIQPm4rGvYwrKUBwfXsKy0ep0U1ZWZg6jjYd3JPJ7V81+LIDbeItRiTkCViOPXmvpbUY2IZSMjvnivnv4jx+V4rvDtxuVXP5V2Ybc4savducyjEcEdTUsnIUdAowSB1qMFdoVOpHPtQ4+RT05ycd67jzBBtxgk8ipMBum5QB0qNlAVcAZx171YbfHuXI3D260xDAxVBkctyrDqKQbQPuEn1zTuG+8cA1JEyKgGzPvmlYZz0SqV5IAzjnqKJGIJVSCozyvekjU5LdumBS+UjMFMwCjjcOmK5ihICEuY8seSCeOldbHax3cOUG5sYyR0965GDYs6k84z3rsdGuFReVGzqDTWzNqEVKVmPsJJrN1jdm2jgnqa3bi+WfTJEaIElCAWHSo3jhn24XJAzkcU9LLejj8ivWsJSi3d7nr0qU4JxWqPL7lfLuJA68ZIHamPllG0rx1x2ra8T6a0F8WJwCOSaw8rjAyTmtr3PEnBwk4sMldp5A613uiXC+VGc8DvXn7Nuxk8it7w/dkAxufu8/Wk1dWNcPV9nO56Xbzoyrtf2xWxDIEtMjBYjp/KuP02cNsOVGOtbkFygIPUYxXm1admfRwqc0U0a9tfBYX3DDn7ua0dLjedRI5I5wCelYdlGJGDdWrs9LgItw/JAAwB0FZLcKk1HY2tKh+zxgOS5PTPpXT2TYAGe2CDXNWs7b2QZAxwTzXSaex+VjkA9R1rRNHLO7V2bNpEihSTwP4Rzk1oNKOAMDGM+9Z0WfLAUYbPXqKe9sQS27afTqD9a1i+xz8t3qWH1AxI4TCEggE/Ss+5ufNTZHzuOWY1XJcs/mAiPoMc0rxr5aiPqevPFJzb0OiNOMSo8mJSGXAAzT95CBsjPUU7yz5qgqeOWIPFNvN0cQLDDFfl9Kyt1OjTRFKWYS5CIw2kjPqasRTmYKkgBwPzqm8hCfKfm9u9Lbn94gI29sCnDQiqrqxX1UMF3sDtY8jtXz58XAV8QoVAG6DkfQmvo3WxttMkHj07V88/F0B9Ws2yMGMg/nXZh3755+Jjejc4JCXIQBRnvShsOxBHpUarndt4+lCL8pLAn616KPIJlTLDaDViRRtZ1bOOnqapqxzz1PHFSqCSwX5R35piF4ZPmHf73XNSRBiuVBAp67WGW4A9BSKC6gj+dKQzn3YnJIGPrTCRnKrj+VOA+cqMIBjOT/WoySXO44zzz3rnGNLAtnbyO1dHojK8K5yCD25rmy2GwRj1HStXQpwkpjYhd3INCLpuzO70psNh8nHQVu2iLk9hjODWHZlWSMxFenNa9sWVtpOfcfpXJXR9Lg3eKM7xppbXOmmREA8sZJrygoU3ZJ3LXt+qo66JdZII2HrXiUr/ADuR0yeKvDybjbseXmsIxqJrqRgkE8c47VPZs6TB1UnHYVAMkHsDjpUxYfNgY4xW6PLudnpt0BGrDkYyK3LCVnHzDcK5LRYyYI9u4kD5s+tdfpqBEUDnjk1jXSsexgpSe50ekqzyByBgcV2tlHNPAgt5jEB8rEDO6uJs5jEjEkFccY9a6HStZeNlBACH35rzW0nqep7Gc9Yna2kSxld+GJ6lRzW1ACuXzgdx7fSuf029SVVAxn1zWtJIQoC4zjkVV76mPs2nZm1bXyR7SB8wz0q7b6kH2Djng8VySyllyCD6+uavWsjhyvpxk+tONRocsPG1zZkZWZgqfLimRyIVB459B2qhJcMoOw4K96LeUSxsJO/fGMUe0bBU9Daihgd0y3zYycGs/V4AACx/Ae9MMhjCYkBY84FU725Zs7zuKj9avnTViIwkpXTKcxCqSqcjj0NNgkMciP1HXr0qFmEjtuzw30qMMTgcbTx7gUkW10ZPqNyJYJQSc4Jx7V8/fFVt15ZKAB8jHn617vI+9Wyo6c++K8J+KgLa1bqTtHlHj8a6MLd1LnLjbRoOPocOCAMEAD2oY/L65OQKQId2GBx6GpChABc44yMdq9S54I1Rty3BpdvJcn5e57Go48uPmwMmgOFcEfMB1yaLiLC/dymSuPzpmDgZBJx1FERY/MoOGPTpirC2pYZIVj67hSGc3I5IYYySeT2NRyEYUhMHvzUzBS7EtgYz9aCisIwATxyAMVzjImZllBCq3HpkUkcmxt4XGD2pTGQzAnBz0prIEPBGO3vQB12iXrskR+bjn612Wk3m8ZcgsTjGOa4DR8iJCSSccewrqdOZgVDc4Gc9KirFOJ6mBqyTSN7xDdKmhXO484wcGvF3IbB6Nk5r0zxddqujuoOSc8ZrzIvkBcD1PvUUY2iRmU+aol2AElTgDJPWngMq54weMUhA2lhg5pFbgZOCK2POOv8ADCfIobBH1rrbVCsrfwn9K5HQ3X7LER/rF4z0zXZxjbbowAzXPiND3cvXNCxfQnCKABu4JHetnTrciSN3+ZQen9axIJEK5J+YHNaVlLINpLHLHj0xXlzPdhFpWR2unSx+dtRcqR37VumRWMYYjBGeK5yxjdArscAjAIrTiutrbCm3pnPpRFsxlFN3RpRscYbAwfStCF1AUq2R15HNU7VFdTwCnXFWVTyiCBx271aWpjLV2LT7TGWbrjHIqqZiYyiHqcYP+NOMjlG3ZyRwT0qOOKMDJbBPbtVJXM78u4+3YqpU/Mx9amuVHynIHrUMYVCBu68k9ae7YiAHJPfrzT20DWWpUMYDEHJHakWJSfm4U9AaVmYkEELzt5pskp2hRwenHSriYzv0M+5lHmBAf4ufQivAvilMZvFrojYSOMBQPevdLtTsySoY5OfavAfHNylz4rvSpJVCEGBnoMV14X4mceP0p+pze2STc2c/3iTSPjhUI45xnpSxCRZnBQ5Gfl9KYsRYktgZ79K7rnjiMWZshxwenSpYo2Eqq6BR1YnoRQgGORu56jjFK2cAkMAp+9TEPeRtrDdxnggVJEqtGC7hT71XZucBcKeSae21uQhII7mhsaMN0LPz6dvWhGkUhsHGeD/Sppndo/vBefu+9QAlGUAg44zWLAJAuQUPP1ppDMMsM47+lLxuzjcKkd0J+UMgHG0dqQGzoU2BsY5wfTtXWW/y9iEIwK4jS2KuwIJRiOa6e1uHDfeyMd+pokro7MLPlldi+MH8vTgoUEgda4Nz0PA7V1ni6TdbhTIGzjp/KuR/hOTxnFKKsrEYufPVbFyyZ7+poAyAM854poGB7ZqRB8pPccmmcx1egKPLjyoz3zXZQoTCoGT6tnp6VxXh199uPky2cGu5spP9HVcAZ6/SubE3sj3stinEfExUlARz0q9A5yAMqvHSqyqB0HPrir1uocBQPm9q8+aPcpytudXpkjRwqzyBhjgZzgZrRWYyM4QDLEEH+7XMWsciRBTG+AOcGtWxyZgfmOenbisE2nYpxW51OkzEwBpGxjv61ozF9uVySD2NZNiitGuwgsDz61pIfKUjILDn3zWyOSVua6BGbI3EgdM1NFscfLkkng56ConlMgBVRxxnpRGxC7X4z6dQKadiJR5i7bplxgHPXPtT2gVsBcggZNOtT+9QHkY60s/3zgcDqM81Ri7p2RmXPGScYUjk8VTuCFYMD9cHoK0LuJmY7cN2rNvAsAXz8EHt3xQpWLSTMjVJykcjFvkCnGK+cb6ZrrUbqbOzdIWYnvzXvvie/jSzuJohtIjY49OK+dkdmV/m+V/brzXo4NaNnk5nJ+7Elkn23HmBTucFWHPpUYcqwLjccd6bJJIQpJb5RgD0pm/B2njAP412XPJRKkpRwpUEFsipt67mUozZOQAev1qtGHEYAI+Y/nTi5kMe0AAnGfei4EwfC7CVPGOODn/GnPEBjIY8djUKE/MUbD52jPTPrUkc80QwOO/HFIZjzAtknOAeeOlQKjGTbgjP6VNcKI2w5Kg8gjp9Kh+YbcYBxms2AjMNxYMfTnrQW5yvGRyDzQcDoD7004C4bGfakBs6PIkkbRkgMDwa3bePYMFiR6+9czouPtLDrnp65rrkRhHnaDgYJHpVdDooK5z/AIoKmePgBWGePWsJug75/nWz4lUrKjjp06Vi4+XcAQP61JlU+JjijKSo4YdRilU5wCpOaSNtvJzj2oTGTjk9gRQQdF4dkGSg4A5613djhkUL6c15xoUxjuihwAwBr0TTJw4GDgVz4n4bnuZS73RqwnD7SOtXbXAkDg4waht4xOcj5Rj86miDAY4bb2rz9z2r6naWdvHcQbo33EAcDtVqCyj8wGcFSvGBxmsjw/L5UylGBV1wQe1dNNJDI4Vh8pHftTcL6nK5uErdBI440DFHwz8j0qVIWd8As2Ocn19qnWCBkj79xmptqIcL2pqJLq9iAZRSsmcjgCpQ6rGgfq3AyOTTWIkkCAnJHGehokGCQT2+6aUkOLu9SzYSKc5yGHar5G5SGBzjOKzoAsWXlO0EZxTLi+EfRSMjP1pRYSjd6ElwxVTj8a5vUpCIw2dzBsbT2H1q7dXTeWwU45+vNYFwf3RTk/N1PTHerihrQ43x5dtH4evB5gXeuwHOOprx+MFYyA2fbtXonxVmEEMVrnJMgcg9gBXnDHBGDwT06V6OFVoX7niZnPmq2XRBvJOCoZvrTYnOeOD346/WnMclpB0B7dP/ANdQlskeX1NdJ5xZDl2cp949AOMA0jSLG2xDgjBB75qONGIOBuwBkg96lWM7juycc5pALMu4xsARjrjrmrEpPmMVwAeetRSBSxKnqRgZ6/WpGjQHBUk99p4qgMa5BMuCeCeFzyBUZ2q3Az6ZpX+fa3XsOetCkYbcFwRhc9R9KxYCKu4Mey8kdKTaBxjmgOMdRk9atWVs1x/Ceeho3C1yfRI2M5fkD1FdnpkW6QB+QeRisLTbdrQhHGASQeK6bTTyAOg6c9KJ3UTvwcPe1M7xfpjSWO9FwE61wJxt5PTtXsd/aefZyQlmIAz65ryTU7c293JGwA5yPpWdKXNEeYUVCfMupVJyAO1OAIzg4x196MFjnHJ6AUnOMHp34rQ88tWUnl3cbE55x0r0PRZRIoUDkCvM84Ykc9xiu08PX+5EZeMDBqJx5otHfl9X2dRHeWk5jB/veh6VfSYZDADrzk8Csi3cSdDwRkVegYkEk4HofWvMaaZ9VaL1N7R5JBdgHb5eenpXZkqsJbZweRXGaNcxLONwIz3rrwomgXyz8p43A04M48QveWgh1UKsWBzn7o5q0Jt+5s988CsVIGiLbcHHOa17KFsjLAt1AHelcqVOK1RbiYl29OACORVqNGiTdLglumOcCls7fYCztk9sGm3TFmXYeTx+FIyb1sRu4ZgSvflu2KqOjyliuQqj1qdBIxw3AB9KnaMAFjyfbrmmlYmU7GM6iEPkZ757H61i3kgSIMRhefoa2rskuVXLOM8CuY1iZnzGqbdpwP6029C473Z5F8SZ5LjVIPUgkZGec1x5O/d8xOO3euu+I0TpqMRThAh69+e1cqsmQnzDcO4XGK9Sh8CPnsbrWkQkDySf4R6dc0salVzwSRwAe/vSPtYOBzx8vqDSxIvmqfTB68VocxNkquVVhGSAR71LBhH384A5GaCyq54VsHPIpiuGZjt2q3TjNUkSWDIMoBHjJ6L3p8jspAZQDjpUG4EBgduBjHrT1kByXwTnuKYzIkKbiUG1QOBmomJ2qRj0p/zFgODg8DvTGOWG0Yxzx61iIWPDEAZDE8DtXWaVbbIlGMH1rB0mKOa6G4Hjn6V2lhH8xDZx6dqeyOnDw5pEsVkSPmG4tyCKvW1iYpeWyvWr9vCCiMgyBxirSQSCTcefwrknVZ9DQwsbaogjLom3j6GvPfF9oI7jzkGD3HrXq0aA4WRdw6ZrkviFpQW1M8PG3qKVCoua3cjMcPelddDy/vkLz7mlJz948dqUsA5C8JnPNDIdpIKhSa6z5kZ8oOeg9q1dDuvLn8tTkZyDWYo3DH8IqW2LRyoyHbg5yKEOLs7o9M0m6byir4Bx0xW3AzMigEYzXLaFNuXDEEsM811enbWyuBxxiuGvGzPqcHWcoJsu2zHgZO4cV2/h6fMIRiCvHQ9K4xEjhIBwwPPvXS6Y0LxKyOAp7ZxiuJuzOyq4ygdakMEo+YbgRU0ACyAKvA4561iQ3sIkjRZMoPvZHAq3JdeXKCHU9wfaq5kznjCWxsSjKMFPOOnvUCZUZfkqcY71QW4YTNnd04J6VqQL50AGRvYdKNWDjyrUgBZX3bSxPPXpQZmYASKFXOR3NTR2rl1DDAH40SoIuTgtjdg9zVK+5nNxWiMy/wARRueCzcgniuYuYzIxYhQAOg7mul1RXuGCHIGOPTNc7IHUOV5jB2ge3em3YIq6ueP/ABQDtLbzKvCsQDjpXCqysfmBB+vGfWvTviTDGdIlK9EcMPUc15ZwMBQef1r0sO7wSPDzGPLXfmS7sZI+UdDUu9nbIHGPToPSo4yN2SAcdiOKlRWYcfeP8Pt610HCSiMoSGzhuhzzT4pN0rtgFumOw+lRNt8sBfvYwQT05pE3Km0cc9e9NMCRJAofKZB6ZNW4QJk3+YigngEZxULDMexzGCRuBzzmohIoADFiRxxQBlIm1dxIyO3ehAFbg498dKGLKVbbgHnrSHDEEsWPU8dKyA2dAjJkZgmQe/rXa6bDvYEcNnkVzvh2KPyY/mxzz+Ndbp5HmHvjgfSlUdonp4CPvGvbQsvKjk9u1acULSZyCCajs540YLgHGMj2rotOWOaTC4UHseteXOWp9H8Mb2KUFqThckADrVbxBo8d1pssZznGR35rpY7V4twwGBzVO4dYW/fMVVhzjpSjdaoyl+80PmXVLZrXUJYnyMHjNVSeNrHv0Fdr8TrSKDVvtEHIkPGR1rhweoxmvVi7pM+UxFP2VRwJwqq6gkZ6kk/pRGSWwuAwzzTQuQH5PPUevpUij5BlxtPOO+aZkdb4fnWSJHHy9ue9drpx+6TkA4ry3Rbzy5+R8h6exr0TRboyRIcjrxWGIjdXPXy+rf3TrGtVniVl+9jAqKFXTKHIGelWLJyozk8jIx0xSTArOcjDk5GK85xuexTm1oX7S58uMqwG0HnNbFkBKV4+X1ByGrnrXDSAHcR3x3rpbAL8qg7ADjApRjqOdTlNmKLcnyuOBwKv6anlSnzCOeOKoWzqwIjXDDj61dhYLg7ec881S0OZyctDZlxsLDgdfrWXPt8zcME5z7GlmuvlYnAGM/hisWW7ZiAN5YjP0ocx06LY/UbgRxyY4cnA7iuavGZbSRiCBkDjv61qXLGYEBi0g4wPWqtww8pFZQAV/wAmocrvQ35eSNjy/wCIikaFOQOGYAfTNeWoNp5J44HbFeofEu4X+xHVQQDIoGfY15ftBCnr83rzXq4X4DwMz/jfIekaszBc8Dn2pwAVTgkZpMiLJYKc+nehZTvZiBjpjH8q6TziREBHAOSeoOaPmDlXyNh5B44qPeSG4yc9uPwpd5IySdzHlt3BNAE2196kAFGwQSAOKe4QscAccURyBdoY4D8HABNKphiyrgk5zw2KAMovh8uMkjGOhFNC7mVVXk9eKkjgYlTyB781omKCGYNG/wArAtzwalIDb0OHEUfbjHTmustY1VFIOO5FYGhfvolLMFGeCTyK623jRyNxyR39axxGiPcyxJrUktVKkNu28ZNa+l3LRSly3zVnrbsDtJznv6VajDBgCvHqK82pZn0dOOljqLXVATjcCQOff2rM1i4WYjZ8xznPpVIsEyue2eBzSFSVBzkNUKTtYXsIp8yOD+ItsX09ZRggV5gc54PGO1e2+KLQ3GkTqQCFGRx0rxeeMxSyIPujpmvSw8uaB8vnFLkrcy6jrbapw7YQkjPpRDD5zEKQMetQfzz6VJHMY2Y7Qdwwf/rVueSPVQoypU4bt/Ou08OXfyKCxB71xcYBUnJAByTXQaJOHKMOvQ560NXTRvh58k0z1SwuSyqCQ2VI44q47P1Kkjtx2rnNImJK8k4OciuohlZY1GA2ePpXlyVnY+mhsmiSykQMjDO4nnNa1ncfvd/qd3uDWfAcsGK4I7VrxQxkKVAII6+9TFak1nbdGravkbR1I7d607ZAqLgkjpyeaxtP3KxUHLDpWnbuzFg3ykGnKOphGRNdhUQZPBH41RmkAb5kBUZOAMGrczjAKjJU/wAXaqM/zFhv25G4/nWckdlJ9yYi3VS0KqXPOe+a57WMRQFiTydpxW7bQgJvGDisDxM2LUgDq+c0rWQo/HY8g+JtxvjhgQ8eZnAriI1CxkvkMB8vpXS+PrgNq6xDkxpzz0zXLx7W2iRjtHavYoRtTR85j5c1eRLEW+ztvQMGHy56igorRhhtBA4AqMknHBIU8H2p7RuY/MIAXHTua2OMFPkschWA53Zp0371m8sYUkHOe/tUalpM4GemT6VL5TBhtI5yNwNKwEQfru3A9uOasQxxeWPMJJ9R6VCgDAhwdq9cnrTkimcZXYR/tGgBIy1u21jjdz0zmp5FeQDaF2gYyw5OaoDb0OcA5zVxJ1aEqMj0I7UIR0eiMRaoTxg7c4711mmzdmOCOhzxXGaEQUTzGO3r8x5rprLaqgKRgn1qaseaJ6eBquEkdPatux0xjip8MOUPzdOazLZgfmLceuKstOWIHJ5zXlVIan1VKfNqWIWOSOp9+1XI1KKu481Qjk2SdevJGKsi4Xpn5e3uaxaN5PsVNUHnRyhwxG2vEtdhEV/IAe5JB7V7ZduHBUcjpzXjni2Ff7WlI79BXdhNmj57OleMWYakE8+vWlBG/djPtS7QpBbBA5OKQEl89M+ldh86KWOCqjHrWpoEuJmQ9uetZuOq7eT0xU+mLtuYzkD1yaaKi7M9L8PuXUjdXa2M4VUDYJIxyK880SZVIYtjniu0gmVljZWXI9O1ebiE4yuj6fCNSgkzoI4FYZR85PQ1YheWLAAJAPIbt9KpabOSyqRnJ5JPH4Vrho1VmYqDnPJ5rKLuzarpoyxBNjqQMcj3rRiYZG1sA9c965n7XGsmSQXPGc1cF1uVAvy444PWq5k0c7pO5rzzowVVYgc8DnNUpH+cjccdGPY1WiDNOGXnPYelSfMJnMgGMVlJnXTjyliK4EUD8kY9OlYmsXO+22AEr146VZkQzyOqnavcnpmszVWW1txADu3Lyc9Kzu27FyhFa9Tw/wAYSl/EtyVIDcLjGaydn7s7+GzyM9BVrWJVn1u+kVjjzGwevGaou+8bc7i3JJr3oaRR8dWlzVJPzLMiKG+QAoRxtOeaQKAiqrbiR69KZFwMBjuPHTipF4UjCEkc4HFUQKqKOQVbJPHenoF4LHao5VTwc9qijRC43ZFSOigZJzwO/T2piHJG8hIHP8RA74p8UKhPmYqfQ1HGoUu7AgH7p7irMNzEV5Y5z3Wi1wMkruYdqsQKGmVemRnjtxRRQJHR6TGBEAeVGBg10NogKtyc47UUUpbHbhjXtlJcDcelXIUyzc4AOOKKK86p1Pp8NpYnBALYHIB59aqFuOcnHNFFYxWp1SbSKlxMywMykg4Jry3WsS3dxI3YgAZooruw60Z85nEneKM3YvGBjI5pSATwMY6UUV0HigydTnBC54q5o8Cz3ID9QpOaKKBx3R2+lWibd2TkV0CR+WFKscnvRRXn1m+Y+ow6SirGpZ71IxIcEgYrSeM7EO885PuKKK51udctyFLUFgS7ZHNadtCDhNzZz1B6UUU4pXCTZqwQKWVSzEHj9M1FccS7RnvznmiipmkFPcq37GJFKHtXNX9yU0u9kYb2jQupPXpRRUwS50Os2qTZ4lCvnPJIxIYnPFMdQHUjjFFFe4fFIdKmGYgkd8UisV+g7UUUNi6iI+85CgEn8qtRqGZyQMBQefyooppgKkYUQvz87FSKeNiZAQEZ70UUMGf/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright 2007 from Case Studies in Immunology by Geha &amp; Rosen. Reproduced by permission of Garland Science/Taylor &amp; Francis LLC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10512=[""].join("\n");
var outline_f10_17_10512=null;
var title_f10_17_10513="Rubella rash";
var content_f10_17_10513=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F61263&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F61263&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rubella rash on a child's back",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 272px; height: 396px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGMARADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDzwKA+CTt71ZjAAyMg0wR55zwaljX5gBj6k16MV3PEY+MM2DkYz61OzhF5I45NMO2NdzkDbk/WsqSd7qXYpwg70pz5Ua0qTqOxcuLxif3OQOhanRK42ln3ZHQd6jiCoMEZz0zUyI/AQHnvXHOo5bnqUqEYbIQRq0m5mPXpW5ZQLIQy9SBxmqcNuIwoIDBsgn0rb0622/dVSq81nc6VGxZtbUmPcUyw659K17OJUjVYlwCO/TNKkDSYVZGUHngdauafbMowwY5OR3xUtjSVi3Fp6i3cKrB25znpWjBDIihTl0GMgDk0kMW6NRyGboxrZEI2IECEqOhP6ipSuDlYVE3qu0Lnrhh3psiMBjc2TgHA71bXjA4GTnNTFApLsxZz/Fj+lXYz5rFBIQTk7iP7mOBUb27tGMsM5zyK0hGAzb1zjng1IIm5JUAbclTU8o+azM6K2LDY25z1Yn19qeE2hQODgEk96turZUlsDt70kiHyg5wB1AIpWsVdyKzAK4QHhunGcGmxiZoWEkYDf7BzTks5WmDwsMueRmtCCz2KWOWOPXr70kmym1EyTbO0MiwsTIRk5OdtV4fPE4jaNs4+YgdR61ufZmDSbmC5XkZ605kZNp2YwMZzwBUuBoqhlS2iONjLvcjOfasbUtChlUFo2DA5+U9R6V1hQhACoQDnryfenPaCQ5BG7ocUOI4VHFnnNx4fCSZADoTgOzYI9q4/xP4SW4R1mjZRn5So5H0PpXsV5aqka5hMm0nGBVWW0jnhyykEnGPQ1FjX2ml3sfMEnhzUNL1ZTKM2wyVk689s+lakSMBvZ2Y4x14r27UtDiuo3URhl3EEbcZPvXDax4SlRS9njrgx9vwNap9znmuxxhO3c+TXPalNvdjuboQcV02oW09mSlzE8eRwzDj865C/lyWKKVBPJHamRYxNQLEKxY/nzWJdK8jfL1FdDMoeMggH0J7VmWkH2i6SPOM9TVQdiauxe0vS43st04beenJGP8atDTER43idw8Y+UgDJOeCfWtBIRFEqIOFGAPalxhxn1rqSsjy5zle51qAlunfpUwUJHvbjHOcdKSFQCcdc4+grP1K4ypjRy2eMZrpb5UcsIc7sV7qd55SEI2H8/wAKmt08mPIbcwOaZbQ4JYnoO44q3Gu7JK4wOK4qkrnrUoKK0JYFGN5/DNaNnGzhn49sU2yh2J+8UY9D2rRtIXAAzgt0BHasrnVGNtR1lCGK7stjGP6mt21GJIwAV3Dt9aoWsBKlIlYEjBHdq1rW0YMuUYMMAYPH0qWy7Js0YVlUiTIwRyCOa1bJJnlwXzsHKj0+tVoEwqhgd5+6MdfWr628pl2xPtYDPTgemaQrGpuBVVVyWPG5QBx3BqxHmJQ2zOMAj1HrSWNszFN4Az2A7/WtCaP90gxHuyBhh972qknuYyfQSziL5YuQRyNoz+dWJCikMX2yHgKRQgkQMApEpUjA4GfSp1VXTY8eJcfN7VQrdxrReXjzNqkc/T3NQvvkGbcMSucN2NTfZpZ7ZhIThcA/3sVYggSGBIlVsdjnv71LLVl6lQxs6kEglSAR6mlntw1m6lC4b5c5/wA8VaFr5zYi4PfjpUkUTbVViyoOOaW41psyDTbVLe3UTNz656f41adBG5JYMv8ACcfzp21I4/LBB5470yOHytzySeZGf4R1FPYm7luN8tXUvkADkmqsuWuI8FHQDOeoP1rUiByziPMWN3yipI4IsFtiqCPlBHb3pO7LTSMsK0joEXBXI+tISTOY9uHHGMdR7VoXSfZoiSSSeMhe1JDbkxFlXk8EjuKT3KVrGa8GEEiB2zkcjPNQTRJLHlCORySMYrfk5jKx43Z4zwM9xWcbeNlcSAspYHA9KSQSeljIa0cowYAjGTVFtMQLkhWDZHTGPpW/Im07eT83LDoB6ConVWjyAcADIPT6U7EXOK1Tw/HPC0ciLKGbGCuQK4HxF8NrK4kZ7f8A0fIOWHKk/SvZp4XQHaPlBwOc1RuLWN9wbOOgBPH4Uir9z5X8Q+C9V05nEUf2mLGdyc4HuKx9HsSk0nG0ucEEfdx1r6ivNOjIYDCsM8MOv4964HxD4XhlJlVBFMecoMA/WrpyUZXZFWDnBqO55hKqAsqkjC4571SP3x610Wp2E9oHjuIy3P3l4BFYt4sgZRIQR1Uiuy6aujyZRlH3ZI6aVxHG7Hr2IrFjHmT72HzkZq7qDq8ojDHOcnFRRKquGAwwOMilUnrY2w9O0eYu2vVsjDH8qtQRGWU7ANoODk4qCJcjnnByB/WtnTrcbQ+Pn9qwOyJcggVTkjgKM/571oJbb3jSNyCO3cimQyEOkbqh4yB1wK0rba6IwwE9ScVDNVew+2iYMOMKv3SP61dtbeSdhGhKAtlsnt9abbrujPUqTk8c1rKSkJXGXGMVD1Liy3YwFELgZwvV+1aFtF5mGxuJIyR3x61Faq/2ZSSDIRg/T1q7BbgIEyQSMZFCREmW4ykMTY+Yk/KAc5qQx3Ek6F1GO4H8P1plrbBXxkqp5UDtV7YfLZgWKqOoq0r7k3S2LljGJFVsFeevuKmKd48F8nD/ANKq2xmVgd5EeOBjP/6qvwosjIisvBIX0+tMzs7kNskkgm2IVII+brmpHjkJB3AjoFx1/CrLsIIslyrnoemfpTLdJmiZ3QKXI+XOKltbFxTa5iOKKZY1k27X9uhzVlFLY8zdkfxY449qmA2/xYAGeOAPao2k8yFWjwSMjGe9K47XEaJUIAHmHGSQOlN+yEFkZid3U46CjTmbLGQMki8EN/OtB0KoWDfJgDj2ouDXKynFFGiooOxR1yamZdwUgDcBgEimSr+7Zo1znkAjvTrB2nhZTw6nrSvqXbTmHuvmou5T2P0oWPY52YLEZC9KsqqpF1yuO4qLycvxwCcnmmSmirJFw3J5OSD1FRvCylduPLAzyM4+lXp0WRcLnPt/KoZdyKW2kADGPSgd7oypdiyNhSMgHJ6A1AFOxyxGfQCrN22chw2V+8VHTNRuxU4ZsY5z1z9KpEu9jPnIEm0L9R3aqU8SKpIUtkZOf4fpWhMVjlYqB5Z565496oyuMnymUjP0wah6FpXRlXdvgSMQGQgYK9eK5/WLF52EkKlCpDENXXlgQ/XBHP8Asn2rLcSSlxjAQ8k96TQ4t7o841TSy6SG42NCeQe4/wDrV59remNbXGNyiJ+RXtWqRI28gZB4IFeeeM7NwRtGec4I5FVGbhsKVKNbSRxCv85JPzE8mrUUJJGF68Z9KqKw35z0bFaNvsZcg5YnHPQVrzXMHGyL1nGDIVQDIOcmt63zvYADIHGO5rM0nH2jkAkcZxxXR2JQoxaIHBAEnr9KTZaQwQSLJ5sYAA4Y44+lWN0ruqqoEagFvx9Kdu8m1w0Z3DLbR059fepYJWMiRqQ2V5JXpWUtTeDtrYvxSPFCiNtDHkEjp7VpaUd90iyHLAZAzxis5EJkaOQ7TweTyR6n2rdsoIo5POTacgLkngikLzNeJQ0yYG7qR9P8a0LdhvMJU7iOX9ff8KqW3HzJ+7+XcSBnNWkmaBArKGUqT6mqRk9SaPK/KANyjIJ6mtOBwYI1cnGMg44JrOgKKyNIwDY+VD2FWbpvJCnBw/Az0474qr21BR5tC0xlmmVE+4R2PHvzU8Plx4WNn/dt8u6o7BJI7QSl+CMfLyAf8aVQN6rGy7VGXbpzRHVXFN8rsi+IWmjJd1LqT7j6Cn20bpCWdv3pPAJzinWZL4jIwuOqj/PNSSbFZTndg/dBqXuV0sQ3LiKIGTLBzt3Y6e9SwwruaRP4j93t9cVI0YljJJyo5GaNu92bovXk/pSF6Dxg5JzxjGMZqO4YR/PMucH5eePrTywyWXG1gO3BNMciVWBIx0ximC31FWUTRggbM9/apYAYmOB8pPJx+tMG2IHOMAZpLecyM5ChoycqR0oKtpoWZGBVkXn1X2piMARlh6E+1OjiKDqD6ZqPejPiPr3oJS7CO5EjKoxnnOKhk82VJcoQcYwDUTs6XQ3ZOR2qaSZi+1WKcg5PTFCdy3GxkNIxTa5PmHjJPQUxlD5ERHygZwOv0qxcIrTFSuRjBbOD1yPrVe8K20RwX2JglwcbvrSuNrsinMN6bScdc8c1n+WCdoU9wPetDzUckIRnqM/0qrMrkAZ3MozjPSk7DWmhTuWKuEjIZx196rTMPKKycPydual83EpZyF2jOe49qoXuA4dBtJPUnJAPb6UK4rLoZF9+5V2jXljyK5K9CXMczMPmZsYPauxvFLKxjGGz1YZya5W+RInkDbIwxBy3Rmpory6nlUy7bsrtG0nOc8VftUDSDdyOwqC+QfbctyMEAVc0+ItIhT8T6VqtDm3sb2mReXIMgfMcc+nvW8sB8pCgXYGywVuSe1ZtjESVU7duOgPX8f6VrxNGiPCw+Yj5gOSB/jSlsaR3EvMysqphTnkg84qSAEkHaRtU8jgGobmTbbNtkAA/iAyQKv2hwke1sgpwRzurJmq2NG3t0hiZ5D5kjL8xznA7CtbTPKkijCZVcZ2kYOR2NZsTCQRrGwGcYHYfWtOz8tCwk4k+8WY0PQNWjYtJ1dlUEZXqcdK0W8sRqjAMyms7ThFICImUhjgD19TWk9r5iIFYljyMnGK0jsYSWpEExfg8lcY2+h9a0XiE8aiRmCpycDBxUChopH+bAAGQw6j2p8Nww3DGYzgc9qltI0ipNpotQzpHCbeJWKsctn09aWO1zBkkooO7AP3vapXhVLMvChYH5mI5IHt/hULMZY1JAUZyp9D9KXNbQv2fOro1PPDRLEq4kPJC+lWNy+WcxljjoR1qkhS2nATqw4y3Gamu2kNmNh+ZT26Ck2JRu0izC6As3CqRg85/SiVwgUNg7unFV7WB449xXJbhvb6VaaISq/mDAH3aLuxLUVIpMrpuVVyg6c5zUFte/vygYkk9/wDCtMqrRqq7Q+MAkdKjktYvM3EDcMZb1qdehpGa1UhbhC/yxt8uOQetWbdUgiHRBj8KijCs20SArjB96kWJXOWGQSetaLuYt6crHyMXHyHcrelQGFYJC6E5b9KsBckYG0YwKJ0yBwOB1oaFGVtCkTljuIzjn196hlKICoDFscZ5zTLqZYJSVYZbg8dDTZJFMJk3B8cA56fSs762OjkdriK2WPz4A5D4/IGs+6ErTqhT92AeccGrcn+qUMScnqDyR/WoGkUgwlecZUE5NDBehQupFidCVwx4H0qqR5jPGnDEE5PFXZUWQsX24AyQf4R9arzKMb3HXgfT3pJ6jdrGSjec7Qzxski9wOGH1rNuIpFvJM4MBHyjFbzowkJQnCjr2NYt2xJcsWC53fN1pivYyrqULHtY/L1GB39K5fUIzNFIJCCQ+4HuBXQ37gR7mOADXN6hMNvB4GfmxVJitY871QYuFwDk+nWrulFYtvcdDmqWqofNQ5PPFXdPh3qpOQo6g9q26nMjrdPkCqqqRjqO3NWvMBlLjCkcnPWs+wZ8M24BcbRn+GtG0iHmkDDFuWB7iokbRshURpZCHb9yBuYYrRtSQxdRjaBj0FUIWWSYxFSM5UjPb1rZRBFGBGigHsO9ZmjH+WrNvdwQcHJHB+la9iI3YJ94MMnPOa5yFnnnVHAIBIGOAK6e2Hkwxndhyo4x0apV7lySUfM2LSBFud6MFyvIUcY9BWtJPtUOEJKrx/8AqrEtUeQ7ihZTwGzgkjtitK2dRGzygI31yfatk7KxytNu+5cQrcCOaSPazAjbu5H0rQiiRZFXACBevXNZIlXcpbLcjDe1ae4iMqigYHOTk4NNaildPTQltZlR9kTBkJwR2A96lnhhiVAUG1ckbj1qPzIoXEMcSoGHA7t9aJGM1viRMAZByetZvY2gtV2K1xcOpR9qGIHcBjI49K0bK5Fzk7AAQN3HBNUPKSWBFKkY4IzxT4k27gM8np0xWabTOmUYuNram7GQrBTkqRjjpVW+llieMQvnnkAc/Sp7dQ8eZGAHoOlLdw7VMkYJPG4+gq+hxqylqA52vsxnAIxTJHU7Qg5Iyc1I53bVPPvUSAeYWUkDHymi6EkNgQRu5Ld889hV1JEbjPGcjNZUxZCoZt0b8e9WbeEhfL984NUuyKlG6u2aQprgE5PQUqZ2jd1ps7FUyKs51uZN1brMXB+Un+lUI4ggkSTHAzgdCP8AGtgqCQc49x2rOnwS5fLMDgYFYta3O2Em1ykCSJ5Yfpt5HHJqkY3W+NwMjI+7/e+lTmEyHdGdrA8gnjFIyqNpyuWHy+xpPUcdGVDOIwRgtyd3v7VTeVjIAxB5wBnnHpU00iJNICmVJw2OSPeqPmqJMnGCOPWsmzVQGmTuWYAHA7n8Kyr7LtnooGV7kVcuJVKskQwg6kn+VZV1dAYGQAOnqapMnlV7mVdEOHZjuJP0/OuduImJeTcGAOQvtXQ6j8/3MMM+vb0rAv3ULuxt+bP+FXETRwmrKP3e3ldwOat2GRJhwQG4qvqIIZQMKCc1dsVZdw6H+8ec10vc44q5uWpX5FdwpzhD71t2xUqZQCzg4yOx9axNPwwyoAdeSO34VtWZ3KpC4Xdjr/Os2abEkMaC4DtgbuoI6mtWOAlGEjHn8/Y1SeMl1P8ACSdxxg+1WUVI5WdpHKkYIPb2qC992EcWHGF++2Ax45rWt0y26ZclflGD+tVIJVZY5CCqjkD+WavxSbzlsHB6+opOxpG7NO1JRss5KsMmTHp/WrUFjHJtcbioJ2sO5qvEpMaZKhGOMnrj2q3BuVTtdmXOMdAvtVLUy2JY2VJmi+8eNo7sR3rRt0LqjSDkZyBWUVRxEc8xnr3FaVvdh1Q7wqHqMcg1cTOT7E8kcQkVuTgdRV2HYUcsS7DGAP5GqhIKlncMegYDgD3FSKrMYliBUMfnJGcj2pMpXa1HBj8+cAKOQeo+lTQZfaoX72CMjpTWhGAULAnjkZp0W/7Su9uG4HP3h61k1Y35rmlCrJJhyCmOAamlchNyYDHhapXBZtkSgliM5FWLbd5YVwcL600+iOeUftFaG6kkLJIm09CccVBaSOZnEpIByc9qs3qtgknGW646VBHGtthGJzJzU+pqrNO3UkHkyfeJO3oTWlAAcNnOelY6RBJ9qkkEZ6du1acKqChYnK9DVxZFVK2jLQIz161BcuWj/dn9Ka7BEZi2MnFVpZSiDZ8xHBzVtmcIa3IHkByMEDgnmsy9leJS0fzo/Ib0H0ouDLE7sW3BgcY6Cq7ThrdxnLBcjP8AKsG7qx3RhbUkhYiBWQ7snODwarXd2G+UJz6HHFZ320TMoAwQeecYqnq0qhPOj6gbV56Vk566GqpWtcYZ1huy5b5WHzDP61UmvDGWJdR/tdTj3rGvL9FYGXOQp5z/AErKuNUQbWXHQHr1+tQmdPs77nRz3qSKBIwO08KvU+9ZNzcqXdlO9Bzx2/8Ar1zq6j5Vy8zNnd0z2qS0vDKzbWwhO4+5rSJnOCWxqby4jwp+Yk7Scc9qzxFHcSGViSgOCPf2qR0a4byoziRhksegFMkURPFHHuCKuBn+ZrVHNNJ7bnB6ihE43f3s89au2Kjkgkk9jVLUlDSAnAwdw9KuacwyGck46egrqe558TfsohsG5gu3kYHX2J9K3bWQIjbhh15xisW1OGwT747e1aoIWM4J54Ix0rOWhotVqTtcr5wCZC7d2CP0q+suE3xglycBTwTWWZxCS0h3AgABR/OtKzi+0IpchARnavJA9ah6mi923Yvxx+fbK0vytn5h2FaVkkVtJIhZiZACeM7T2/Oq+nbFePkKFHO7+tWbWTzJpWIVjn5Xxjj0pdB31ZeiQgCSRyrHgA8g+9WTBOg5dWbGQR0FYt9dmLygEL5BBJGCK19Ok82EHfu2gVPNqU6bULsHDFVO4iQdgeT61JaSGKVU2ggnGT1H0qm5kN+TC6quMFiKntjN9sIKbotvEp9apSJlTS3OhtpWZWV1B+bGPUe9KwMbB2L7FOAuelMtFjuof3fJU4Yk4pLl/OYMwbaONv8AjVN9SIroaTSbokKZdZDk4PQfWrRVcgsgwAMEcYqhBIIolAQnb0AHNaUZSaMMrB+M1N7hJWHAquXIy4HJA6D2oSYOuAflA9KhjDlwAfkI5UnpUjTpbhkC4LdBSb0Fy9OooXevzjg81G0aTDeuDsOCCc4NLbiQqzFiMnI5qQSAqxYcc9PWkN3T0GwfOqs/DKevf60qTB3fdxg+vWo49qkk4A7Edh700PGNjADLc5FF7By3Lk8ilBuxisq7uRGrc/PjOM5xUgYRNKsn3e3+zWDcy7pG5wmMZJ6fU0pzsbUqSFvNQdFKECRAeSo6VnSzLgMhwmPu9KfPKFHDLtDcjuT2/Csa4uEPmAOPQDPQ5rFyudUIaDbu7BkLRrsA4OB29awdQ1CQspR2KEFQO2ak1OcyQnbISqjJ2muZu5m8slu3KnPU/SoTOpQTVxmrXZXnPU9R2rm7y+Mas6MeTnmpdUvMhnJHPXHQ1y+pXW9WwcYOadgc7bFi91oQxH5sFjjjkmup8OJIbUNtJlYYA968/wDC1l/bfiJHkP8Ao0DcL2Zq9v0uxS1VdoRivGewrS1jn5uZNsZY2jW3zPgyuMszH17Cq1/GFlLFsk81syKdyb/m3ZJPr6YrF1nYAcNls8nt9K0RhK7d2efai2OCcrnOAKn06T5ztADAcD1qte52kqOn61Z09V8xcH5SBxXUzz47nTaeQ0K5G7ZgkAcCti1IAVXH3s9+cVjWuAAFJAwRtHFaln5sRRyEKheFIzn61k2apXRc8lJZEVVHJ2k1LZwEzTOrsY4xxtOT+NMtjHPIrs3yRcZ/2q0WaAKyswRm6EcFvpUNmsbrQveWJ7ZCrJnsFPT/ABqS0hAkxvyVHOeKgtIxDCiRg/KeNvIOfWtGIDzVDfKp657f/XovoRZJk72Ymg8pSVGc5z/OrlqvkR+SmSCPmwcEj2qCG4yWExIUHCsOp9sVa2qgJIDJj6gVNupfNpylLa+4RxtmNupJ+8Pf0qfzjFGETGzAaMnnP1pRj940AMuDhsdMe1WBDHM2ZQcYwoXg0eg79yzbXBSTYQFMgBYjnFXnXcrqSCVIbHTikhtRGg7ZHGecmmuk+z5ZAc9RnGMdqNUtRu0npuXo9ogMmTGe65zVuymUIq7cMRz6CqEAYsgPzMw+bjlajmEkE4kX51xyAe1Jya1DkT9023Zc5OMkcYqJkR8FiQw5A7mqyytJbBiNisQAKlMzhlIRQCMDHX86G+plyNaFg7W3LGcHHbt+FVllx8rALjqelVprpzdqqLtEYIz71GkyzDaOSeCvoe5qXPsaRptK7L/2iKTIjO7+9g1Vu9wTCkBh36YFV47d43xCy7yMkGluI3VkBJ3DtUt3RcYJPRkcsvmRBZHzu5OO3vWPeSRiX5pMAt1PA/Kmag1xFKXLKUJ/L3rP1Q+bGu0ggHDZ5qHK51xpW1uQ3lx+9EYHzchuc1i3suGHzbck9OtW2lVrXBcEr2IxxnsaxryQCYlWGwLwOxqGzphHW5nOHSWVpZgFJ4HPP1rE1PJJAICqN3FbmoAyDkBd46HpXN6jG0SHIOM1Q29DntRuWEpXoH5OOgNctrcphhkcYwucAdM10OsY/eKAVLf5zXG60xlWGFz+8Zwpweo9a0grs460rJnofwpsVOmKZFwWO/1r1OFyIhGuFLHgE4wPSuW8AW4ttNgQoAuBnH+Ndu6Awo65OTkbhzTvdjtyxSKBLF5HlG0A4XjOBWBqUZ3EKowOeTxXQXkjRZUhHcjOc8fhXPX7eYcMcbjk57iriYyaOIuQQhJBA9cVJpbbtuDwetRXILjrnHHJ7Uaa+whR37dq62eZE7HT0kdFMRAOcsT1xWsIy3yjoTjmsHSJZRlw+ZMc8YretyZEDKeB2z3rFm9i19nxlIUVjnoT29auwRIHQsA20ZJPJ+gqpbSLNkhQJFGMjqBV+2Yj94wVF3YX1qS9iaycjzkkVo1J3KCcD/8AXV+NXOJFDOf4uOP8iq8TebKy7Bhup/z0q5A0iojBSG5OM8E+9Ib12JbP7jqylD0yfT1zVoMfs+1VI2DnjJIFUrdJvNkB3FgOBj5RV9I3kU8hGZMBT92mR1ESYlThW8ojlhgGrdrIrqGf5oyfxzWZ5LKJYpF2MRjcDkMPUVf0+0AWIFgWUfjWabZs0kadujmWJiDtI6k8Zq3iHzHLMTnjHfNUrWYRFkAbPIJxVq3DOAzLukP8XYe9Vp0JbbWo9GBkwOXJ7VZtXZNxZeenAzVSMhDKyIHYH7wHX1qzG+4DAO1udvdfr70bCeovUkK4XByFxmoZZHVdwUtg4yp/OozmO6UiXAUZJ9asKRJDubCFjuxngVDdyrWCe4RY8pGTuHX0PvUNsibvNRwHAyTmnKUZ8O+Qxxz2pHgVYpPlBIH5j2qN9S1ZKwiSgNgyL5h4JFJczBSVHzM3BI7VmRxH7SjqSo6YzVi9ZVVmYgMP1qLmzgrqxSvCAuCquf7pOKxpiGLqjbQ3c881oTSIUMiDIHyjHNZ0d1a+UGb7pypGOh96zT1OtQfKY17ZyGORS4ychMDFUPL/AHSwzAZ2gHHr9a22mDLtPzEnG0H7v41n6gbeAsCCrYyD/SjY2u5aWKN1FsdWbkKCDgZIxWDqsYMBeYLt9c1s3ExkkyMLuXBwOuPWuZ1afEb+XtJb5RntVLUl3WjOV1lFCsw78YznFcC5E3iS3Rju2cnI7ZrudbkO3G/p1XFcDDKW8ThsccA+9dFLqefiei8z6L8IuPsQRlwByQD7V0/mgI204+TgHnIrifD84WBBnK7e56H0rpRcL9nUZIxkZYc1GlzoabRBqLZAAycjnjG2sKYZBJG70xW5tkd92FAHJJ5z71k3q4diBgdMDtW0TkmrHnV3MF3sDyOKdprhmyfl+nesq+uSFfDYPI5HWp9EuMthcnHUmum55yO10rEW+Vn7Z554rft5OEKnaSMAAdRXN2EjR/Ls3RtyT1rprEy7oiGOGPHqKykdCNGB1FrIIFZZFPQjqasW/mSOJZjjI2lcd6j2fv1KhiDklgelXrcqA2wZZuDnjj/Gsy0XbO4gE3kqjFyAC3O0mnSQ3PmExzFtpyqYwOf51UAMbGW1mdtwxtIxV+KSNTD9rkxMwzgH9almkbJ3Ro2xlj2+ccORwD1HrVhpVRlYEFwOQzUixpNZ/eJBGVOeQapi42SJHdBPMAwDjccZ9KfNbQjk53dF9w0s4RIzGNuF3D7p9aktIcWzC4eUN3ZeoxQ8Rt4VJ3yOG3E9DirUTb5BGiuFABJcdaSepdnbTYdZiPYCsjyK7Y+YdPwqeCURq0DEMwb5cenv61HvZGIUDBH38c0JHETHOoKsT1/xp7CfvbkludrTOZeM52g4qe3UN+9aRg5AwvaqksTS2m0Knmk/eHfntU0UUyLGsaDHU7j0pXsNxVrpkl2A7MRhem5T29qWJGSHagQrnJzUZaOSdllLFs5Iz09KfO2wIoAKt8uAahtbis7WECHeGk2tx2HanPMqsEZsNgqM1CWCgbMkg4GKqXjlnY8hkOOmciocrFxjzbiM/ky8FiCe3UUy/jjuGO47XxgEdhUDgzlgoKZON3eqN5DcKNxkw68KCevvWcmzrhBX3syNLV42aNZg6HkADGKrPGYrk7lQKww5I6ke1SXzXEcqXCR4kOB6j8Kie6zE4DqTjJLenpmpR0XluVL4Q28ZfAcg4QHIye1ZNyUcD7SpLLzgVpXEu9TGTuHQcZ4rKxud5Z3BcHKjoAOmaDRaIzZ5AqLIu4rkoNw5A9K5/VLhOdrYB6k/wmtfV3LByGJJ6DsPf3rjtSnZCykhmXgk9x9K0WxlJmLrEgTJHJPJPrXn0Mzf29IcjcGH0rrdauNiSOzZXHFcRpjebfSyg8s+RXVSWjZ5mIl78V5nvnhq7LW8TP6DnFdlbMXhJdwxBzjGa4TwohnsIvnw6jPFeh6ShEYQqCv3juXvWNjsbajcfcx7gqodqk5BHSsa4hKSAkjbnGD3rprrzFjVz8gHOAO9Y11ESjOQcjpg9f8A9VbLQ4ZNnglxcKQVBOWOPmqbQZVF+Y8kZH4E1kTrcbjnBGegqTRmaHU4SQQAea32ZxaM9T03G32OM8/pXQ28zRxyGPPovHFc5Y5ZOgZG/NT61t2rt5ieWf3IGCamRvFLc0dNuvOjIVlKg/Pkd617WYPcJBvcMFznFZDwSIqva4YMQCMc/WtGG4fzjx8m0bmC4OaybNlG+pp4fzVwB5fXkcGrCNAZlWWRfu5GRn8apw7be0+eQnzTgex7Yp6QF7f96vzhjlz3A/pUy2NKa1uzQjgmW7jMDsyDkg9xVqEw290GuMmRuFJ6D2qlaFU2ASsQWwCTyDWixaaVAH2Bchgyjr7UkuopSd+V7GxKqyTSF1zuVSzA4AHpSyTsGihUFdw6dc+hqksyhiACRwuBzk+tXZArW4dhtZBw2MYHpiqM/wAgWVpPLaQ7CucY5GPehboFfII+Z88j7ufpVNwyRCS1/e4HQDGc+1MYBwJElO9R93p9aQ7J7mvFL5kYwBvPUA5x70NPLFExlUZJ+UdyPU1nQXJBLKhTyxt9N2e9X0uIWjLTDY543eprNts1Ubbq5Dp08U13vL4yOEf+9VhpmQgmM8/3ucGqEts0S+YsTSCNtytnGSasWN0k8bBTnJ/iHQ1nfoaSh9pbENxcmORQRs3nOR0rNTUyJWEmUGe46+/1p2pmSAuFXeMgHPQVQmiEjLkBhuHLcFT7VDdzohCKV+5ObxkuTIi/u84OR3qzcTs8e2Xa3pg9faqNzmKQqCpc9Aec1QnuWWRgFKnGBjnHrSvY19mp7Iv3d5HDt3yttP3uOAe34Vi3oaSfeuFzgswGA3tinifznJkG4Doe35VBfOsaOSMMR6YzRuXFcuhFLc+TIyAYUjBFUdRkRYwRtO1eD2qPcp/eqw56k8/hVG9JjBLOC3J+gpItozdTuH3Ku5BtHCk1x+pzr57EfMVByR61ualNvcsCAAMBj1NcnqE2WIEYXnLHpk1ukcdR20OU8TXQFvOQeW+Xr1rF8OriRD1yaf4qkYyxgtwSSRS+H4ySoBzk8YrsirUzyZy5q68j3LwagEMYlAJPGc8V6Rp0Tqp83/V7cjJzn3Fea+EVdbeF1YAnr3P5V6Fp05WMM29ieCD/AEFc63PRl8JrzXA8rjAVxye1YOoM2w4Iz1Ix1rVkw5UlmBbqnHH0rGvwxBLyHucdxVnNynlzaZBMHJALjoCKdFoURAl2/N1wB0q2BtGQ4BI9KvwuAgHcjg17nJF7nyKqzjsyvpkmHZe6n8j6ium04BoEVlxn9feuXhZY7piemefU+9b1tKVj3Lnjn8K8ypGzaPoaUuaKZvW7AKsiSMF+6Qe/tVxC/nqpVwi/Ngc5FY8OE/eRsoD9c84HtV6C6fYEidmlH3RnrjtWFjoe+hs3BlbaAyo642qe4qWSMyXEYlYFioHDYC/UVUW4kljxHFH5wG5wTgqPapYxJLGZQFEhXBAPcd/rioZvG+iL8IhaIg8MDw69607dVUO5fK7eA3OR25rmYpmt8ggtu7sOAPetLTN72sqRtuYkbPXP+FZqb2NJ0E1e5tWtz9s3ytG0IjG1RjqKlW7PnDzHyuMbQMAH3/wp9tbeTpyqhyQdzM3UE+1QRRNDMCYcyOTvJOR9a16HO37zsI7NLDvuVEbK2QV6Y9cVWkleG5Z4QJIiBjcuOvWrF3bM7FnldVA2keg9feo4sC3SKR38hmBQhfv/AP16zldG1NReu5ftbiGzj2zlpGdsAEdB6Ut2I7+JWgIRlyQuOp+tLcm1QLvkUEkHcw5FSKsSmMwfLGvPByCKhmkdPeW5PHHczaaiXI2kL0B6ccVWtLVbW2Zt4ZifvdRRdMVmjcT4H93PP0qH7UmxGZWUMeB1/SobVwSlay2Yy7ZHkPmZKJ1AGc+4NZ10yqZhIEKcMT3+lW72MvJ9ohfa2eVbpiqcwijkkClirjq3Qn0HtSubxWiMyeSJoy67+vKnoPoayZLyMt5Y2hwfz+lbN1IjA+bEPK24HqW+npWK9nEspkI27uQuc5rM7YPTUlS4VVJf5lByFHNQXlx9p/eI3y52kHjOO4pIwBtSR+cFQy+9F3NHHGsLfMR90/3fwpoTKaxDZ/CVGSOwrn9VmWWV/LYsMcAdBWtNMqIywl3jyckjGTXKapN+8ZEJ8tP4V71SIkjLvnG5hkE9fWue1CUiJs9Se/atu6AkmyynaT0PFZOopv34x06YzitYs46iPNtemWa8IUk7eK1vDYxOmBgZFZGt2whumZe55+tavh4gTxEgkAjNd7+DQ8aN3W1PdPDYHkIdnyBefc/Su806LdaqcFQT8pPeuK8MzIbSPI+bA4H9a7zTox5GeQp5A61yLU9WekSw6fMSQDgAZHOM1h6sMMycYBxx+hrcmJAZVZQRwRWHfOoLJ9yTvkfyrQ57nm6zZJAGP7xUVPC54ySwPQ+lZSk57jJq/Z7mwQ3zDr9K90+OVwufkuUYHGeDV+0uyqsMEt0B9qqXyeZECD05yaihbOzb9eTXn142kz3cHO9NHUW1yI4kYg4ztKg9PetOwAaVHWPfj7rdh71zVs4icZyY3OGzzWzHdLaQrJHjyQflK9PoRXK1Y71aT0Ozs/Je3YqUd2BDN2xWe8Zj8yESZHUL2aqtjN5KKsfzRy/OCvbPtWxC4mYrCEaYAbV/z/KsZanTTTg32GLE4iRJBgyH5cDjPv7V0umxm38pIyjbhhsr1+lUN0zCGYxKHC7ZF7n3q/HKpOxyMn7oHr7VFrDlUctEXZI50uJJUkUBQVCsMj2pVSZo1aTaXwWLZxioIZGXcZCXD8ZI6D0qVykeRGGVCOQxzkVotzBvSzII2lmXbco0ayHAYH7wHvTiY4tqh/KZWwoI+VvpThIkUT+cw8nO2MkcZ9qe0UN0FaQBSuGAz1pSTLpyjfXYkvrWKWOOZkKyEYAH3vc1Fb3H2VRGQCqHAY/dqO58+zxL5zODxg84/wAalgd/Ik3Rho2+ZSg5asZXudMPg11RBqkUYgMu6Rt54I5APrWfYl45ZFkO/HAGOo9auwO1qGhfCmQeYM889hiqd/IkMSpcRMW28NH1B/qKyZ0Q25Se5mjYMqSBtrA7GXGBjpVCQLdROPM345GODn0HpUH2hJYRFCg+0Kp+Yck1VhItIXcjO49zz+FG5UYqLsSRkIGWR0ALbl3D+dVri9iEilgVOCByOB7VE0DyI0ZVxnkZ+6Kzrq2YxFHDF4xgnv8Ah7VB1JLqTyXkIO9AGwwBJ7CqMsWJxkHDHcDnI+tQR25KhDIcD7wB5FRSXjWsRiDCSLGAxOSapClbaJQ1F5y7O+di/dAGMnvXO3krtk4C5bBJHNbF9f5cGJHJAySRWZcS71ym1mYZwR0+lWjGb0MiaOQRFs5Ttj9cVk37kRsQeuSpJrp5oUNqS5BK9D0IrndUt0M+04ZeuTWkdzlqJ2OD19PMBPBON3FN8OOCyKeua2dStVxsRQAvPPeudsf9G1Fo24Gdwrsi+aNjyqkeWqpdz3TwtKFihD9M4+td5a3oWM4yR6g968u8NzlreMqSMjjPSu0sLsRBWcYXPzL2Fcr3PUirxOpiuS4YMmWAGM+nrWTqcreZsJwM9SKlj1GFwBnCjsfWs3UbzccEjIbOBzxVrQy5bvY4W3iG45OOepP61oQ/IxUYIJwCKyBMA+QOM96kFw2MA9TzjqK93mSPiVG5q3n+obNVbJGYBgef7uOKhW4Z2Kk5B7nt9KvaepZSoYh+xFcmId2evgVaJqWq5jZVwc/w44FaVjbso8mZcpnKn1qtp2UX5k+Yfe54PvW5AQgVyoXceGPOK5JM9KCaLE7QrY4WQgrhQBweKuaHexEyb8IqLuVh94VXjEbcuowx5OOK0raCFE/dRKyvlcg8kVi1dnQpqMOVo3YWSa2VY5SWYEqw6jNU3nW3nCqxaThW3fWqlsiw+Y0Abev3ELYFatuYpJjNNHidwMk9CB/WlJXFCUYu+6LkiqI5PJ3bAgHHXHrVW+nkglRtxYdDuHSrSuHBCHlD26k+lMLrG6xshYYAJYdT6U4ohy8hPKkmiGJAzbt4BPGPQ1OrgxBZMBRktgnj/GmQqINxQAtjIElIf3xJYsGxkE8An0qmlYzjNt2LUM0N6Et8Mqlfkm7Z9D6VNBamBTC1xhvvKwI/Ssp4pWDFWaCVBkxr91vT6itCzYX0ouJk8gqApIH9K55a7nctI6PQinjL3MfmKk0eMCXGMUl6I3nWGWJg7r+7kUcKPerepRR3LLCHEflkNvU/0qo0N3HKEkn3wc7iQPlrNmkdUjOCR2kzSQRfNjBdh/Kqk7RrBIzfvAx3MMcf/qrTmVli3rnDDnI7DvWfdW+wZtU5xysh5APtS6aGsHd2ZmWl7NK7xDG3HA6//qrL1V9qbzvO49W4wK0p0Sz2mVGG8YABxism7yFcJsMZ5YSc1B1xV9UjJubiSGElEGJOpTqfc+1ZMszRvhxhSeK1LjHlCPOFLDHtWYyhiwHY9fWrTBwKM0gkfy1I4yQT/ntVSQSHeY1Bx+VXroEygE5HooqsqOqhgCcU+YzdIqS5KKjt25NZk8JMRJCtk8E9q1bgNIsmU2s3GSarNFL5QQplRznGM1SZhKHRnL38W4buuByMVx2sAwXscoAH8J9MV6BexcMjDGeM1xXiKMmFiRwvQ11UXqedio+4/I7LwZqW+JYiwz2B7j1rsftEvlnadwHP1rxTQL94WUqeV4r03R9VWSNdwOzHGPWoqw5WaYetzwNY6leblVIxnGDk9aa17csCGyoJ6+tMlId9wwB97cDjPtVOSaRsIzcA1K0Nm2zKFy7u/lKSF6mrNpI8jEkBU7Dufes+3VNxDNycsRngVpwKcK2TgDgdMCvbPjNIuyLCA7hg8+tbGngFgcnd0AqhZxMZFZQOTjmtKL5Js88H0rGrD3bnbg5pSsdJZoWeMqMKRgg9q3oYBIE3ocDKhR61g6S2TgkBScg9SK3rKTAw5IJzx6e9cMketzEc9vKGyoLDGOD0qfSI5lk/eSDYOcHPFQiKdIjPE5bHBNXYpQkyLIxBY5yPu5rK2p1c75bGxIsfylwwY8gr60sY/eNtjxtGQW9RTUl3sw3o0gXnHH5CrOxnAKRqCefn+nWmYJ2RHa3UXmMG+YMfmVThs+tWy8rwvtjyrH5GPQ/Ss2O2SG8dyJIyCC+Rwc9xWjb39rd3KW5JBjH7rPc0r2NOVPVIilWaGF1idt5I4Y5yf8alkaaziXfCfNZs5HIz3HtV1YY0ZFmmXeTtAbjNOmM1tGiM6MMli2OB9amTdi6cYyauieOVbiKCXOZCpHA7VYtoGyxVQQwOSepNZgmjaGOZzyp/gON34VoRIPKx57Osg+QoeQfU4rPmuVOly6oqOryOTDapuXlOSCB3q7JDHNC4kybgr0HAH19abOZGMaJK8cyj723qPQmkl1E2kUe1BIDnJK421F0jX3pJcphNLFCUj3Tl1OCpH3vpVgmYzJi3ZQ397t71fiuYro4lhAfOAQMEf/Wqa5gVEWR51CL0zkYNKxpKdmk1qcvqdqJ7jaJFYdHJ5I/CsW9sVDExMJQPlXdxmukkitjdAxPiRh1zx71XuI1MjFXBVRxtGT+dQzrhKysctNp4ZTEsYG0/eJ6VR1HRHg/1aAk9fUe4rpZ4PJiMkilnzgY6c1Qe6uXHlMQFUcHGcfjRc2ir7HLSWMiudquYxzuxjIpz2KPbggGQN0P9K3biQwW0nnNvGeQBj8BWU148Cny1EfOQpGePUGmncpoyLjT5I0dVxgjIyOntWRcbFL43E+/aumub3z4x5gAI6gcDFYN1JE4+TJYc5FUjCpHQ5jUgd25snJ49q43xAMQyFjkBjk122oFmi2gZyeWrhvFbCO3KAn5jzk966qO6PIxWkWczaz+S/P3T1rrNDv8AynAySp6c1xVXbG68ohWJ29j6V1TjzI8yhV9mz1GK+zGpdeD0zU32t9+Rggjk1yWnX4wAxJJ9TW1DKjAEkLnpiuVxseoql1cu2kQKEsuA5yeK14IAwGMbRyT6CoI4s5PTB44z+Nadou2TP3vTntXuKJ8W5alu1gKKQCMelPnUgAgfKBn2FTxjA9Ez+NRXhwgyBx0qqkU4M0w0mqsTW0iUxyDaAFYA8f54ro4sKqsrbNxA46g/SuZ0sfINx4PTBrctnZZCWOQeh29a8iS1PokzbRdsYR8bWxyPWoY7NmcCR18vpz1PvUdu258yI23ORx1qS8V5MBDzxj2rNpGtObia0FksLNcPtYkcnGQP8KePtbxqZ2RBkdepFVrKe5MMfnZVgSM9f0q+0iq8cdwwKnBYgcg56UnBDVaS0epeRy0e1YwxQYORnI9ar3Fm7tvjZUQE7sAZHuKnjTF1IV69lB5q2iCTajGMHPJAzihq+5Maji7xKFraG8uSpeaNm+VA4yGA6n61et7SaON1uP3yBsB884HQe9WVj2TNn52U4z9adJI+IyAJFdtuAc4NLkXUv20noilew28ULBImjBO4lRzVu3mhlYJCm5hjcV4AHarMqukhB2vAR909abp01vCsqxYRQclSOaxnGzOiNVyhrqOuRKrL1KnqyjpU8AxFi62OzHg7f0q3G6Txlo2BGOaZ5LjJcZA6nvU8vUj2l1ZkFzKlsquYwccAKuTis7UJYblCs2xQBlVzitGaJXkQMfnT+IDmsbVNLaZv3jqYz3BwTUyubUeW+rsznriGN5yYpdrIOcjmpII2toi2dwzkq3+elaM2lR2wAGC4PHPJqpc2jnO1145INZWPQVRSWjMu6ugrKrKyjJ6nqe34Vm3N2gC4j5J6qO1a2owuGUiQZ9CefasqZZPK3hVLAZyBz+FBtBoy57mSZmMmPQZHSqckpjD79gwBtz3NaN3iOJx5aBD1PWufuFkaUby24dD6imkaNlO9JGDkFc5CkVmuAQxOOnH1q7clgRvCgBjwTWTcuIySeQw6jsatI5as1sZuoSAZQY3dyOhrzbxZcK90sScBf1rudVnCJIzkDjrmvNr3dc3jkfn2rtw8dbniY6ppy9yhS1ox2ajkjJ9zUwssqcpx9K6rruecoSfQoW908JAByo7VrWusKpAYuv60yPS0ZScAfWnjR0JGG5PQVD5XuaxVWGx6ygXksCee1XoVGxRwecge1VVHz9MKfTrV+3tzsVmJyPQ9TXsqNz5jmtqWrePcoZQe5weSKbfQssAJwRjO6tazsjkO5+bPAHSk1m1/cFuFMfJFXUp8tNtlUKnNVikV9MYCEFjkg8Ec5rftSRCZN2MH7uckVzmmRneuzJXHeuosF8tsTL971714EnY+qUbovxu20eR8x757VckQmKF5uW6bl6/lUMJGWIAwBkkVaEqvHuPDA9M4qUwtdiiZrcRsq+aAcFuy1du0iIG5gJm6fNwe+Kozl/JTySu5en+NXLVISys6b5c9M1DZsopK7NC02rGA3GcAAjoe+TT/ADGMrwwsQ36/TNKQHYE9B2zipVtkaRS/DdE9/rQZrXVl6NZEijD4dz8rMDwalYxxSeU42uehHP40ySNyMq7KhAHtUEZnhVQzjIJxz1NEnoOK5maj25khjjnOdvOVPIoisoooXViAvdOpPpzS27LJakGTdJjkqeopqzS2yyedgpxgkc57VnJamik7WIzaPEytCXjQtzn+IVcjbywEdmI6ZqvJeJOn75wuznOcY+lWbedXiDxYfJP0JqEknoXJtrUWdULq4ZmJ6elZ+oT2rQtE7gHOACOhq9K8U1un8J6fLVK7t43hbzFDqO4x1+tKRVKyfvGfM8kUKRLMryDkYXPFQzzL5wVQHcD5j2/CrKmKInGQcYyPSs2eSNYiTwBnLg/xVidsVcpatAks394H8gfWsS5AjclFYj0z90etat5dQzoyLL5fGCP6isK5uIobdkLF2HGW7j3pHVG6WpWuYE2iWRh/fIHQGucv77bG6wAAhsA46U/U9Uj+dQ+CMgqqk/hWDeXrhMxROUI/iXFXFCnNLQivJmLDcQVI5J6msO9njBcgnHcZqO4u7ydmFtbFz7ngVi6pa3Yiklu5iDj7idK2jHU4Z1LrQw/EupqxMVu4PYnsPpWVYwM2A3Ln1rQh0xnbO3g98da1dE0lnuAAM4PFdfNGEbI832U6s+aRHBpzvGBs4A4J65q9baWW6kg9MetdtpmiYXLYIHXjrVqXSEUful2j1HNYSqM7YYc4xNMxklQCB0HpVmDTAdrYU46Z7V0FxZiI7WQHHp3o0+HdKwkXgnnHWoU9TR0dCeCIOwPOM8gVv2dv+5HA4AOPxrMgUKMr1B9a2bFy+VAIyM5JwMV9jTikfm1STNu0h/dAqFCj5iG7e1UdeK+Q4Iwu3PHX6VatpGZFBfg8Y9KzPEsny4LfvFx26ili9KTLwC5sREqWEhO35WA659PaumtXjcJHtYgdj2+tc/pjqYlwAFHYjvWzZHax6lvU18xI+2S0NmGWNWwpI2jA2jNSyKqvlRvzggE9v8arRK5yuAUIOO2D2xUnkmOMndjafuk85qbisTxqsgZo8LIx49jVrT02qXkIjJ4JXk1nWQlJ2k7z1GTjBrUiwbhZnbbjHB46Umiot7M0rRUCEthhn5S3WpvPSONX8xjnhcdvrVdbgDYyuhiLYLdsetW5owyANt8o4wQKRLXVk0NyGhZQcMx/CrTlHjzIgCr2z1x3FUUjUArGQUHAJHNXoIgwBZfujjB7+4p2bRN7O6JbQwifKbotozt/lVp2V3IlUFmzwvIwKy3EsDrLIgfPJP8AFip4rqPd5jSMFXgv6D6VC8zVpvVEkKWi3Ma+YDCf4cZOfStmRYgD5OxF6ZArCUQljJCAzHo2KuREiMqj7yw+XC5pWsKTcrDnAijU/Jg8ggcVG8avBmEnIzgeh+lEUbqFimUkk5RgvAqX/VKSTjP3RjHNQ0rGkW0ynFFIYy8mwuBjpg/jWZcxRlyotxznnoDWu6BCWc58z7uBUd1GyR7XZcgYGBWTR1U52ZyV1pqrcMUg5B44zx9ap3dijRlkijG3g57GurNqxjUlCpzncG61C1tG7+XgkYz0xWdjrjVOEu9FMvzZRj0bAA+lZNxo9urM/l7zgqpY5Fd7eLGM+QoLdWbHQDrWHfRbwSu3YOm480XN4u6OGuraKIyLGqoAMAjoeK4vX7c3TpDFjOfmI7V6NqVtHGXKFSScHPArnpLBd7YXnORWsX1Mq0ObRHNppS7NpGcAZI7VoaRpqpcZ25jHzdOTWsLchGjPOcdBzVuxV0nCHHTHNNyIhR1ub1laI0aqQAMcAd/rTLi0R1BVANp6+9XLSKWRsIhCYyT1NWprbYm5QSB96p5m9i3FLc5PUrJQ3zjLdRWfHblZgAgHPBz0roNRMaXZDKxGOKy2YCXamcdietFy1FWMhZRuCkkZ9K0bWf5gucg+/pVHy2zkqAepqSJSPvcA/pX20W0flMkmjobSZXPC8H5uvWqmtjfnDDORjvkVVikkXILDaAMHOMip7qZSm4kAYwOM8VGIlzUmjTCLkrRZXgSUJuC+xrbs5H3DeCqtjlqo2OSvJznnOK17dkZSx+/2Oa+cktT7OM7o0YJzH94ng5K9RU4uEKndj2xzUFnKky7HAwBkL9KZLa5OYzwOcZqBMuQXAYgbgWHp1+ua0laN1BZlcnvn1rm3hkRCUPGcAHtT47uTcEnjBQHkjpkU0JrszoHhAgEqgbcFSvqPpWvZXEa20ccZLMFGM+lczHcFv4vlJ/MVr2V0u1lUg7egxyPek0VzNrU20nWMuNikY596txTbYRIz7YxgAn1rnrq6SCIOjBwuM+tTW2po4TzgHU8BexpOTBQT1OhI3JvcBkC4+v1qu1qPszbEDKDjCnrUQvlWDG/aRyCTwKmjnikQkuNrAHg9/epauNaK9hLYHy/LiVkxzjt781bjRt4T5tg5GODVNLzhgGxkYAA7d/pVqJn3y5ctGRle5xUbFbsuLOzAK6sSDj5eaQgXB3OCNjEe4pu6NTujxg8Ed80yF2jy4KFM4Y45pMautSZ48Rgkkg8gjtUMqCRRhdwIznOKdJIxUjOxuqjPUVmzTFl+WQjHAHrUSNYJssO2IxsIOOSuelZl3JI0oCny0HKgfeNSh/mZZBwef8mqd9NtfMRVl7k9jWTOunF3sRXPklCzZOV+ZugP4VzGosG2hvmWPkcYBFbl3LvTdIdqA9e5PpWBcxmX5i21l6E0jrprQyZoxOzMkQfkbgf0NUpbLY5mYc9iOtbqIoBxklueeMVVv0KQqwyd38IP600glMyRHlwGwMfxDuKZbQZvjg7VPpVkIQu5l4HUdcUW+0vI2SVz8rAYP1psUZWN3S1dIjsfCZxgmrdxJIM4KkMMbfSqVtIFUNu+bGcipJRlw5YkcdetNES1MrUbVLlyBgP7nrWHLEscgPLHPQc59q3p2BZ8E59T2qhcogbdwGxgAdvemkxuaSsUwis7AdOwxyatQ2YflFG7HQ+tR24RpcKegzkjvWxZwmSM5G0cZOa+8tfc/Ir2MV9PJ+VdvJzk9Qfeqd3bOsbs3fpiutaEMynIIPUf/XqKa3VoJATxnOQO1ZzpKS0NadflaOX0+XCLncMcZP64rYsn3OURuB2P+NYhT7PeyI33QetaNi+51K4xk4OP1NfPVocsmmfX0KnPBSXU3VUALIPkUcEDqa002Mv90jpnvWPDIDgAsW9/T1rRRlbJyBu6965tEdWrCWRNzh1bK8n/AOtQY1aIYUc8gZ6VJGhkjwVBA6Y4xULmSP5RyFwMYwapInbQSGZoiyyKTzx249RVy0ulhT5SAc5Pr9KzZJPtG2RSA6no3GKDcLGMNtz2JAwfakolORsSyJcgBlOGPOD1ot4k89A75T+HHUe1ZcVxGpZwwAzkgdjV+GRCu8Z5G4c96mUC4VGla5vxrFMPJkAI/l+NNFrLDKwtzuQnO71PpWZZecE3DkE9CetayTuS+7KlR0Hes2jRSa0voJNK9rGvmf6zPzf41f02WZoGcPnOMY6D1rPuXFwAnl5I5OTjFXbNXSALEQwLYPHSpZSs9S87gtISWRc4GB/nNEe9FDMDj0PXFKGkJLyAFV6gVbgRZH3F2K9B6j61PLqWp8qK6yKY/m3OeSufWqb5eUALlc5J7H8a0ZIfL4UK0fbnrUSRBiSN+w/N9Pak43LjNJXMnyH/AHh3kYzjjNV7qJ2gVXwMjPTritic/KNhPy/3uM1QvnaOMygB3/hQdPp9KzcNTpjWMIxsqMkgBOTgZplza74vlwMYPXOferEzSNKH3KpI+YjnBqCSRImSNBkE5I9PXNJRsaubZTnjU27K25X7cVnNGQoZtuemc9Kv3MgaQtwoAywB4PpWTdSMJsjbkDqf5U9BK7K13hbkbVOT3B7UsQyCc5Y/oPpVaSQK2GYgofnIHWrJkXI7Mw6eoo5R8xZhYqinIQBsMakuZSmDGSMDkk8mqonQDaGIQn0qW6vE8tVbjJA5P6VaRDbKUz4JGAF6kk9qzp5GeJio2/N37VYvGLseDg+npWZckqrYP0JqiQtbyKNGIyJc9a6Cxv4toB7gE7ugrj0splk4B+bgEVdWyuQBjp14r7KEnbVH5fOEW9zrVvANgUDaeTtOAaSScbRtYsCD04zXOKl5Ft498e3tQbm6iYnYRyTgmr50QqRJrMIJMylOBkhuDj2qG0nxGpHTHQn+Qpl1feZGwaMkgYqhbzAkKr4PQA15WNp3lzI97La3u+zfQ6G0dzKrqcNnOPQ+tbsDtsUu2GIyOO9chaXDpN8hIGOmeM1t2l0SSzHcAM59PwrzHA9pVG1Y6aGQYHPX3+X86lVEUNtDM4AJ75GayLGcYLHsduD2961POWQBRwvTJGBketFiCtcRL8xjC7e49M1kXDqjFQNwX5SDzW5MFA+YHZ1BxmqNzaJkMikocHnjNNeYjnPOZZioVlUc9eTV3T76RX3CRsngAjp+dVr+yHmHAJGe57/4VRtwfPwSS3Tp0qtxK6O4s7ze6o2Xz3BrZt5+QVyxYfnXIaNMETEiHrgEnBrpLB5CTsRSO3ciuaZ2UldF7zGcMDyQcE44NalgrxAFSGU8HPeqYtYpY0dGbKHAPb6VetAsMZyCWUc7u5rOxq2rGnGQ0RRDtOCCTQvyNtZ2OznGOg9qhW5yqBiu0g8nj8KZ5wHzZzg/KM9apEdbotJIm8NGGO7u3f2NKbpVTcVIIHKiq1zdlOSpBI49zVBJZGQ9C2eQTwKlvoUkWbicbvnI3Ell9AKryXCNH8yIdvccflWXeNIt2qk4Xk/L0qpeOySoEyyyNkbjwuKzbOmNPbUt3UiMhKnBxgd+tZd2yMzbfl6dRiiZ2cMpwRn+HoRUD3SxcsVCtwn4VJrFWM+48zeWIzGMhvYVmS3Ebsww3Bzk+lXb2RMN5crbcZbniscsWUvt4zkr70ammhIZVSMhuMHkkcmo/tJQEjDKehNVnfzZRnIyecnjOKa67VVM4UDcapRE2aP2sMuFIyO4HBNU7m4DlecYyVGM4qB53CosfyEcDPTFQT3bBVDHLemKexNyaSbHJ3fQVn6lOGyCxIbjb7VVurtlBbePz6VSmnyd8hzjGcVaVzKcrHolvbxkKSAWZuT710UNnCw+4obHBzXKWVx5boffBOeMV0ttcgorKfm/lX2jPy2RdGnxOc8ZB/i6ke1ObR4CpxEpY54NUU1EruUjDg9j0FLJqcwBdFyCAVx0J96lpgiO68NW8wJCgYPORgiuc1bws0TFoV6dvb1rojrlxFkSDORn6+1MbXhIoSVBz6elTKKlpI1hKpDWJ5/MJrRwJgVUd60bK4Q4PUsQOK0tensbleVw5GeB+tcnJcLayhFcFR0PSvKxOG9m7x2PocFjfarlnoztLK5TcVcAA9QeuK1Y5hHIrkDj+90NcPZ6gjhtzA84z3JrXivQzptfdxziuCx6e500k4lhAQZY8k/4VSWUqoDvk/xCqAuCYwQcKOwNNnnPlg4AOOcdM+9PUXKkQapfKsZLEA4xgVT0+RJn2rg85zmsrxBM+SDkFRnntTvC86XCct8wOCewNU1oSpXZ2NnGyAiRjz3xW1p0Y3AqXV29e9ZtpFIzIGzj1PFdBZFI/ldsMF+XHODXNOJ3Up2NrSvkAjdNrdcA5Bq7IgkkJGGI6gVnW26NQ0UgklflR0zVlmbYsgBVT+lQlYqTu7kuxoyCMFc4GRTBKY3ZNq8cZHOaBKjHAOSTgDP51VedYzznLcELQ0KMmTOzso3A+vHPFU2maOXYhzuG7j+L6+lLdXEW1lUnOOHB7+lZr3HnAbeO/I6exrNo6IPuW3ZXlDyEhWJwB9KqXFxHndgKu3AxzWdLclS26QgFuB2X6VQupW8sliSTwAOg+lRubxilsWnfaMZxnpzWdduvIC5wepPSonkkIAU7WHQHoKoSh8Or4YDpz19aVrGqYjXKuSqBm7celVpCpj+dsZ4GRyR3qOR1V/lXLYx1xkVDvBwHU/UGqSE2PZ4/MxGHHXFVyzNhvmGDgg+lSGfy0GSR1z7VWkmY7izAAd81VjNy0JNyYYFgcZ/CsjUJmSQgMMdvU06W6XcGTkKCCT3rA1O/hj3bpASeTjt9Krlb6GUqijrclnn3SN0Ix3qlcXSQjdI2TxwDWes9zeyrHbodjHHIzXUeHfAd5qd0jXmY1IyM+gropYaU9kediMfCGjZ0sbOpJLfhXQWhk8kFHY555rMa0L7cLyf7veuisLIJDCjKQ4/SvqYprc+GnJPUhRZDk4w38XGTipws2SQx9NpHatGOzZskYwSR9B9acloXkCsCq9Mj+tMjnM9VDx7WVRgYYmkNmhUZQAn+XvWsdGBJIZsE1DLo03ARn3ZJ9qm6KT7MxpdKQuxZDtU8EdBWfquh2oDFTww5NdWNGm2klzwMUh8PtyZJSw71LUWaRm073PIdTsZrP5rfPy5Kiq0OrywkCZSB9a9cl8LIyEs/bAzwc+v0rIu/CELq42KSDxkcmuGphFJ3ielQzBw0eqORh1mN1GJBuJ7mrY1NwpIfO78akufBkIUmEFcc9P0rFufDl9CSYnbHTJPFc0sJUj0O+GYUp+QmpXOYmZmy3P1qp4Vv/Ivmi3csw6+tQz6LqpBGzPbmsySx1CznWfY29TngVDpzS2NPrFO+57VpknnKpV2I6DJziugiUg4wT6Edz7V5r4e15XhTnbJtwQfWus0/VA5TD7mTlT61zSidkZXR1tszRyYlDcdDjkVdhvfuqWwMHrWFb6imzDkF2HAI/WpzeR4XyzluFIPG2smjZNpWNSSSGFmeMc9SD61WuLuOUbNpznG4nGD6GqEsoLHfgZPr6VHK6KjSFhye5pWNEx5uPmKoFz93JPT3qrczYDHftI4HP61TnulYnA2qOhHaqEkwEfDbt3+eazep0xXcts45G/gdgOtQRzCMlnXcAeKqG4bICk5A69qqPdouA0gwD096nlNlNLQuXNwu8ggAZyR6isy6uEJKq2MngHtVKW4Y7snqScn+LNVpp12g8ZI47j8aOVg6iSLDy5fc2MHrj1pjTY+Y7QPc1k3eqQRqQ8g34O7bzn6VmNqN3fusVhayy5OASDitI05S2RzzxUYbs3Li63M2cKB1JPBFYl1qkSFkDNIxOcD1rd0X4eeIdbb/AEgtBDxuBGK9A8O/COz064V9QzOwbqelddPBSe55dfNox+E8v07w7rGvEG0iaONhwSODXQ2XwauG/e38v3uSB2/Gvf7XT4LGFFt4kjRe2O1PngWSPIyqk/Kgrvhhqceh41XH1pvc8p0P4dxac5AjTC4xuGea6WHRpYiN5CAfdVR3rozvU5wMjqSO1WDho8llUnufSuhQS2OSVeR43bqu5PmGegOciuogO4LtG1l7+ufWuZijX7Qq9i3IrpbIEjBY4BHFdhwSWiZpwAArwDzkjHNTrtB4UA5JBIxmqyMe/Xpnvipl4QnrzjmoZJaiwRkjb0Occ1IJMrlhznJyaiiLfe3HIAFSMoA6d8VLLRP5u5SCgViOAoxTfJkkDKsYA6YPTPrUIyM/MeDVwlhGGDMCV55pPQpK7sUbmBiD5g5B5Zuad9lDIFKln2+nStYAFUJ59jV5IUCBgMEjn3qHItKxzEekySrwhBA646/Sj/hGIpAzY+8M7T/niuvj5VHwASxBwKYwyeuMsM4qVUY2cmfDlui8ID+Gf1rOu/C6OARag+gxXegDzpBtAAJ7VYVQgJA6+tDrNBy6nhXiHwHvcy2kbJJySB2/KuMkttb0yXKrJKoOBkV9VCJNrHaMjFZV9o9jNI4kt0OD1xzWE4wq9LM7MPiKlLS+h83L4mu4TtuIJUJHOe1W4/GSbV3E++a9M1fQNPeUq0OQTz05rn7nwxpZZkMHyhgMVg8GpPc9JZjKKTsYUfi21lC7pQOM5zSnxNaGPb5wwPerLeFdK2giAjOe9Lb+E9KkzuhY4HrWf1Nvqbf2hyv4TKk161aMukoy3v0qjc+I4QpCN8x4IB612Nj4P0d92+BiFyQCa07fwXohiUta7jkHJNNYG63FLNmm1Y8sn8RPIB5aysoGcgVUGp3UzEw2cz5HUg819C2Hg7RVCYtQMnketaEPhjS4YnaODGD0zxVLBR6sylms3sj5xWz17UDtt7ZwD7VvaR8Mtd1HH2qZokbrjoK9/tNJs7dwIoVUgjB781saei5YYAAOKv6vThra5hPH1pqydjy3w78KdNscm8jM8pAxnkGu4sfDum6cB9ntIo9uMYX9RXTsoCH9PaobgDae5C9auM+iRySlKT1Znom1VXCICc5pZhgL8zZHJOKbIMqT0OO3am2EjTOUkORnH/1608yGS5BHy5YkDAqI+WqsrNh85GOn0q8UES4Xt61Sv8DaMA7upI5oi7uxi2ytOo6x5ZSO/b2qrPJ8wRGD9iBxim3jMlwm1j0qrcE+YDnkjmt12Ieiuf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The distribution is similar to that of measles (rubeola), though the lesions are less intensely red.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Image from Centers for Disease Control and Prevention.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10513=[""].join("\n");
var outline_f10_17_10513=null;
var title_f10_17_10514="Mitral stenosis barium swallow";
var content_f10_17_10514=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F57247&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F57247&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Barium swallow in mitral stenosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 287px; height: 390px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This lateral chest radiograph, obtained after a barium swallow, shows posterior displacement of the esophagus (arrow) due to a dilated left atrium (LA) resulting from mitral stenosis. The left ventricle ( LV) is of normal size.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Sven Paulin, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal lateral chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 368px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Steven Weinberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10514=[""].join("\n");
var outline_f10_17_10514=null;
var title_f10_17_10515="Principles of Doppler sonography";
var content_f10_17_10515=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F56895&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F56895&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Principles of Doppler sonography",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 409px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dev Maulik, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10515=[""].join("\n");
var outline_f10_17_10515=null;
var title_f10_17_10516="Acanthosis nigricans";
var content_f10_17_10516=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F53776%7EDERM%2F72964&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F53776%7EDERM%2F72964&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Acanthosis nigricans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 162px; height: 283px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Classic hyperpigmented axillary lesion in acanthosis nigricans.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey Flier, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Acanthosis nigricans",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 410px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A velvety, slightly verrucous plaque is present on the neck.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10516=[""].join("\n");
var outline_f10_17_10516=null;
var title_f10_17_10517="Naproxen and pseudoephedrine: Patient drug information";
var content_f10_17_10517=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Naproxen and pseudoephedrine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/62/18407?source=see_link\">",
"     see \"Naproxen and pseudoephedrine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F3033586\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Aleve&reg;-D Sinus &amp; Cold [OTC];",
"     </li>",
"     <li>",
"      Aleve&reg;-D Sinus &amp; Headache [OTC];",
"     </li>",
"     <li>",
"      Sudafed&reg; 12 Hour Pressure + Pain [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10021035\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10021037\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691980",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat nose stuffiness.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10021036\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702825",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to pseudoephedrine, naproxen, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703758",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had recent heart bypass surgery.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701061",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are more than 24 weeks pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10021041\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are a man with problems passing urine, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697235",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had an ulcer or bleeding from your stomach or bowel, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697564",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your use of caffeine (for example, tea, coffee, cola) and chocolate. Use with this drug may cause nervousness, shakiness, and a fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10021042\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10021044\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10021039\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695904",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with food to stop an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695714",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695899",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with a full glass of water.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10021040\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10021045\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10021046\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11803 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-1F43DE5731-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10517=[""].join("\n");
var outline_f10_17_10517=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3033586\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021035\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021037\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021036\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021041\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021042\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021044\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021039\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021040\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021045\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021046\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?17/62/18407?source=related_link\">",
"      Naproxen and pseudoephedrine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_17_10518="Alpha chain variants reverse HPLC";
var content_f10_17_10518=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F56378&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F56378&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 612px\">",
"   <div class=\"ttl\">",
"    Alpha chain hemoglobin variants on reverse phase HPLC",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 592px; height: 439px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Reversed phase HPLC separation of variant alpha-globin chains. Normal beta and alpha chains are highlighted. The separation of hemoglobins into their component globin chains and heme, which is eluted earlier, is achieved by the chemical composition of the buffer used in this technique, namely 0.1 M trifluoroacetic acid (TFA) and acetonitrile.",
"    <div class=\"footnotes\">",
"     HPLC: high performance liquid chromatography.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10518=[""].join("\n");
var outline_f10_17_10518=null;
var title_f10_17_10519="Diphtheria and tetanus toxoid: Drug information";
var content_f10_17_10519=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Diphtheria and tetanus toxoid: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?10/30/10721?source=see_link\">",
"    see \"Diphtheria and tetanus toxoid: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/31/30198?source=see_link\">",
"    see \"Diphtheria and tetanus toxoid: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F161214\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Decavac&reg; [DSC];",
"     </li>",
"     <li>",
"      Tenivac&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F2934425\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Td Adsorbed",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F161226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Vaccine, Inactivated (Bacterial)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F161216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Primary immunization (Td):",
"     </b>",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Decavac&reg;: Patients previously not immunized should receive 2 primary doses of 0.5 mL each, given at an interval of 4 weeks; third (reinforcing) dose of 0.5 mL 6 months later",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tenivac&trade;: Patients previously not immunized should receive 2 primary doses of 0.5 mL each, given at an interval of 8 weeks; third (reinforcing) dose of 0.5 mL 6-8 months later",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Booster immunization (Td):",
"     </b>",
"     I.M.: 0.5 mL every 10 years (for routine booster in patients who have completed primary immunization series). The ACIP prefers Tdap for use in in some situations if no contraindications exist; refer to Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine monograph for additional information.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tetanus prophylaxis in wound management:",
"     </b>",
"     I.M.: Tetanus prophylaxis in patients with wounds should consider if the wound is clean or contaminated, the immunization status of the patient, proper use of tetanus toxoid and/or tetanus immune globulin (TIG), wound cleaning, and (if required) surgical debridement and the proper use of antibiotics. Patients with an uncertain or incomplete tetanus immunization status should have additional follow up to ensure a series is completed. Patients with a history of Arthus reaction following a previous dose of a tetanus toxoid-containing vaccine should not receive a tetanus toxoid-containing vaccine until &gt;10 years after the most recent dose even if they have a wound that is neither clean nor minor. See table.",
"    </p>",
"    <table border=\"1\" frame=\"border\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Tetanus Prophylaxis in Wound Management",
"     </caption>",
"     <col align=\"center\" width=\"145\">",
"     </col>",
"     <col align=\"center\" width=\"85\">",
"     </col>",
"     <col align=\"center\" width=\"85\">",
"     </col>",
"     <col align=\"center\" width=\"85\">",
"     </col>",
"     <col align=\"center\" width=\"85\">",
"     </col>",
"     <thead valign=\"middle\">",
"      <tr>",
"       <th align=\"center\" rowspan=\"2\" valign=\"middle\">",
"        <p style=\"text-indent:0em;\">",
"         History of Tetanus Immunization Doses",
"        </p>",
"       </th>",
"       <th align=\"center\" colspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         Clean, Minor Wounds",
"        </p>",
"       </th>",
"       <th align=\"center\" colspan=\"2\">",
"        <p style=\"text-indent:0em;\">",
"         All Other Wounds",
"         <sup>",
"          1",
"         </sup>",
"        </p>",
"       </th>",
"      </tr>",
"      <tr>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Tetanus Toxoid",
"         <sup>",
"          2",
"         </sup>",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         TIG",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Tetanus Toxoid",
"         <sup>",
"          2",
"         </sup>",
"        </p>",
"       </th>",
"       <th align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         TIG",
"        </p>",
"       </th>",
"      </tr>",
"     </thead>",
"     <tfoot valign=\"middle\">",
"      <tr>",
"       <td align=\"left\" colspan=\"5\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          1",
"         </sup>",
"         Such as, but not limited to, wounds contaminated with dirt, feces, soil, and saliva; puncture wounds; wounds from crushing, tears, burns, and frostbite.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"5\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          2",
"         </sup>",
"         Tetanus toxoid in this chart refers to a tetanus toxoid-containing vaccine. For children &lt;7 years of age, DTaP (DT, if pertussis vaccine contraindicated) is preferred to tetanus toxoid alone. For children &ge;7 years and adults, Td preferred to tetanus toxoid alone; Tdap may be preferred if the patient has not previously been vaccinated with Tdap.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"5\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          3",
"         </sup>",
"         Yes, if &ge;10 years since last dose.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"5\">",
"        <p style=\"text-indent:0em;\">",
"         <sup>",
"          4",
"         </sup>",
"         Yes, if &ge;5 years since last dose.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"5\">",
"        <p style=\"text-indent:0em;\">",
"         Adapted from CDC \"Yellow Book\" (",
"         <i>",
"          Health Information for International Travel 2010",
"         </i>",
"         ), \"Routine Vaccine-Preventable Diseases, Tetanus\" (available at",
"         <a href=\"file://www.cdc.gov/yellowbook\" target=\"_blank\">",
"          file://www.cdc.gov/yellowbook",
"         </a>",
"         ) and",
"         <i>",
"          MMWR",
"         </i>",
"         2006, 55(RR-17).",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\" colspan=\"5\" valign=\"top\">",
"        <p style=\"text-indent:0em;\">",
"         Abbreviations:",
"         <b>",
"          DT",
"         </b>",
"         = Diphtheria and Tetanus Toxoids (formulation for age &le;6 years);",
"         <b>",
"          DTaP",
"         </b>",
"         = Diphtheria and Tetanus Toxoids, and Acellular Pertussis (formulation for age &le;6 years; Daptacel&reg;, Infanrix&reg;);",
"         <b>",
"          Td",
"         </b>",
"         = Diphtheria and Tetanus Toxoids (formulation for age &ge;7 years; Decavac&reg;,Tenivac&trade;);",
"         <b>",
"          TT",
"         </b>",
"         = Tetanus toxoid (adsorbed [formulation for age &ge;7 years]);",
"         <b>",
"          Tdap",
"         </b>",
"         = Diphtheria and Tetanus Toxoids, and Acellular Pertussis (Adacel&reg; or Boostrix&reg; [formulations for age &ge;7 years]);",
"         <b>",
"          TIG",
"         </b>",
"         = Tetanus Immune Globulin",
"        </p>",
"       </td>",
"      </tr>",
"     </tfoot>",
"     <tbody valign=\"middle\">",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         <b>",
"          Uncertain or &lt;3 doses",
"         </b>",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Yes",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         No",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Yes",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Yes",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         <b>",
"          3 or more doses",
"         </b>",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         No",
"         <sup>",
"          3",
"         </sup>",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         No",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         No",
"         <sup>",
"          4",
"         </sup>",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         No",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F161223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/31/30198?source=see_link\">",
"      see \"Diphtheria and tetanus toxoid: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Primary immunization:",
"     </b>",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Children 6 weeks to &lt;7 years (DT):",
"     </i>",
"     <b>",
"      Note:",
"     </b>",
"     For use when a pertussis-containing vaccine is contraindicated: 0.5 mL per dose, total of 5 doses administered as follows:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Three doses, usually given at 2-, 4-, and 6 months of age; may be given as early as 6 weeks of age and repeated every 4-8 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Fourth dose: Given at ~15-18 months of age, but at least 6 months after third dose. The fourth dose may be given as early as 12 months of age, but at least 6 months must have elapsed between the third dose and the fourth dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Fifth dose: Given at 4-6 years of age, prior to starting school or kindergarten; if the fourth dose is given at &ge;4 years of age, the fifth dose may be omitted",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     For children who start primary immunization series &ge;4 months of age, refer to current ACIP \"Catch-up Immunization Schedule\"",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Children &ge;7 years (Td):",
"     </i>",
"     Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Booster immunization:",
"     </b>",
"     I.M.: For routine booster in patients who have completed primary immunization series. The ACIP prefers Tdap for use in in some situations if no contraindications exist; refer to Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine monograph for additional information.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Children 11-12 years (Td):",
"     </i>",
"     A single dose when at least 5 years have elapsed since last dose of toxoid-containing vaccine. Subsequent routine doses are not recommended more often than every 10 years.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tetanus prophylaxis in wound management:",
"     </b>",
"     <i>",
"      Children &ge;7 years:",
"     </i>",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F161217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F161202\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, suspension [Td, adult; preservative free]: Diphtheria 2 Lf units and tetanus 2 Lf units per 0.5 mL (0.5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Decavac&reg; [DSC]: Diphtheria 2 Lf units and tetanus 5 Lf units per 0.5 mL (0.5 mL) [contains aluminum, may contain natural rubber/natural latex in prefilled syringe, thimerosal (may have trace amounts)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tenivac&trade;: Diphtheria 2 Lf units and tetanus 5 Lf units per 0.5 mL (0.5 mL) [contains aluminum, may contain natural rubber/natural latex in prefilled syringe]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, suspension [DT, pediatric; preservative free]: Diphtheria 6.7 Lf units and tetanus 5 Lf units per 0.5 mL (0.5 mL) [DSC]; Diphtheria 25 Lf units and tetanus 5 Lf units per 0.5 mL (0.5 mL) [contains aluminum]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F161191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F161205\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For I.M. administration; prior to use, shake suspension well",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Td: Administer in the deltoid muscle; do not inject in the gluteal area",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     DT: Administer in the anterolateral aspect of the thigh or the deltoid muscle; do not inject in the gluteal area",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     For patients at risk of hemorrhage following intramuscular injection, the ACIP recommends &ldquo;it should be administered intramuscularly if, in the opinion of the physician familiar with the patient's bleeding risk, the vaccine can be administered by this route with reasonable safety. If the patient receives antihemophilia or other similar therapy, intramuscular vaccination can be scheduled shortly after such therapy is administered. A fine needle (23 gauge or smaller) can be used for the vaccination and firm pressure applied to the site (without rubbing) for at least 2 minutes. The patient should be instructed concerning the risk of hematoma from the injection.&rdquo; Patients on anticoagulant therapy should be considered to have the same bleeding risks and treated as those with clotting factor disorders (CDC, 60[2], 2011).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Simultaneous administration of vaccines helps ensure the patients will be fully vaccinated by the appropriate age. Simultaneous administration of vaccines is defined as administering &gt;1 vaccine on the same day at different anatomic sites. The use of licensed combination vaccines is generally preferred over separate injections of the equivalent components. Separate vaccines should not be combined in the same syringe unless indicated by product specific labeling. Separate needles and syringes should be used for each injection. The ACIP prefers each dose of a specific vaccine in a series come from the same manufacturer when possible. Adolescents and adults should be vaccinated while seated or lying down. In general, preterm infants should be vaccinated at the same chronological age as full-term infants (CDC, 60[2], 2011).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;text-align:justify;\">",
"     Antipyretics have not been shown to prevent febrile seizures. Antipyretics may be used to treat fever or discomfort following vaccination (CDC, 2011). One study reported that routine prophylactic administration of acetaminophen to prevent fever prior to vaccination decreased the immune response of some vaccines; the clinical significance of this reduction in immune response has not been established (Prymula, 2009).",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F161203\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Diphtheria and tetanus toxoids adsorbed for pediatric use (DT): Infants and children through 6 years of age: Active immunization against diphtheria and tetanus when pertussis vaccine is contraindicated",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tetanus and diphtheria toxoids adsorbed for adult use (Td) (Decavac&reg;, Tenivac&trade;): Children &ge;7 years of age and Adults: Active immunization against diphtheria and tetanus; tetanus prophylaxis in wound management",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     The Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination for the following:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     &bull; Adults and children &ge;7 years should receive a booster dose of Td every 10 years; may substitute a single Td booster dose with Tdap",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull;	Children 7-10 years of age, adults, and the elderly (&ge;65 years) who are wounded in bombings or similar mass casualty events who have penetrating injuries or nonintact skin exposure and who cannot confirm receipt of a tetanus booster within the previous 5 years, may also receive a single dose of Td; children &ge;11 years and adults may also receive Td if Tdap is unavailable",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F7913819\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Diphtheria and Tetanus Toxoids (Td) may be confused with tuberculin purified protein derivative (PPD)",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Pediatric diphtheria and tetanus (DT) may be confused with adult tetanus and diphtheria (Td)",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F161224\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      All serious adverse reactions must be reported to the U.S. Department of Health and Human Services (DHHS) Vaccine Adverse Event Reporting System (VAERS) 1-800-822-7967 or online at",
"      <a href=\"https://vaers.hhs.gov/esub/index\" target=\"_blank\">",
"       https://vaers.hhs.gov/esub/index",
"      </a>",
"      .",
"     </b>",
"     In Canada, adverse reactions may be reported to local provincial/territorial health agencies or to the Vaccine Safety Section at Public Health Agency of Canada (1-866-844-0018).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Percentages noted within 2 weeks following booster dose of Decavac&reg; in persons &ge;11 years of age:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Central nervous system: Headache (34% to 40%), tiredness (21% to 27%),  chills (7% to 13%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Gastrointestinal: Nausea (8% to 12%), diarrhea (10% to 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Local: Injection site: Pain (63% to 71%), erythema (20% to 22%), swelling (17% to 18%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Body ache/muscle weakness (19% to 30%), sore/swollen joints (7% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Fever (1% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Lymph node swelling (4% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Vomiting (2% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Allergic reactions (angioedema, rash, urticaria), anaphylactic reactions, arthralgia, chills, dizziness, fatigue, injection site reactions (cellulitis, induration, nodules, warmth), lymphadenopathy, musculoskeletal stiffness, myalgia, pain, pain in extremities, paresthesia, peripheral edema, seizure, syncope, weakness",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F161207\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to diphtheria, tetanus toxoid, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F161194\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anaphylactoid/hypersensitivity reactions: Immediate treatment (including epinephrine 1:1000) for anaphylactoid and/or hypersensitivity reactions should be available during vaccine use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Arthus-type hypersensitivity: Td or Tdap vaccines and emergency doses of Td vaccine should not be given more frequently than every 10 years in patients who have experienced a serious Arthus-type hypersensitivity reaction following a prior use of tetanus toxoid even if using for wound management with wounds that are not clean or minor; these patients generally have high serum antitoxin levels.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Syncope: Syncope has been reported with use of injectable vaccines and may be accompanied by transient visual disturbances, weakness, or tonic-clonic movements. Procedures should be in place to avoid injuries from falling and to restore cerebral perfusion if syncope occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Acute illness: May consider deferring administration in patients with moderate or severe acute illness (with or without fever); may administer to patients with mild acute illness (with or without fever).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bleeding disorders: Use with caution in patients with a history of bleeding disorders (including thrombocytopenia) and/or patients on anticoagulant therapy; bleeding/hematoma may occur from I.M. administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Guillain-Barr&eacute; syndrome: Continue use with caution if Guillain-Barr&eacute; syndrome occurs within 6 weeks of prior tetanus toxoid.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Vaccines: In order to maximize vaccination rates, the ACIP recommends simultaneous administration of all age-appropriate vaccines (live or inactivated) for which a person is eligible at a single clinic visit, unless contraindications exist. The use of combination vaccines is generally preferred over separate injections, taking into consideration provider assessment, patient preference, and adverse events. When using combination vaccines, the minimum age for administration is the oldest minimum age for any individual component; the minimum interval between dosing is the greatest minimum interval between any individual component.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Adults: Td should be administered to adults.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Altered immunocompetence: Use with caution in severely immunocompromised patients (eg, patients receiving chemo/radiation therapy or other immunosuppressive therapy [including high-dose corticosteroids]); may have a reduced response to vaccination. In general, household and close contacts of persons with altered immunocompetence may receive all age appropriate vaccines.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy of DT have not been established in children &lt;6 weeks of age; Td should be administered to children &ge;7 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; DT confused with Td: Do not confuse pediatric diphtheria and tetanus (DT) with adult tetanus and diphtheria (Td).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Latex: Some products may contain natural latex/natural rubber.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thimerosal: Some products may contain thimerosal.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Effective immunity: Vaccination may not result in effective immunity in all patients. Response depends upon multiple factors (eg, type of vaccine, age of patient) and may be improved by administering the vaccine at the recommended dose, route, and interval. Vaccines may not be effective if administered during periods of altered immune competence (CDC, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299214\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F161197\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Belimumab: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fingolimod: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Immunosuppressants: May diminish the therapeutic effect of Vaccines (Inactivated).",
"     <b>",
"      Exceptions:",
"     </b>",
"     Cytarabine (Liposomal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F161199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F161210\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reproduction studies have not been conducted. DT is not recommended for use in persons &ge;7 years of age. Inactivated bacterial vaccines have not been shown to cause increased risks to the fetus (CDC, 60[2], 2011). The Advisory Committee on Immunization Practices (ACIP) recommends booster injections for previously vaccinated pregnant women who have not had Td vaccination within the past 10 years. Pregnant women who are not immunized or are only partially immunized should complete the primary series. Vaccination may be deferred until the postpartum period in women who are likely to have sufficient diphtheria and tetanus protection until delivery; Tdap may be substituted for Td after delivery to add extra protection against pertussis. Td should be administered during pregnancy to women who do not have sufficient tetanus immunity to protect against maternal and neonatal tetanus, and if booster protection for diphtheria is required (eg, travel to where diphtheria is endemic). Tetanus immune globulin and a tetanus toxoid containing vaccine are recommended by the ACIP as part of the standard wound management to prevent tetanus in pregnant women; the use of Td during pregnancy is recommended for wound management if &ge;5 years have passed since the last Td vaccination.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F161218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F12740779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inactivated vaccines do not affect the safety of breast-feeding for the mother or the infant. Breast-feeding infants should be vaccinated according to the recommended schedules (CDC, 60[2], 2011).",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323114\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Injection",
"     </b>",
"     (Decavac Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5-2 lfu (0.5 mL): $25.08",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Injection",
"     </b>",
"     (Tenivac Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5-2 lfu (0.5 mL): $25.79",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Diphtheria-Tetanus Toxoids DT Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25-5 lfu/0.5 mL (0.5 mL): $44.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension",
"     </b>",
"     (Tetanus-Diphtheria Toxoids Td Intramuscular)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2-2 lf/0.5 mL (0.5 mL): $20.91",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F6839267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor for syncope for 15 minutes following administration. If seizure-like activity associated with syncope occurs, maintain patient in supine or Trendelenburg position to reestablish adequate cerebral perfusion.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038602\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      ADT Booster (AU);",
"     </li>",
"     <li>",
"      CDT Vaccine (NZ);",
"     </li>",
"     <li>",
"      D.T. Vax (FR, MY);",
"     </li>",
"     <li>",
"      Dif tet all (IT, MY, PK);",
"     </li>",
"     <li>",
"      Diftavax (FR);",
"     </li>",
"     <li>",
"      Diftet (HK);",
"     </li>",
"     <li>",
"      DITE Anatoxal Berna (MY, PH, TH);",
"     </li>",
"     <li>",
"      DiTe Anatoxal Berna Adults (NZ);",
"     </li>",
"     <li>",
"      DiTe Anatoxal Berna Children (NZ);",
"     </li>",
"     <li>",
"      diTe Booster (DK);",
"     </li>",
"     <li>",
"      Dual Antigen (IN);",
"     </li>",
"     <li>",
"      Dultavax (IL);",
"     </li>",
"     <li>",
"      Imovax d.T. Adult (EE);",
"     </li>",
"     <li>",
"      Imovax DT (IL);",
"     </li>",
"     <li>",
"      Td-pur (PH)",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bentley DW, &ldquo;Vaccinations,&rdquo;",
"      <i>",
"       Clin Geriatr Med",
"      </i>",
"      , 1992, 8(4):745-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10519/abstract-text/1423132/pubmed\" id=\"1423132\" target=\"_blank\">",
"        1423132",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Syncope After Vaccination -- United States, January 2005-July 2007,&rdquo;",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2008, 57(17):457-60.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10519/abstract-text/18451756/pubmed\" id=\"18451756\" target=\"_blank\">",
"        18451756",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP),&rdquo;",
"      <i>",
"       MMWR Recomm Rep. 2006",
"      </i>",
"      , 2006, 55(RR-3):1-34.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10519/abstract-text/16557217/pubmed\" id=\"16557217\" target=\"_blank\">",
"        16557217",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP, Supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for Use of Tdap Among Health-Care Personnel,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2006, 55(RR-17):1-37.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10519/abstract-text/17167397/pubmed\" id=\"17167397\" target=\"_blank\">",
"        17167397",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants,  Recommendations of the Advisory Committee on Immunization Practices (ACIP),&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2008, 57(RR-4):1-51; published erratum appears in",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2008, 57(26):723.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10519/abstract-text/18509304/pubmed\" id=\"18509304\" target=\"_blank\">",
"        18509304",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control, &ldquo;Recommendations for Postexposure Interventions to Prevent Infection With Hepatitis B Virus, Hepatitis C Virus, or Human  Immunodeficiency Virus, and Tetanus in Persons Wounded During Bombings and Other Mass-Casualty Events -- United States, 2008: Recommendations of the Centers For Disease Control And Prevention (CDC),&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2008, 57(RR-6):1-21.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10519/abstract-text/18668022/pubmed\" id=\"18668022\" target=\"_blank\">",
"        18668022",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), &ldquo;Recommendations of the Advisory Committee on Immunization Practices (ACIP): General Recommendations on Immunization,&rdquo;",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2011, 60(2):1-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10519/abstract-text/21293327/pubmed\" id=\"21293327\" target=\"_blank\">",
"        21293327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gardner P and Schaffner W, &ldquo;Immunization of Adults,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1993, 328(17):1242-8.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Prymula R, Siegrist CA, Chlibek R, et al, &ldquo;Effect of Prophylactic Paracetamol Administration at Time of Vaccination on Febrile Reactions and Antibody Responses in Children: Two Open-Label, Randomised Controlled Trials,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2009, 374(9698):1339-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10519/abstract-text/19837254/pubmed\" id=\"19837254\" target=\"_blank\">",
"        19837254",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Steering Committee on Quality Improvement and Management, Subcommittee on Febrile Seizures American Academy of Pediatrics, &ldquo;Febrile seizures: Clinical Practice Guideline for the Long-Term Management of the Child With Simple Febrile Seizures,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2008,  121(6):1281-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10519/abstract-text/18519501/pubmed\" id=\"18519501\" target=\"_blank\">",
"        18519501",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9372 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-199.231.185.123-2A680BD67D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10519=[""].join("\n");
var outline_f10_17_10519=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161214\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2934425\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161226\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161216\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161223\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161217\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161202\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161191\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161205\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161203\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7913819\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161224\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161207\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161194\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299214\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161197\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161199\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161210\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161218\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12740779\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323114\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6839267\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038602\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9372\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9372|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?10/30/10721?source=related_link\">",
"      Diphtheria and tetanus toxoid: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?29/31/30198?source=related_link\">",
"      Diphtheria and tetanus toxoid: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_17_10520="Femoral nerve anatomy";
var content_f10_17_10520=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F66562%7ESURG%2F52007&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F66562%7ESURG%2F52007&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 504px\">",
"   <div class=\"ttl\">",
"    Femoral nerve anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 484px; height: 655px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAKPAeQDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKCaYzUXAfmk3VHupM1PMVYl3UbhUWaM0cwWJc0ZqPNLmjmFYkzRmo80ufei4WH5ozUeaXdTuFh+aM1Slv4Y5mjdsMuM0ovYT0cVn7aF7XK9nLsXM0Zqp9si/vj86Q30AHMgo9tDuHJLsXM0ZqvBcJOhaM5AOKk3VSmmroTi1uSZozUe6jfT5hWJKKj3Uu6ncLD6KZuo3UXCw+im7qN1FwsOopM0ZpiFopM0ZoAWikzQDmgBaKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigBM8kUmaa/DZ9ajZ6TY0h7NTCaYW96QGs3ItIfS0zNG6lcdh9Lmo91Jvo5gsS5pM1HupN1LmCxLuo3VFu96ralcNb6fdTRgl44mZQPUCk52VxqNx8uqWUUxiluY1cHBBPT6mrauGUMpBB5BHeuB0uSGeyXJV2I+bPXNWzK+nRGSylZMdUPK/lXnQzLX3lodEsL2Y3UNSt49XvI5pNrCTGevaiO/t5F+WVfzrH0++kmMtxLYx3CzOzkL1XJNWzdaYx/eaVKreyZqJYanVbnGotSlVlDRxLj3sS9JAfxqs+pwg/NIKrT3WnAfu9OmB9fLNUJnMw229lIWPcrjH51P1GC3qL+vmHt30izvPClyLmymZM7VkwCfoK2ZJFRSzsFUdycV5rpGp3VhINOjZIzOfMZ15YdselbhWNW3M7SN3ZzmtfrkKMVCGtifYym+aWlzqoriKbPkyxybeu1gcVJmuT0aVTr6iPABjbOOnauqzXXh6/toczRlUp8jsOz70ZpuaM1vciw7NLmmZpM0XFYl3Ub6i3U0tRzBYn30u+qxemGXHenzhylwPmng1ned709bj3pqaBwZf7Usf3ee9VBcAjHc1dAwAKtO5m1YKKKO9UIKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAILttiBvfFZ8tzg1d1Mf6DKR1UbvyrmDcFsHNctepys6KMOZG0s+akElZMMvHWrIkNY+1NXTLvmUnmVU8yjzKPaC5C35lJ5lVPMo30vaD5C35lHmVU30m80e0DkLfme9KHB4PIqnvNKHoVQOQzL3wxaTSNLaySWrtyQh+XP0rn9YtbnR/LWa9jmEuQqEEN/hXXXGo29u+2WUB8Z2gEmub1i3GranBYP/rpP3s7DrHGP4R+YH1JNeRj6lOnywpK85M6aHM3770Mrw2glWUcqVkbBHUZOf61fu2kszEsuoxR+c/lxJKwUyMeirnqfYVMlvBY6ldJCNsRbIBOecDNcV8W47qaXwne6dY3OoLp2rx3c8VqFZ/LVWzgEgfrUQhefI2VKVldGlrWvjSruG2vtS0+1nm/1Uc8qI0nOPlBIJ59KbcT37giWdgvcLxXDfFe9m8TWNhZp4S1LyLxFa8u/s0LXMEayEiJQXwGJXOd2AGzyScdktz5sabI3jBUYRvvLx0PvROCjFPqxwlzNon0W1uLvWVjsxmUJnc3RRk8muzt/DMhOby/dieoQYH5ms/wKoSW7dlxIVUZPpk11sk6xqWkYKo6knFdeHo05Q5pmVSclKyG6fp9rYEtAp3kYLscnFXt9Z0F9BO7JFKGYDJHt61P5ld0JRStDYwlFt3Za30b6q76XfV85PKWd9G6q2+jfT5w5ScvTGkqEvTGek5jUSR5aiaSmM1Ru3FRzlKI5paaZ8VXkbmq8smB1qectQNfTXM96ijovzH8K6Guf8KpuNxMe2FH8z/Sugruw/wAFzkr/ABWCk/iFLRWxiFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFADJ08yGRP7ylf0rz6Bzyp6g16JXntynlaldJ2Ejfzrhxi0TOzCPdF+3aramqNuaur0rjTOiSJM0ZpKKokXNGaSigAzRmiigAzTgabSihAYUzPHrN2ZMC2RFnZj7DgfmKxovm0+4vpiftVy28MDyqfwj8ufxrW1/MirbjO++nWAY7Iv3v/ZjWdr2kTabaF451eAkKA3DZ9B6189CDq4ipXW0dF/X9bnVFpRS6v8Ar+vQj0k3ktoGhlik3clZRk/nVr7NeY+ewRvdGP8AhWRpkUTWSMzSxvk5ZD3ye1WxJcQt+71TAHZ1r2Izwk0uZNM5nGtF6O494pFY79OIHqzimSO6ISttDH75yaZPc3Ug+fUogPZP/r1UlktUXdcXcs3+ygxmj/Yo66v+vkP9+/Im0+/uI71FWcqJTtbbxxXTCKJSrMTI/cuc1w8E/wBp1K3FlbsCCdqjknp1rqYtG1K5wbq5WFT/AAqNxrmm3Vl+7jZGsVyr3nqXbOVJNdAQjIhYkL25FbmaytJ0iLTnd1kaWRxgs3pWnXZQi4RszKbTeg/d70bqZmjNbXJsP3UbqZmjNO4WHE03NGaKVwENRydKlqNxxRcZTkNU7hsLVyaqFyeKhs0SOt8Kpt0vcf43J/p/Stis3w6MaNb+4J/U1pV69JWgjy6rvNhRRRWhAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcLq4C61dj/az+ld1XBaxIG1y6PYNt/IYrkxnwI6sJ8TJbar6dKz7Y1fTpXAjrkSUUUVRAUUUUAFFFFABQ7iONnbooJNFV9RbFjMP7y7Pz4/rWdSfs4OfZXGld2MqH97r9p5x4s7VpSewZsA/oWqt4mRtRWCBQTdTNiCM8BF7s38/yFW5UNreX15cEC22J9TtB4+nOfwqXw1D5yyalOVa5uOAAc+WnZfr3NfNYLmxcY4aL93Vyfz0X4f1Y6XJQ/edjBWzGnzvZmQybMZYjGSRk/qa53xzqbaNe+HIbeGKRdT1JLKQvnKKwJyMHrx3rq9Xmtv7VufN3gggb1GR0Fc54l0LSvE0FpFf3lxEbSYXEEkErQujgEAhhyOtery+zqWmvd1Jbco3i9Tlfidq2qeF1hu9Pj06WyLJGY50l3s5fDfvAQkagFTuf39s9TdRwqg28+lY+p+A9H1GOKG/1LUrqBVVJIpdQlZZwGLDzBn5iCev09K6VI7NCPMfKjgKq8Cpm1KKjBajjdNuWxr+A4EEV1MVG/IUNjnHpXV1h+F3haKfyAQoYda2JJo4ziR1U+hPNehQTjTXNoYzd5aElFQxXMMrlI5FZgM49qmrVNPVE2sFFJRQIWkpKKBjqKSlpiCmNT6YaQynOOtZ1z0rSuehrMuOlQzWJ2vhxt2jW/sCP1NaVY/hR92joP7rMP1z/AFrYr2KTvBeh5VVWmwooorQgKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACvOLl/M1S5bOcyt/OvQ7iTyreWQ/wAClvyFeZ25LSFj1Jya4ca9kduEW7NSA81oxdBWZAfmrRV1jj3OwVR1JOK4kdMieisufVkOVtV3t/eIwv8A9eqE09xLzLcso9EO0fpXPUxcI6LUFTbOhd1T77Kv1OKYLiAnAmjJ9NwrlXgtyxMj7j3LHNRsLJeroKx+vPpEv2XmdkGDDKkH6GlriwLYnMUu0/7JxU0d3eW53Q3LyAfwudw/Wqjjo/aQnRfRnXVXvvnSKMdXkUflz/SqularHfDYw8u4UfMh/mKfe3CQtLcO2Et0P/fR5/l/OozGvGOElJPfT79/wJjFqVjL1y5W71aHT4yBCh82Yk9QDwPxP6CpZQkCNNbExyAc7T1qLT9DgvLNbq78wXNx+9LBiCoPQfgMVn6zaDSAm2+Zt5wI3XPHqT2riw2GlhqPtJ6X1fzN9G1CPQZpd9dSNLMEgmaSRiyHg8MR/Sr7XwP+t0TcfUYrI8OqJpLhXHAlOMduAaPGGpW/hTw9ea3fXF19jttm9Yhub5nVBgEjuwr1KWOraQWpzzw8N3oX7i+Qj5NHYH1+WqTtczjbFZGPP8TkACszxprbeFtJm1LUrto7WPAwq5ZyegUdz/QE9qrWV7Nq2lWl8k8zW93Ck8Ybg7WUMMj1wap4+ty81lYSw1O9rm3ZXU1ldpZpMv8ApBy7R9QR2z+NdEq28PK43d2Y8muM0q0mu9WijtuHCklj0UZHNdjb+HYl5ubiaVu+DtFczVXEPmZtaNNWQ22lEmtQbMHhs4+hrfqta2Vva/6mMKemepqwa66NN042ZlNpvQQ0hrJ1bWktJPItwJbjuM8J9f8ACsv7Zfz8yXPlg9kAFRUxUKbtuxxpt6nVZorkyN3+tu5GPvIaFt0PKzPn1Dmsfry/lL9l5nWg06uYiNxD/qbuT6Md386tQ6ldRH98qyp7DBrSONg99CXSfQ3DTTUFtewXPEbjd3U8EVMTXUpKSuiLWK1z0NZdx0rTuDxWXcdDUs0gdT4NbOmyj0lP8hW/XNeCD/otyvo4P6V0teth3emjza6tUYUUUVsYhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBneIZfJ0a6bPVNo/Hj+tcFajvXXeNpNmkovPzygfoTXHxFgFSMZkfgD+teXjpqMrvoejhI+4W2uBFwo3P2X/GqdzJgGW8kz3weg+lPu2TToHkmPKjJNcXqGoSanIQCRH2FeFUrSqu2yOxJLU0b3xBy0dmoPbdWfG91O+6WVyT70W1oFxxWpbwACpUR3K6RSEcscVKLfI6VfjiFWEiFN2QrmbHatkYq7FA2epq0sdWIowDWUikzPmiljZZoSVlQ5UitO8ha7urLTX5L/AOk3WPTOcficCpoIle6jDDKpmRh7D/6+KZoN0s09/dld0sjhEA6lRkAfnk1yJqriI05v3Y6v5Cbt7y6GtJcDzWhjOZQMn0UepNc9dCDWbsWiOPskTbppSQGlP90f54pdX1FfOewt5FEshzcSg9PYUXj2w0sxRJGFRcLtHStnUeNq+0n8C2Xf+v681CPIr9STyoLXUZjAgSI44UcZCgf0rC+JejDxf4I1PQra7itpbrysSyAlV2yo/IH+7ip9D81rYi3u1jyT8jgEda0xa3xHMdtL7jivYWFrKSqQXmc7qwd4yZ5/4s8NX/izQjH4j1K3TVIFuEtW0xWjgxJGE/eK5Yk/eGQR8rEdzVjw1p8uj+HtN0p5pLl7S3SEyNzuIHb2HQD0ArrZI7iNzutYAB33H/CopbiVVOPIT6Dmh4fEzXI46fIFUpRfNfUt+D0MV1OzphynBPpkV08twkWPNkRPbPNefW15Il5Hid/nfa2GxkV1iJBEoYKN/ctSlOWG/dvcpWqe8jRhvYpbjylc7iu4AqRmqfifUDp+lu0RxcSny4vYnv8AgMmq9tcJPr0IQglY2Jx0FZ3ifNzrttF1SEDj3PJ/QCm6zdFy6jUFzJGZZWzpF3LHksepp80cuDgk1uJCqp0qvJGMmvK6m9zmnhk3fNmnhHQfKSD7GtmSEE9KgeAAVorCZmNNcKOJG/Okh1W7t5BvbencGrE6AVRlTmqsmBuWmo216wGdsg/Oti1vZrfAlJlh9epX/GuEa3IYOhKsO4rb0nVQpWC5PJ4BNEXKm+aLBpPc7CSRZE3IwZT0IrPuTwaaoeHMkWTH/EtJOwZQVOQea9ClWVVeZHLY3/Arnddp2wp/nXWVxfgjP9ozjt5X9RXaV7eFf7tHl4lfvGFFFFdBgFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHLeO2P2e0XPBdjj6Af41z2lsouWd+ijArf8ef6uy/3m/pXO6YyCK53dcnFeBmkmp/12PUwq/dnM+PL9nZbdDw5yfpWVpsYwvHWo/Eshk1Yk9AMCrWljIFeTE69kacajirSDFMROKmAxVkk0farKVDFzVqNaLXEKp5qdKYFFOfIQheGb5R9TxWNRqKbfQpCXJePSbudP9ZMRDH9M4/mc1CI20+CG0skBv7hfLjz/wAs0A5J/ma2b2SGxtVMm0JAg69jXO6Rby6hqVxfXBZG2DaM8qDyB+QB/wCBV5GGhLEVnB7df8gjK8bvb+rG/BolnHYrbyoJD95pDwzMeprJ1fw88du76e7MAMmNuT+Fa8c91GNpZJAOhYc08X7oczxYTuynp+FfVJUJRUUrGF53ucLpcUJtP30bbwzAsrYPU1YkEcZyl9cR+3WrN4Yzqly0WPLd93Fcp8Xr640P4d6tqmkzCC9g8ny5NitjdKinhgR0Y9qwpTqc6pwl1sXOMLc0kbj3HBD6hKR7AVXklsQN8jTzH0zjNcr8TZdUt7exfwvdxRqskjXRR4NxjVc/L5vGckdPxq/4Wv4tV8J6bfpLNOZ4txkmjWN2OSDlV+UcjtxVzq1+RTc9GTGNPm5VE1LeSW/1C3jtLYKQxKKo9OMn867G28P3M3N9dso/uR/41k+DJY7Oe5kmGCyAL6nnpXSHV5CfkhXH1zRSjTa5pvUqble0Szp2k22nuzwby7DBZzk4rEkjE+tTyggqHxn6DFWZ7u7ujtz5adwvGaqSxGynjuoz+6LCOdfXPCt+BwPofanWnFx5YLQUE07svsOKqyirjCq8q157RqUnODUMrVNLxVV6L2HYp3Byarugq1KOajkX5atMCvjANZmonA3pww5FaT8Csy8OQQaq9xI7rwvfLdWSmQ8suD9aa/7t5Ix0ByPxrD8FSfeiY8bq3bwAX7qhyNtXQk1NCa1NfwX/AMhdv+uTfzFdzXD+DRjWW/65N/MV3FfT4T+GeXiv4gUUUV0nMFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHLePUJtLSTsshX8x/9aub0mLel1ntk11vjlSdCLAfclVj/AC/rXHaVOY7h1/hkWvDzSK5rs9PCtunZHnvijMWuhD3Ga1NHwVFQfEK1aO8huVHTrTdDm3KteLE7XsdNEBxVgIDVSA8iriN2rUzJIlwQKsgECo4Bk1ZA4pMCNTzzVizHmX8akfLGPMb+n9agYYNW7LENlNO3G8nn/ZH/AOofnXmZhV9nT9f6/wCAN7GTrkv9oarb6bu+UnzpvdQen4mr2jtk38o6PcEf98qq/wDsprJ8LK15cXuqy5zPIY489kH/ANf+VbWir/ocg7/aJSf+/jVvltB0qSvu9Sq1o2h2LYBNEkZZCGHBGKtBRQVGOa9NUzDmOMaI29wyupZSTx3B9qh1K203UrKWx1JIp7aXG+G4T5WwQRkHryAfwroNWsllO5D8w54NZpeSP5ZUjl7c8H/CtadKjUXxcskTKc49Lo5Z/B3hg2gtP7K0r7KshmERhXaHIALAY6kAD8BWvbQWkapDaQ+aEUIkUKYRQOAB2ArYhkt4wCbCMn1JX/Gp/tcso2RLHCp/hiGT+J7VbwtNa1Kt15EqrJ/DCxm2dmzXv7z73AKr0X29zXRLCAMAUywt44QCx+atAbSODWMlGT9xWRabS1KEqbU4qlP+9tLqLks8LhfY4yD+dalwuQaoLtiZnfhVViT+FZNWZa2FspvtFlbzH/lpGrfmKJelQaMrLo1kG6iFB+gqWU1zs0KcoyarulW2HWopKkZnyL81RS8LVqQVVl5zTQFJzkkVnXowCa1CvJNY+qybVb1qxG14HUzSMe27FdDcIU1GQf3VxWb4Gg+zWSSOOSdxrVD/AGi4uJccFsD8K0w6TmhSbNTwYSdbcf8ATJv5iu6rhfBIzrs+c/LCcf8AfQruq+nwn8M8rFfGFFFFdJzhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBl+KIjN4fv0HURF/++ef6V5xYP8AvYW/CvWZY1lieOQZR1KsPUGvJvIe0lmhb70EhU/gcV5eZwvC534OW6HeOLFZrDdgcrkVwugHGFJ5BruddvjdQRQoMsRtAHc1yGnWUttqFzBMu2SOUqR+NfPvV3Wx3x0VmdNagEVaVeeKp24KVowjIq9ySSDIqyTUKgA1MvIqXoBG2dpx1PA+po8TTrY6EYlOGKCNQOpLVPbxiW8ijPQHcfb/AD/Ss3XD/aHiKxtf4Im89x9On9K8PGN1q8aS/rq/0NIK8lfpqammWostOt7cY/doAcevf9aksGEbXUZGAJdy/iAf5k1KTis6+uPs1wj5+SQbD7HqD+pH5V9DBcqsjJvm1ZpzXSouSaxr3XI4c5dVHqTis6/vWfIBrmr+xN1MZJGJwMAelOTYKKOil1dpOUcEHoQcioTfO3U5rA0qN4I5Q4KqWyoNaAfPSpTKsXTdE9h+VSR3kg6HAqgDViKrQjRTUWjAMjqoP944rRt9TBAJII9RXKyQPJdtvB2HofarFtG1urKGyucgelVoTY7CK7jmBwRmquqMPsjxKMyTkQqPr1P4DJ/CsCO4ZGyDjFXtPu/tV2srn5YxtQfXqf6VMh2sbpUIiqowAMVXdc1YJ3IDUZFYTVmOLKUgxUDggVfdM1WmGKzsVcoSDNV2jOavMtRsmaqKC5nXACRniudnTz76OPrk810t8PkxWTp2n3Et1NeKh8iHC5x1Y9h+FW03ogTS1Z3FlbC20cHGPl4qKAbLNT3PP50pvVk0qOJR8/Sm3reVbhB2GK6MKk5XXYh36m34CTfd30x7KqA/Uk/0rs65P4epixu5D/FIB+Q/+vXWV9HhlamjysQ71GFFFFbmIUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFeY6sceIb9CODKa9Ory3W+dYup05DSt/OuPGfCkdWF+JlvTdPtPMDnd5ueAxyD9PQ1LrulJdOl3br++UbW/wBsDsf9oVVt/wB/EVJIyMZHUVPoGqSTAWl4MXajbk/8tAOv4isKFGlVpuk0XXlKnNTTMtIc9qnRNhrf1HTfNTzbfBb2GN3/ANesR9xJUjDDgivKr4eVCXLI6qdVVFdCjkVKhxUcak06Q7FLHoBmuKbNkXNOwTczkfdGwH/P1P5Vi6IPtGpahfNzl/JQ+w6/0/KtLUJ/7P8ADbSMcNtJPuf/ANZNVtDj8nSrZSMMV3t9Tz/WvHwK9rXdV/1f/gWLWkZS76F25l2rkVhahKZ1ZXPFad4TtNRaLZLd3TPMuYk7ep9K+hppydjJ6IwowXHzfeHBps6rHGzuQqgZJPau21HS7ee3fy4USYDKMoxz71xN2q3Nu8MgIzwR3FXVpuARlzGP/aVm8oQSkEnAJU4q/GmKqXulJNEEiCoc9fatOKLAA7DiucsRVqTcqAsxCqOST2qVYxio7i1E8EkZOAwxmqQiumqWjuFUuMnAYrgGrTHiqdvpu23Mc6qx6ZFXLS3N5fRWaMQD80jDqqD/ADiqV27IDPvJx9xT1647CptJuCs+0HgV3K6bZi0NsLeMQkYIx+ufX3rzwQNY67PanOEfAJ7jsfyrSpTcETGXMd5bSb4hUlULEnYKubuKwa5h7CtVWVM1YJyaCuVocQuZ7rzTWXC1aMZLZqa0spLuUKgwo+83YCrp03J2itSZSSV2Z9lpj38pB+WJeXc9AK6O2tYLe2EMCKkQ/iP8Oe59SandUgiWKPiJfTqx9TVWXJHP5V7VOjDCQu9ZM4nKVeWmiRlGxjjuzIpPlLyAfX1qpckzybR0rQu2LKVWo4oBFGc/eNckYqN7I6zpvA67dPnA7S/0FdHXOeC2H2a5TuHB/Mf/AFq6OvYw/wDDR5lf+IwooorYyCiiigAooooAKKKKACiiigAooooAKKKKACiiigAqDUJGhsLmWM4dImZT7gE1PTZEWSNkcBkYFSD3BoA+dPAnxU8UWvgW48X+Khq2o2gtgIoTp0FvbSzPOsa7Jo2ZzjJyCg74yQAexPxV1qHSbRrnwhLHql1rUWjwRTyzWsM3mRu6zI00CvtyhUgoPXPavRbfwzotv4cGgR6Xaf2KEMf2J4w0W0nJG05zyc1Q0/wH4X06C3hstEtIUgukvo9qnKzopVXznOQCQPrQB57o3xpupfsc+teHFtLG4tNRmElveec/mWIzKu3aPlIHynOSe3elufjPe6bot9d6r4cgF0mm2Wr2sFrqG9Zbe5nWFVdzGNsils4wQexHWvSbXwh4ftZLN7fSbVGszO0Hy58sz/67Gf7/AHqpbfD7wla6be2Ft4f0+KzvGRriJIsCTYwZAcdlYAgdBQBxPjz4sat4SjT7R4ds5LuC1N5fWUd7LLJDF5rIrb0gKKCqg5dl5bAzjJ6H4d6/faz4t8cwXVw8tnZXtulpGygeUj26ORx7knnNbfiTwP4Z8TXa3Wv6JZX1wIvJ8yZMtsznaT3API9D0rT0zRtO0u5vLjT7SKCa8ZXuHQcyMqhVJ+igCgDzbw18V9Q1fXdChufDkVrpOr3t3p8Nyl/5sglg35JTy1wp2Hv/AC57/VPE2nadBbTP9uu4bncY5NO0+4vlO3GcmBH29eM4zzjODSWvhPQrT7D9m0y3j+wzyXNttB/dSyZ3sPc7jn61d0TSbDQ9Kt9N0i1jtLG3BWKGMfKgJJOPxJoAw/8AhPNI/wCfPxJ/4Tmo/wDxij/hPNI/58/En/hOaj/8YrqqKAOTfx7pCozG08ScDPPhzUP/AIxXnH/CXac5O+21sknP/IEvf/jVe0avIItLu3PaJv5V5tH1rhxjV0mduETs2jHtPFmnI/8Ax7a7/wCCO9/+NVDc+JdMkmlX7PrqMsgljYaHe5G4df8AVf3hXX23UVn+I0dLm0mjJAkV4WwepxuX+RrGhUUJaG86Lq+7ch0T4i6bIBBfW2ti6xyqaJenzAP4gBFkGpdR8S6TcHzYbXxCZf8AsXr8bv8AyD1rnbbUWtdXgupCQm4b89lPDflwfwr063uCreXMchujev8A9eumThiF7OaMa2HnhWpJ3OFHi3TBwbXXgf8AsBX3/wAZpl14s0wxhRa69lmA50K+HHf/AJY+lehXFqsp3bgHPRuzex96yLlWN9bwMCGGWIPbsP5187mlBYWlOUk3ppr3+RvRq+02Zh+IbhNRtNLgiWVY7kqdssTROFPJyjAMp56EA1ov8vTgVVvF+1eL4+fkt4mcD3PH8jU9220mvNyyko0XNdX+C2OluyjH+tRk3zKa0dCQJYDHVmJP8v6VlI25a0dHl/ctETyjcfQ16+HspGU1oama47XbP7Pqjso/dz/OPY9x/X8a67dWX4ii8yw3gfNEwb8OhrqrR5okQdmcZqTTwxxraoGkc4yw4FQaXc3TTyw3iLlQCGUY/CtoJurPF7CblY9kgDNtD44JrznE3TLQNULxrxroRwNsXbkHGc1riIAVBaXcNxJsCuhP3dw600gILeWUw/v1w44Pv71t+FLQqk17IPmnOE9lH+J/lVG4ti4CL95ztH411MMawxJHGMIihQPYV0UIa8zIm9LEtcl4ltV/t+1mUcvHhvfB/wDr11ma5zU3W51sKvIhTafqef8ACta+sSYblm2G1BVtFzVVDggVdgAIrCMCmwCU7y+KmAAqe2gMzc5EY6mtVRc3yrchzUVdle3s2uGwOFHVvStJ/LtIAifd9B1Y+9I8iRx7IztTtjqf8+tQM3Id+o6D0r1KdKGEjd6yOKUpV5WWwwhhl5Tlm7elQO+ac7NI1KI+MmuWcnN3Z1QioKyKxQbs45qOXoasSDFVpelZmiNbwbIFvbiI9WQMPwP/ANeutrgtAm8jWrc9nOw/jx/PFd7Xp4SV6duxwYpWncKKKK6jmCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDB8ZXHlaT5YPzTOF/Ac/0FcVAMtW/45nD3tvCD/q0LH6k//WrBt+teVipXqPyPTw0bU0X4OtVvFcog0hJcZZZkI56ev6Zq3bDms3xsf+JXBH/fl/8AZT/jUUY80kjSc+T3uxyGrptaQgZXO78D/n9K77wleDUdBgLndJEPKkz6jofywa4ZgbnT0Zhzt2H6j/JrV+Hd95GoT2Mh4mXcn+8vX8x/KtZo7a0eel6HexSPASrfNGfWrWyK4KOwG9R8r9wPQnuKhIBBB6VnWd1Irykj92sjKOegBxmpqYmhOKoYq1paK/U8WdKUffgZNtb3EOv6m9zEyABEjJ6MOTkHuOlOvz8pNdaUjuocEbvYdR9P8KwdX0+SNCR80Z6MP6+lcUss+qU1CnrFHVTxKqvXRmNaPk1M5eFxLGcMvP1HeooIjG3NXCu5feuVXizp3L9pdrOmejDqvpU0gWSNkcZVhgj2rBt3NvOV6EdPcVrLJxXZCfMtTJxsYs9pPZs3yGSEdGX09xUJW3cI21PlOR7V0PmVyWo2kdtdOJBKEdiU2k4xWNWmlqi4s0lZD0YH8aFjj3qscYZ85UAVlRrbj/nsPxNbmi2/l7piD8wwu7rippwuwZas7RllEs+Mj7q+lX81EXprudpx1xxXWkorQi1yrqV+YUaODmXHJ7LWXpkR2tKxJZyTk96ZITKwiXJZ+WNaQQRxBQMYFc8pOT1LSsRBv3gFaEJwtUIYXlmCoCSa6GysxGod8M3bjI/Lv/KtqFCdV+6ZVakYLUS2ti2HmyF6he5/wHvVq4lCptGMAYCjjP8AgKglud8rJD87g8t2U+/qajciJSWbc56k969K8MMrR1Zx2nXd3sIMqS8hy5/IewqPcXao1LTPx0q5DCFHNccpObuzqUVBWQ2JMDmlepSKiekBWkqrIKtyVWcVDNEVBIYbiOVeqMGH4GvSY3WRFdTlWAIPtXm1wOK7zQZRLo9owOcIF/Lj+lduClq0cuLjomX6KKK9A4QooooAKKKKACiiigAooooAKKKKACiiigAooooA+f8AxH4s8QaR8RZpNa1PUDocmrRWdhNot1ayQxZYL5E9uymQtnO45yP4egq7J8Z9Sj8VT2cVlp95pMg1IWtxEJIzutIpJMNuOWyEwSFABPBbFeuDwxoI1n+1xomljVc7vtotI/Pz6+Zjd+tRf8Ih4a+3y33/AAj2j/bZi5kuPsUXmOXUq5ZtuTuVmB9QSD1oA8rvfHfjmc/Dq9RdB0218QyeYYfPeRZImthIokZowUOSxwuedoyeav2vxX1GXxMsDWFh/Zk2rXejxQLKxvI3gRm8116bDt5GAVBBya9OvPD2i3unWtheaRp1xYWm37PbS2yPHDtGF2KRhcDgY6ClXQNHXVZdUXSdPGpzLskuxbJ5zrjGGfGSMcYJoA8p0vx7r2tWPgHVdTsbWytdc1KOOBLG+lLFTFKW80FQCMqMLkj1PFN0740TXmm+GpYrHTpb/Ul1Vri0F2EMBtElaMEt9zf5YyW4AbPSvWY9C0mK3sII9LsEgsG32ca26BbZsEZjGMIcE8jHU1UXwj4bS7kul8PaOt1I0jPMLKLexdSrkttySykg+oJBoA5L4P8Aj3UPGMurW2tQWtpf2Swu1rHDLFJEJAx+bfkMOBhlPPPA4zyyfFXxbeazb2mn6RoIivrzUrC0ae4mDK9oCxeTCngqpG0ck9wK9h0TQtJ0GB4ND0uw02F23NHZ26Qqx9SFAyaZF4e0WKWKSLSNOSSGSWaN1tkBR5RiRgccM4JDEcnvmgDI+H3jG28U+GNBvriS1tdT1KyF39hEwL4BwzKp+YqD3xxkU5/E+rK7AeBvEbAHAYT6fg+/N1WxZaFpNhJbSWOl2Fs9rCbeBobdEMMROSiED5VJAOBxWjQByv8AwlGr/wDQieJP+/8Ap3/yVR/wlGr/APQieJP+/wDp3/yVXVUhIUEk4A5JoA8Y8Q+JdSuNYuXbwlrqYIXa0tlkYGMcXBFV7fXdSAz/AMIlrh/7a2X/AMkVt3ErT3MsrfekcsfxNW7deBXizmnJux68IuKSuZNvr+pj/mTteP0msf8A5IrH8Ya/qUhslbwprcO3c3zy2Zz06YuDXoFstc34zb/iY2inkLHkD3J/+tW+Gs5rQwxHwvU4iLWr+ITJ/wAIxrH3vMAMtpwD1/5b/WpbO7mtru3vvs0ttKjCTyZSpYYPIJUleR6E9a6G9jMdzCzcb02n/P51kahF+6Vu6cH8P/rYNbVVZtHo4KfPBNvyPWYZ0mgSaM5jdQ6n1BGayrUlNJaRupXcfxyayvC2oCbw08DN++hJgA74P3f54/CtbUyItGnxwAp/QV8VxHUvOnS7Xf36IyUOWTj5nFeCvF97DfXlveHzrOOXan95PUA9xXqdjd22o23mW8qOrj6g+xFeC+FU82K5kP3ZJmdj+PSuns765spvMs2Kv12joR7+1fZYWo6dOMJa2SDFYKNR81PRnoV7pi7ibdSHHJiPX6j1FZu0qcEYqTTfE1teqkN0BHN6E8E+x7VqSRRXSg7izHo38X+DVNfBRqLmpnFGtOk+SqjCliViGI5U5FShsjirE9pLFk7dyjqV5x9fSqjKRyvX0rzbSpPlkjrjJTV0SA1U1WPzLVmH34/mU1KJR0bKn3pzYdSDypGDWl1JDMhBK5QM8ZDED5RzW4uFQKvAAwKzLS1aGYFhHtQHaQOTV/dU01ZagyTdTJZRGpZun86iaXj92rSH/ZGalg0+6lYSXCFB23cAVS5paQV2S3GOsmVLO32l5CPmY5+ntWnbWMk7DOVU/mav2lkin5jnHU4qea6jiUx2yh37n+H8fWuulglFc1ZnLUxLk7U0JHDb2UTH5QnUsec/j3qrNPLdkhS0UB/76b/AUu1pG3zNvb9B9KbLIB8q1rUxCS5aeiIhRbfNMXckEYRABjtUSxtM2T0p0URdstV1FCjiuXfVnTtsMihWMcVLRRTsSMaoXqZqiekxoryd6rtVl+9V3qGaIp3PSup8FS7tNljJyUkOB6Agf1zXL3PStXwRNtvp4SeHTd+IP/1zW+FlaojLERvTZ2dFFFeseYFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFUddm+z6Rdyf8ATMqPqeB/Or1YPjSUpo+0H/WSKp/U/wBKzqvlg2XTV5pHDwjLitKBelULZcvWpCOleMeuy3AK47xC5ufFLRD/AJZBE+nAb+tdojLHEzyEKijcSewrzDTLk6jrFxdsSonnZ/ovYflgV2YRe+c1eN6bl2Oh8Tp/osM0anbERg+uOtZN3GHjfC8EBv0wf6V1mr25uNJbcNox8i+1YVleSjSGaeR3J/cBScjPQk/5708fOdNKUFe+m9v0NMvqe64lPSoptH1fT0fy5JbwhHj3f6oZ4Y++3dj611986XWlyrEwYPF5i47hhwfxxXn6WdzPJcy2rATW8f2hSx7r2rqNCulSTyDghLayhPPqjf1r4rO8K5S9pzXmlr9/b7rHfWWqkcL4YQwaWquMEM2R75rbOUXbjLt1x/Knajp407VZUi/495D58Z9Q3P6HNRoeN/c/d+nrX12HqqtSjUXVG176oa6eWxI+eU8cfyFaul+Ip9OCwz4uIjywbsKypJBDEXb7xHH0/wDr1kzmaeZLeBS9zMwVVHcntW6k46omVGNZWmtD2HRNXtdYgZ7J/M8vh1bh4z6Zq03kgktGm71KjNZOh6OmkaXDbQn94o3SOP43PU1K7ybvnYmsq+J548rR5HsIxm3B6F9vIf70SH8Kp3lvaGCRkQRuqkgrxzULSketRTOzxOuOCpri5kbKDRi2DXDTW7TSFo3cKRgDjNdWtjZJICY95H94kiuYto3/ANHUA/K4JreMje+a3rpJqyM4c0uprpKi4CKAPQcVXlnjEp2AFh1YHP6ms4uxHSpIIztxjAp0K7p3sTOgpbkzyPK4GSF9KeEAGahJEYqNpS3ApyqSlrJlxgo6RJZJey0scO47mpIYx1NWVqUNuwqgDpTxSAU6qJCiiimIaaicVMaicUhogeq7irLVC4qGaIozrwaNAlNvrVq2M5fZ/wB9cf1qWYcGqAcwXMci9UYMPwOaIPlkmVJc0Wj1CimowdFZejDIp1e4eMFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcj46m/eWsI6AM5/l/Q111cL40l36uFzny4wPx5P8AWufFO1NnRhleoZVqK04ByKzrQcCtS3615SPRkY/ju++x+H3hRsS3TCIf7vVv0GPxri/CwAMWRkbsn354q18Rr0T63HArEpax7SP9phk/pto8IIAbd2HAAwPU16GFWosZHkw0V3dz0JVLwjzf9ay/d/uiuKmiKS3NqTgBi6j0z/8AqruIEyrE5z/E39BXJa9F5GsRSfwyDaf6f1rorRTjfscWCly1bdzLgupoYJkhjVvtI8piRyM8YH51R8PfadPvNdjvchoJLKVQ3VUWX+gNdD50EFlDbiQbzciWRf7ozWB4nuY2l164gfK3NnsVhxkqVI/9mr5WvzVpTj7Oyb378sor8Vf7j3Pi0salyj3N7qOku3+mWkjTW47yW7ncVHqVJ/KqBI3iPoAMkeg9Kj8UTSXX9ja1ZyGC6ltUljlXs69QfXrgirNzqlpeWlrdzwPZyXSESTINyLKpwwZeoHGcjPB5rTBV5UKcFJXjLt0a307OzenmEbpIxdet7XUojFfRLLCrbgDwQ47gjkEeoqXwdoOs6aRrGl30U6FjHDbaoGcFe5WZfmX0ywfv61LHpsmo6vbWUTo0Eg3+bG4ddg6kEf5ya9Jkt40s1giULGihUUdgOlep7VSV4u6IxMoqKS3f5GWnjOGy2p4osLrQ2P8Ay3mxJan6Tr8q/wDA9h9q6aGSG6gSaCSOaJxuR0YMrD1BHWoLJ/MtU3cgjBBrBn8G6fHM9xoM1zoV2x3F9PYJG7erwkGNvclc+4pe6zzdUdI0CHtSfZ09K5aXVPE2ikLqenwa1a5x9p0391MP96Bzg/8AAXJP92k8TeObTQ/Bj+IktLu5gEqQ+Q0bQSbmcJgrIARgnuKSp3eg+ey1On+zIDkAVJ5a1xWmfEfS5rLUpdYin0m50+9GnzW8g85mmIyqx+Xu3kjPAGeDxVkfEbwwLK1uTqRkS63+SsNvLJIQhw5MaqWUKeuQMU3B32EpLudaI19BSSHaMCvP5fito0i6+tiN02kyRIzXO+GKUO6JuDhGxgyAAEZJ9vmF/VPiF4as9UfS5dUVdQE/2Ty/KkwJiOELbdoJ7ZPNHs5LoNTT6m3JKZ7oqp/dx9cdzV2BO9cZpXjbw408tp/aam4jWWVyYpAjCPmTY+3a5XnIUkjFa03jbw5aW0c1xqkMUT2C6mrMrfNbsyqrjjuzqAOpJHFTyS7FOStudOtSIKy9A1qx160e5015mijkMTia3kgZWABwVkVW6MO3euaX4t+B/KeQa6hRIvOyttMdyZwSvyfNg9cZx3xVKEnsiHJdzvaKjtp4rm3int3WSGVQ6OpyGUjII9sVJQAUUUUAIaY9PprUhorvULVO9QtUstFaUVm3A+atSYVn3IqDRHfaDIZdHtHbrsA/Lj+lX6xvCUvmaLGO8bMv65/rWzXt0neCZ5FRWm0FFFFWQFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV5prkxn1e7c8/vCo+g4/pXpZIAJPQV5VNJ51zJIf42Lfmc1xY16JHZg1q2W7QcCr7SpbW8s8pxHEhdj6ADJqpajpWX47uTB4fMCNh7lxH77Ryf5Y/GuCKuzvjHnkonnV7PJdS3NxN/rJWMrexPaus8JAgwnHO0Kme3vXH3HEW4dSMGu38MbUIlb7qrx9K9LD9R5tpGCXmdyv3FijJwO5/U1z3jGLNssyKcxnIx7c1tWxcRbj/rJSAF9Pam6uhlhEcQDMvK+5Hetqsowg5Sdkl1PGpycZpo5a90wNqltCjkNIuHJGcHBP9P1rmdV0u4vobu0shvmQMy4IGRznr+NdTBqJWRru4QPLGzBgvHIyKztOuls9VjuJQShDKwXqcjivnv8Aa6dOV/eagvnLW/n2PpKcnYxNGLXngFN2S+mXhQf7jgEfq36UtvMselXEZ+8bgyJ9GUA/qtO8Esraxrmj42x3kDNEG7MhOPxw2fwqDTrOS+1S209VP7xwjeoX+I/gM08PFe0nTelnzL5r/O5rFK7T6anX+A9IFrYNqEiAS3P3eOidvz6/lXUk5HNTvGsaKkahUUBVUdABUDe1dTd2eZOo6knJjNLf5Zoz/AxFXgax7RzHqcqdnAatPdSIsR3pxGGHYg/rWJ8QPC0XjPwxNo01y1tHLJHIZFTf9xw2MZHXGK2brmF/pVi2bdEh9RTi2ndCkrqzOJ8SfDTQ9S0C203TYItKW2uxfRNDCrq0uCCZFb74IODk54HPFZOk/DibTL+G90bW10/VYYpLdpodPiETxSMHI8roCGAO7OfXNenSdKqQnF24/wBkGrdSS0uSoROE1n4aPfr4iiOuzC21o20syNbKzLNC0R3hgR1ERGP9rPao9c8BxSrfr9vf/iYa3Dqp/dD5Cm35OvIO3r79K9ImrG1J8vAP+mq/zpOpIapxOF0f4S2OnXspivVaxcXCrG1nH56LMjqyif72BvOOM9ASRxS2nwlmEBjvPEb3gTSV0eFZ9PiZI4VljkUFejcR7eeecgggV6bGKsp0pqrLuS6cTm/h34RTwbo81hHfTXglnaf5xtSPIA2xrk7V4zjJ5Jrm7D4SQWmjW1gNXkYQaJd6MH8gDInYsZMbuoz07+tempT6OeW4nFbGD4b0O60YpE+qyXNjFZ29rDbNEqiMxrtLgjkluOD0xW9RS4pPUewlFLig0ANNManmmNSKRC9QtU71CahlIglHFZ1zWnL0rNuuhpGkTpvAsmbS6j/uyBvzH/1q6auO8CPi5u09UVvyJ/xrsa9bDO9JHmYhWqMKKKK3MAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAKuqyGHTbqQdViYj8q8xiGWFej+I3KaJeEd0x+ZxXnUI+avOxr95I78GvdZpWo6VxXjq7+0a3HbqfktU2/wDAmGT+m2u0jkWGJ5JDhEUsx9AK8uMz3lzNcSf6ySQykfU5x/Suekj1cLG8nLsVb0bE2+4/U12Phx/NljXPyqAxrktYAEkODwcVr6PI8MamM4d+BXZSnyseOw/tqaa3R6RbzZYv2Hyr/U0SSYjLHG5hxjsO1YWm3fnMIS+AOp9h1rSubhMogYbQMk5/SoxnLWUKDjdTevklr+iVutzweSVOTvujG0qPytT1BCPlMRkA9+n9KyYI1a4tlkAZRIoYeoDY/lWi8bXWo3E0cojS2jy3Gd+e2fwrPm/dzNjg5Dj/AD+VcjhGVetyy1dl6af8G57WGvyK+9jG8RSL4e8eWd7EoSGOZC2P7jDa36Gu58OaMYPFWq3jr+6Q7Ij2O/5iR9BgfjXD+ObK6e3D3xDzEAlsg5U8A/oK9I8G3M0+h6e1yD5klqjH3IABP4gqa4ad4OjNyvePK33aV1+TLrtqnddVY15hVV6uSVTlHNdzOBGdMdmqQMP4lINaYasq7ONQtj9a015FIsSQ5BHtTtNbdap7cUxutJpR/ckejEfrTW4nsXJfu1RjP+nH/cH86uy9Kz1/4/v+Af1oe4ki1K2Qaw9Rb97CfSVf51sScKaxb3JK+u9f51LepSWhvxdBVharQ9qtqKpEMkWnUgpRVIkUU4CgCnAVSRNxMU01JimNTaBDDTDTzTTUMpED1C1TyVA1Qy0RydKzrrvWi/Ss+570mXE0fBDY1aVfWI/zFdxXCeDTjWiPWNh/Ku7r08I/3Z5+L/iBRRRXUcwUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGP4t/5AU/1X/wBCFcHAPmrvPFn/ACBJv95f5iuHgHNeZjPj+R6OE+ApeKrr7LoE4U4efEK/j1/TNcNYf6xSeh4/Gt7x5c5ubO1B+6plI+vA/k1ZemQh43DD3qKa0PaorlpXfUz9WU/a4k/hGSK1rAYQP2AwP61jai5a/Cn7yjaf8a3LcDyoox0I5+netEaz+FGvoEMcs7yT/wCqVS7Z/ujp/jWfqNyYYXUZUO+5VznA9K0LqyNubV3k+eRd7R4+6O3+fasjV1yUfsTgfTmubDyVScq8JXT0XbRu/rd9TmUYzlqNh1U2Wl3sexna4VQr5+7jP+NaUrJNDbzLyJFxn6//AF8VDbRD/hC9Rz1eUKM9sbTVbSHM+hbMfPESv0x0/pU4SUZzquKs+az87Jfd2NJJWuu5Y8T3Ud4luikn9wEfI79/513Gkyq2maZPEoVDEg2r0XA2kfhkf981xmrwxPoNndxIA+8q5HfPStzwRcG50Oe1LYe2lOPZXz/UtXFKMfqrVJP3G/8AyV/r+RhVSdNNdDrnHFU5hzVmKTzYUcjBI5Hoe4qCYV3KSkro4NjGvf8AkIQfQ1owvkVnamNt1bv23bfzqxG208UMtFw9abpowjf7x/nUc0xFtIy/eCnFPs9vkqATgjr60IGi3MRjisxm2aihY4DIQPrmtAovUkms/UXAj+Uc7hj65oYkWJjgGsa6b54veQVp3T8e9Y1wxa9tkHZtxqepa2OltuQKuLVO0+6KupVoyY+nCm04VaIY9aeBTVp61aJYEVG1THpUT05CREaaaeaY1ZGiIXqB6sPVd6hlojfpVC56GrzdKo3HepZpEteETjXY/dWH6V31efeFjjXrf33D/wAdNeg16eD/AIfzPPxnx/IKKKK6zlCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAyPFYzok3sy/zFcRAOa7fxX/AMgSb6r/ADFcTbjmvMxnx/I9HCfAcD4pl87Xrpu0bLGPoFGf1Jq1YDy7cP8Agfoayr6QS6reP2eZ2H03H+mK2bVNtkUPccfSiGiPclpBI56//wCQo/4V0ujW/no0jsVjUcsOw7Ae5NcldMz6gwPXIBrsLObzZtPtY1EcKOjMAc7jkcmufEymqb5Pv7f8HsVV0ikW5Vll1CSO4mMrR5UvjHyjjFZniDgRqvBzxWhA/wA8jv8AfkYu3sOwqOd7aC9hn1FWMQfJUDP0B9quP7jDrS7S2X6HPF2kQf2RNb6LFcTybfOI/dY6ZBIP6Vn+HJNl7c2z/wAQz+I4/wAK17vWm1WzEWwq6ymTrwRzhfyNYTsLbV7adfuyfKT9axwLxDpt4lWld/d0NY8zTUtzZFvcS6XdIH/0aF8lc9z0P60/wNc+Trht3OEuo2jP1AyP5H86sw3EVut7HLnbcxDbgZ+YZ/xrn45fsWpQ3HI8qVZOPTOaqkpOdSE42V9PNNL9bkJc8ZR7nq1qTiRG653Y9M9f13UsoyKAR9qDKQUcce+eR/Jvzp7iubBXVL2b+y2vu2/Cx5j3MrUIfNgYD73UH3qlaXHmKQ/Ei8MK2JV6+lYepW7B/MiO1/aullJl9XGCD0NNsZCpaE9U+77r2rF/tGSDidN3uKZLq9uxVkZo5l6H+hpWHodU02VrNuH8y7RM/LH8zfXtWKviJzlcJu9RmmRaoVRhHGzOxyzN3NOzC6Ny4mCqzucAVT02Np7hrh+/Cj2qrbxXF5JunJC+ldBZwrGoUDpStYGzQtxhRVtKrR1YjqkZskFOFNFPFWiGPWpFpi1IK0RDCo3qXtUb02CITTTTmpprJmiInqvJVh+lV5KhlogbpVOfvVxulU5+9QaIl8Nf8h+1+p/9BNehV534eYLr1oT/AHiPzBr0SvSwXwP1ODGfGvQKKKK7DkCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAyfFWDok+fVcf99CuIiIjRnPRQSa7nxOM6Jcf8B/9CFefai/laPfSf3YHP8A46a83GfxEejg1eNvM81t90gRjy/U10uD9gV1528/UVztrlCn4D8a6XO21HZW6+xoR7tXdHJyANqUjDpurotPkKTwyYPDCRvoDwK53bi9kUn+P9K34jsg3/xN0/pUuKknF9S6uyNLTx5tyMkAA4yemf8A61P8YSoYYrSHBiiOWb+8xq3bWiWelxvKM3Mx/djPQeprI18BIVUcsTn9a5IcmLmqqbtBtLs3tfztqvvOWNnURauMQ6BoyDhmDnP4/wD16wNbjPliRBjDbh7GtCWwNtbWLyTFhcJvAx/q+lR3SGSCSJ8bwO3f0Ip4GMY0nyu6bk7/APbz/LY1g0ndGzobRXU1k8yLIjcYYZ6jisXWYPJu5E/usyfrS+HZHfTnRWKywsQCOo9Ksa3azW7FbhxJKVDlgSc/iarl5cTzOXxR29Hv+JKXLOx2Ph66+1eHbKYt88A8th67P/sR+tbr+tcR8Prr93fWjc7cXCj6cN/Suzh4hCE5KEp+RwP0rnS9niZx/mSf3aP9Dgrx5ZNDJFzVC5iDDFaT9DVKTqa6TJGLdWqkHIrJltkDfdro7nGKxrn79SWiHULGKCCwkjUAywFmI7new/kBUmnwqVBIq1rS403Rz6wN/wCjG/xpmn8IKqejFHVGrbxgKMVehHIqtB90VbiFQgZZXpU8dQLViPpWiM2PFPWm05etUiWSrT6atPFaozYdqY9P7Ux6bBELUw09qYaxZoiJ6ryVYeq8lQzRFd6pz96tyVTnrM0Q/QBu160H+3n9DXo1eeeGhnxBa+xY/wDjpr0OvTwXwP1ODGfGvQKKKK7DkCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAzPEgB0W5z6D+YrzXxA+zw9fH/pmR+fH9a9M8QjOi3Wf7v9RXlvig48OXXvsH5utedi/4iPTy/Wy8zibVQZcHkHmuiKgWnltyMcH1Fc9ZDcVAOCDwa6d03aeHX769v5ihHtVXqjjgCb6QMckvjNdVpVk180jbgkMCEl2HAOP8/rXKoc3sjLzluBXWtcTWunDTDD5blt0jHgke9cuIlU5VCj8T/BdXbrb8yq19EiS0mklkEk0jNgbUyc4WodbQrCWb7xI49OelOsD+/wCB8q/z7U3W/wB5Gx/hXp7muqMVGNkjBfGireXv2yOxjjQo1vH5fJ4apE/ex8D516Z/UVN4hIjbSkxj/RE5pbaMyHev3wMEf3h/jXJgXGVFOCstdN+rLurJlLw9tXU7qHtIu4D37/0rS1e6julhjCsJYU8ty3f0x+tY9yTYa7bTfwOdp/H/ACK6kxJNpV6Ai+YjCUNjnH+c0sXKFPkqyWzt6c2n6k1NJKXcw/CFyLPxHbbuEkJhb8en64r0eDALpzkYzn2+X/2UfnXktwWhuN8Zw6kOp9xXqtrOtwbe5jPyToGx6blyP/Qf1rPGLlqU6nnb7/8Ag2McVHaRYaqkq4q41V5xxWxxGXdd6yZ1y2a17sday5uppFIu6+uND0N8f8s3X/x6qNj92tPxIuPDWhn2k/nWZY/cFXW+L7vyFR1X3/mbVvyBV2PtVK1PyirqdazQ2Tr1qzH0FV061ZTpVozY+nLTactUiSZafTEp1aozYopjU6mtTYELUxqkeomrFmiI3qtJU71BJWbNEVpKpzVckqnN3qDVFzwmudeiPorH9K76uF8GjOtsfSJj+oruq9XB/wAM87F/xAooorqOUKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDP18Z0a7z/cryjxaSPD0+OpeP/wBDFesa8M6Pd/8AXM15N4sP/Egk/wCuif8AoQrz8X/ER6mXbr1OLtHxMD2auqZitmp7EAH/ABrk7bBbafWupibdY7GGTjB96UT2ay1RjeHhap4iDXsqxwxuZPm6EjoPz5/CtG4ujdTTXbfelbKg9h2FYOp20ltLG8nHnDcp9QGI/pWpZN5kasfuoOPrXNClF1XXTu7W9LPX8d/QqaT940bFcSBc49TS61xAUQclT+AqO1bDBj1P8qtXyE27s45I/Kuroc70kmZeq2ZtLqGKSXzC8SydMbc54/StHSdyuobr1B9RWVq1+NRvI7iNCgWNUC5zwK2dIZZIlyeOoPoa5sJ7T2UfbfF1/pGk78quZvi+P7rL16g+hrT06JtVt7YRzeUXUEn14zio/EcXnWrA8MB+Rqp4OuykGDy0L9P6flVYhTdOSp/FZ29egnd07roUtRTawyMEEg12XhC5M2gIp5a2dk+oBDj9MiuV1SQXJlmVNgZi23Occ9K1/AlwFnu7duhCyj8Dhv0IrmxsZVMK3aztf5rUmqr0/Q7p+pqCX7pqSLIiUHqowfqOKjm+6auMlOKkup5tjNuxkGseQfMa17nvWWw/eUykbXiqIr4U0UkdB/MZrCsvuCus8ax/8UpppA+6UH/jhrkrH7grXEq0vuIw7vH7zZtegrQiFULUcCtGEVii5E6DFTp0qFanXpVozY6lWkpV7VSJJlp9MWn1qjNhTWp1NahgRPUTVK/eomrJmiIHqB6neq71mzVEElVJ+hq1JVSboag0Rq+CFzqdw3pFj9RXa1yPgVP3t6/so/nXXV6+FVqSPMxTvUYUUUV0HOFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBV1ZN+mXajqYm/lXj3ivP/CPzY670/8AQxXs9wu63lX1Uj9K8b8UL/xT13/s7T+TA1wYte9FnpZc/e+aOIh5YMOorq7L99ZApyQPz9q5WDhwf4TXW+H4zLLGijqw3D29aylNU4ub2Sue5X2uY/j+UL4hgsI/uWlmin/eJJP8xTbAf6NHGO/J+lU/F7+Z4y1lz2uFQfhGoq3pTfuWY/T8BXPglahC/VX+/UIr91E07fBuACenP+FalwhlEMIH32AJ9s1k2/G1j95vmNa8Q89EXOPMIUHHQV0zdoSu7aHPPR3MLxO//FRXWPu5VfoQoq9o4wuVPBPI9D61iahEINSuLdnLmNypYjGea2tAPVH54/MVjg4RhRhGLuklr8jWatBFrWR+6DHpjBrm9CcW2rzQ54fkV1GqLmJkbkY/MVxUrmDVoX/29pNdEtx0lzRaO18UIGmhlHSSIfn/AJxWL4cmFtrloWOFdjA30YYH64rUvrUNYRXofJZvLK4+prnJ90UrOhw6kOv1HI/lXDg4QjR9jF3Ubrtt0+RFNXjynrUDEhg3B4P5jJ/UmklHFRWk6zxxTIeJY9w+nUfo4qWU8VjhH+6Ue1192h5rVmZdzxms3BaUAcnNad2RzVG1TfdRgdSwH610jOw8eR48Nqv9yRP5EVwlgflr0jxlF5vhy7GOVCsPwYV5tYcZFdGMVpmOEd4G5angVpQ9Ky7TpWpD0rmibTLCCphUUYqUVoZMWlFJSimIlWpBUa1IK0RDCmtTqRqYiF+9RNUr1E1ZM0RC9V5KsvVaWs2axKspqpKeDVmXrVSY/Kag0R0/gZMWd0/96QD8h/8AXrpqwfBabdG3f35GP8h/St6vZoK1NHk13eowooorYyCiiigAooooAKKKKACiiigAooooAKKxPFGvHRktIbSzfUNUvZDFaWiOE3kDczMx4RFAyWwewAJIBNB/4SMzyN4gGkJCV+SOyMjMrehZ8ZHXsKANuiivlEeHtVtPi5Prl3otzFpKeMpJJNStbWQ3aoFygPrbMT8xAPQ+oBAPq6ivn6HWfiMPiBqCvNexzR311Hb6dLZyta3FttbyCrrD5ajO0l2lBzkEdqyPEA1/W/hpmTVPHE+uQNZXWqW0ummNIZBMokEQ8kbguWbCbhhFJ4yCAfTFFfP/AIo8XeL9Mj8VWWmDxLdGWPSZdDvG0tmzERELhnIjAVyd+5WAIJOAO2n4M1fxbN8YLm01KTWr3S2nujvED21taxKD5aSJJAFYnja0crE9TxmgD22iiigAooooACMjBryPX4C+l6jDj5vLfj3H/wCqvXK851WEJqd5E3Kl2/I//rrixi0TO3BS5ZM8mtWzgHoeRXVaDNJbXljbow+03MqnHdYAcsx+uNo/GuRjVkYx5wyHbn0I4rqvCLCTWY5JiZJ5JAXdupPb8PQDivOxsHUpSXSzv/l/n93U+hxC905/xAudY1yQjP8Apz4PpjFSaXJujVP738u9WdUjD3mtgjn7dL/Ss3SG2zLnsMVrh/4UPRfkOnrSOiHzOq/3jg/TvWujYMZXj5geOwFY0JDSlv7uFH9f6VsWmGjLHvwPpXRZSTT6nNUOY1tw+sXUqcgysR7jNa2hsWIK8kDI9x6Vjaj/AMf0mRjJyK19BBWUMPun9DUUoKnFQWy0N5/AjR1U5g3LyRyPcelcPq5P2lWQ9fmH5V3GqEDgdGGRXD6mf9LCdgSauQ8PudbDeGbw9sVNw3LJu/ujv+lY19xID68VreBnE1pd2khxmJkOf0/Q1m3SloAT95ev4da46EoqrUpxVtn63X/AIj7s2jufC0wm0KzYdY8IR9Mr/wDE1ryniuU8Bz5tby3P8Dbx+I/xT9a6mU8Vz0lyVakPO/3r/NHBWjabRmXZ61HpQB1K3B6GVf5in3fejQl8zVrRR/z1U/rXVHVoyeiZ6Drcfm6PepjJML4+uK8rs+Gr1+VPMidD0YEV5FCNshB6g4rrxy1TOfBPRo1bXpWpB2rLtq1bbtXFE6pluMcVJTUp1aIxClFJSimIkXpUgqNaeK0RDHUjUUjGmxET1G1SNUTVkzREUnSqstWZOlVZTWbNYlSTrVS4+6atP1qpc/dqDQ7rwumzQrUY5ILfmTWrVTSE8vS7RfSJf5Vbr3KatFI8abvJsKKKKskKKKKACiiigAooooAKKKKACiiigDlJQJPipbl+fI0aTywf4fMnTcfx8tPyrq65W4GPipYEcFtFuM++J4Mflk/ma6qgDzHVfigunfEXVNFu7UWmh6NZC71HUJ4piRuVioTahXGQo5PzHIXJFX4vi34WaymuJZdQgkhu4bKS2ksZfPEkwJiHlhSx3BTjGelW9c+HWka5feJbjUpLmSPXrOGyuIlYKEWIsVZDjIbLZ5yOBxWRp/wj061htUk1S7m+zajZ6jGRbWsHzWxYoreVEm7O85JyemCOcgF/w/8AFfwxrup2dhay30M92J/LN1ZSQoHhBMsRZgBvVQWIzwOvUUy2+LfhSezvbo3N5Db21ob8PNZyIJ7YNsMsWR867iBxzyKSw+FmkWmoadcm6u5hZXuoXoifbtkN4hWRWwM7QGOMc+uazR8F9HbSruwuNX1e5ifTTpNoZmiJsrYuHKJhBk5UfM+44AFAGofiZo/9qITciDShp1xfyPc2s8UuyJlDOqsgymD9TxgGt3wd4ssPFlpLc6ZBqEUKbSGu7V4RIGGQyEjDDjt074qjrPgSz1TWIdRe9vIJ4tKl0lfK2cRyFSX+ZSNw2jqCPUGo/hv8PdN8CDVH0+4mnn1GRJJ2aOKGMbAQoSKJEROCc4XJPU9KAMqX4z+EkmaNDq0zbZjGYtMnYTNC2JVjO35ivU44A5JFd3oup2mtaRZanpsvnWV5Ck8MmCNyMMg4PI4PSuHsvhRpVp/ZWy+vm/s/+0fLzs+b7b/rM8fw9v1zWx4d8EW2jWlpYG/vL3SYNJXSTp91te3lUE5kdMYLsp2nsRxigDraK5X/AIVx4H/6E3w3/wCCuD/4mj/hXHgf/oTfDf8A4K4P/iaAOqrhPFCbNcmPZwrfoB/StH/hXHgf/oTfDf8A4K4P/ia5Xxf4A8IW13btD4V0CNHQjCadCBkH2X3rmxSTp6nRhnaeh51qaCPVLwL0Ez8e241s+F2H9rWh7+YuCPrXK6/4V0C21y6jTQ9LWMlSqi0jAGVB4GPXNT6F4V8PvqNsH0DSZEaVQVazjPUj26VwVeV0pXfR/kfSSc5U72W3f/gHRX8Re/1tcfOl9Jj3BAOK561YR3DezZrUvvBXh1NZ15U8PaR5cNyu1BZR4VTGp4G3jqeK5a78MaFFesBoumbG5A+yx46/SjD8vsYNPovyJw8pONrL7/8AgHbQ5SFf7zfzNa9ueAg4BH6VxVt4X8OybP8AiQaQQBk/6HH/AIfWup0DTbDTLeRNMsbWzjkbLLbwrGGI4yQoHP8AhXQrGc+bqjL1oYv3GOwIrR0KUZ54yPyNZ2vEi/HHy4wauaWuHUg8Hg0upu1eCNLUyZITjhh0+tcXqOGvIyO+Sa7TUsRqp7NwfY1xeoZ/tHA6dvzpSKobmv4WIbXhAzbVmHb1FXdQg8m6uoOyucfSsq0k+xaxYzqOjD/61b+slnvzK6bDKuSPpXP+89vv7lvxv/kRP4790R+Cp/K1ry2PEsZBHupB/kGrt84jCnquV/LivN9OkNvrVs/TEwB+jcH9Ca9Ekb5mPTdh8fUc/rmuat7mKi/5l+T/AOCzlxUdblO8PBq34Pj8zXIT2QM36f8A16z7xuDWv4E51eT2hP8AMV10Veojiq6QZ3teU6jH5Or3kfZZmA+ma9WrzTxVH5XiO69GKt+aiuzGr3Uzlwb95oW26CtW2rJtD8orVtq86J3TLydKdTFp9aGIUopKBTESrThTVp4q0SwprU40xulNiQxqjanmmNWbLRDLVOarcvSqc1ZSNYlV+tVbkFiFHU8VZfrUUC+ZqFsn96RR+opRV2aPRXPSYlCRIo6KAKdRRXvHiBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHKXuU+KmjdxNot9+Gye0/n5n6V1dcrqX/JU/D3/AGBdT/8AR9hXVUAFFFFABRXCfGTXtY8K+FYPEGjSDyNOvIZdRhMYczWhbbIBnkEZByOwNcrB8TtSktNb12yayvdKudXXStCtpPMHniND5kiGGOSSTe4OAFwAM5AzQB7LRXh03xyvf+Ef0rU18NC2hnSc3dxdzTfZ7d4pTH5e+OB2DNtJBdVA9eDUp+K+u6Y3j3UNS0mwutH0S6torbyb3axEzQqoz5ZBBWUybu2NuDndQB7ZRXl3in4pXWl3/iWy03w9JqE2j3lnaeZHK7KVnhMpldUjZ1VMYIUOT7duw8AeI18WeE7LWF+y5n3hhaytJGCrsvBdEYdM4ZQRnB6ZoA6GiiigArm/GsBe0gnA/wBW5U/Q/wD6q6Ss7xDAbjRrpF5IXcPwOf6VlWjzQaNKUuWaZ4T4zj26tG/aSEc+4J/+tUGj3a2BkvpRkWqbwv8AfYnCj8WIrU8axborOb0Zkz9QCP8A0E1gQbpolhYqEWQS428lgCBk+nJOK8qcHUpcnfR+nX8D6im+aikdrqLLH4m1eP8A57xwzj3ypX/2WuJ1uLy7hT/Du4rrtTYy+ILB2A/0jTEyR3Ksf5Zrn9djJSRWHzr+voajA3+rQT6K33aGeGdmN0yTFu7d+grodPfChccAYrlNIk3Mi+p3V02nnNyq9h8x/D/69dkS6ytco+IofLmjJ75zT9EU/dYcEcH2p/iokKhAyc5P0pNCbcgI5xyP60dQi70y/qa7oSrfQ1xV22dQ5PKgA/ma7bVHHHowri5U8zUpPqKJF0SzqCkWSTD724Ee2Olddr8iXUVndRsG3xoxwfUf/Xrmr2LfYv6IMD61a0GTztFki6tGSB/T+lc86CnVhVv8N/xt/kTNXSl2Kt4Ck25eG6j6ivQ1lE9tBOvSRP8A7Ifo1cDegFVb3rrfD0vneHbfPWJyh9scfyC1y5g1B05/3kvv0Ma6vBMfeGt/wAgN9cNjkRYz9SP8K526bJrrvh+gEN4/8RKj+dduGV6iPMru1NnW1wHjqLZrcbj+OIH8iRXf1xnj+PFxZSeqsv5Ef4124pXps5MK7VEYtmflFa1tWRZ9BWvb9BXlLc9KRdSnio06VIK1MWLQKKBTJJUqQVGlSr0rSJDENRtUjVE1EgQw0xqcaa1ZM0RXl6GqU1XJapzVnI1iVW61Loyebrlovo+78uf6VE3Wr3hVN+uK39xGb+n9aqirzSCq7QbO5ooor2zxwooooAKKK5zxP438OeF7mK313VoLS4kjMojIZ2EYOC7BQdq543HA96AOjoqK1uIbu2iuLWWOa3mQSRyRsGV1IyCCOCCO9S0AFFZup67p2l6jpdjfXHlXWpytDaJsZvMdVLEZAIHAJ5xU99qNvYzWkVx52+6l8mLy4HkG7BPzFQQgwDy2B70AW6KKKACiiigDldS/5Kn4e/7Aup/+j7CuqrldS/5Kn4e/7Aup/wDo+wrqqAKl1fx21/ZWjw3TvdlwjxwO8abV3HzHA2pnoNxGTwOaXUNQtNOs7u6vbiOG3tYWnndj/q41BJY+wAP5Vx/jrwzqOs+NfB2p2SxG10v7f9oLPgjzrZo0wO/zGvLrH4IX0Gg6XaxWGnW93L4dvdO1KXzMiW5cAwM2PvBWAOe20egoA97uDputaKEuDBdaZqUIQK/KTxyL0565BrNn8EeGp/D1poUui2TaTaP5lvbFPlibJO5e4OWbn3PrXiWsfCDXL/TPD6HSLSOztdJbTrjS7a8gUxzlyzXKPLbyKGfuVCuOMMeRXU2HwvuzqXjTUtStYZ9QvdOgttLnkuTI6SDT/s8pJwBkkkbioyDnA6UAdk/w58DGK2t38P6V5dqSkUZQYTe2/ZjuCxztPHPSr974M8LXmo6hNd6Pp8t5qNuILrcgzPECuAw742Jg9to9K8OvvgbqQ0C7hsNNsIr9tA0+GF1m27dRiYebKD2bbkB/cjvXR3Hww1w/FeTX7hTe27axFqNvex3kMLwRAAGFw1u0rKFDDYsgRgRnacmgDqNU8O/DfRbi38PS6DZCXUt91HaW1szl2tYslgE5DhJCBjltxHOTXc+GrTT7LQbGHRrEWGn+Urw23kGExhhuwyEAq3PIIznOea8D0r4S+JLW4sFl0vShdWtnq8F1q6XIabU5LlGETyAqGGCccscZPTvLqfwz8aQ6Be6bptlplyuqeGdP0qd5b0xm2mt0w2BsIcHnHI/xAPoYyxiURGRBIRkJnkj1xSyOsa7pGVV6ZY4FeIWvw38QQ/Fm216Kz05bL7THNc3F3JFcsyJEFAhzEJYmz2EhTvyOKvfF34a3vjLxNqF/HZ2lzD/wjU1jaGZ8FL0zB0YDtgZ+btQB7Cro5YIyttO1sHOD6GldQyMp6EYryXwZ4P8AEHgrU/Et1omnWLx6gmmeVA9wVUyIjLdSH/aJbOf4iOa9B1vRr7UbtJrPxLq+lRqgUw2cdqyMck7iZYXbPIHBxwOOpIB5h4ytm/sm5Ug74JA2PTBwf0JrirVzvBH3h1HrXaeKvC2pLdahbt4s1yYupPzw2Q3ZHfFuP0xXlkGnXhIYa9qYP+5bf/Gq8uMeVtXPpsHUcqdrfl/melXUiyW/hq8DbSjTWpPuRkA/981D4ggDRFwuGHUf0rn5NIvpPBs10PEurt9ju45Vi8u0xkkKT/qM5wT3x7VoXWhX81j5o8Uay5xyDFadP+/FYYJJRnC+0n+Ov6kqTjLbr5GLpb7LwDsOK6mxkxM7D2UVwEmk3cN4ca/qeDzny7b/AONVt22lXwtw48S6uOM4Edr1/wC/NdSXmdNZt68r/D/M6bW18y1Zz16D6CoNBBU+x6Vmahomo/Ygp8TauxxjBitMep6QVc8Nq6RpFJK8rqADI4ALH1OAB+QFN7mdNtwasamrDbEwHUfMtctD817Lt6luPyFdTrR/chx1XnH8xXL6fj7QxzxuPNS9zWn8LNoxAxJF2xk1X8N5hvJkb7khJX3x1/pWmsZ+zE9Hf17elNEEcGm29zkBo70xH3DIv9VFZ1ans3Fvq7GfNo13Kt6mI2H93+hrqfD0ezw/HGP+WiyTEd8hhj9FNYOox5kkAH3uR+Iq9o95u8WHTlOYrS0jtmI6NJyX/LzAPwrz82i5U1FdLy+7/gtGVR3jZepcuPvV3PgWPbpEjY5aU/yFcJLk4z1xXpHhSPy9BtR3YFvzJr0sF70+Zdjy8U7Qsa1cr4+TNraP6SEfmP8A61dVXO+OV3aRGf7sw/ka7sQr02clB2qI5Sz6Cta36Csmz+6K1YO1eOtz1JF1KkFRJUorRGLFoFFAqiSRalXpUSVKtaRIYjVE1SNUbUpDQw01qcao6jPKhhhtgvnzMQGcZVABksR39MepFZstD5elUpqqzX9zDpks0zQtIJzCjEFFxv2ZIye+T9KgN/JLpdzcxCGRotwVgTsk29SPxyPwrKTNoosP3rZ8FJm9upMfdQLn6n/61YFvcNO06tC0ZjIBDMCckZ7cdx3rqvBUe22uZP7zgfkP/r1vhVeojLEu1NnR0UUV655YUUUUAFeK/Em31nwV4k8U+MrTSk1vS9V0yKzlTeQ9my5QErtJaI7stt5GCcd69qrg/jh4i1fwr8N9R1Xw8EF+kkMSyvtPkiSVU3hWBDH5gADxzk5xggHlun+B/FNl4btF8LC316xvfB8uiG4+2m3EUzSSv5ih1yy/PtXp0GSo5puo/DbxnceJ9Cv/AOzbdZNPfSyt5bzwq4jiRFmWRmBkLAhsBGCEdia6+H4qX+l65F4duND1HV7qxe1ttTvFO6RJZVViVWKEIypuGTmPOMgGnv8AF7UZPELaZp/hF7lX1S80e3mOopH5txb5JypX5VIGc5OPQ0Ac1YfDXxJD42sb+50eCa5g1a+u7nXDdqZLqGWN1hXYfmULuVdvQduOa0/Dvw01jSvD/gAQwPDq9pfR3GsStdmXAWKVQRuYggFx8q8e1XU+NhvNEstQ0nw69yx0WTXr6KW8WL7PbpI0bBG2nzH3I+BheAOQTirmsfFKe4j8URaLo121tpOkJqUmorcRI0SS2rzRkRuDlvlAxhhnrxwQDj7f4ZeJh4M1LSYdGtrPxHJbGO48QLqRZtUP2iOQo3G4B0Vhlx8uNv3WNZN/4R1Tw/Z+HLKfQrt7e78RLL/ZUl5AY3Bt3DKBEqxxoSBweD3xXoD/ABcew1Tw/plzpTeXf2tnIdQ1C5+zrM0ygnyysRjZlzyC0fPAFdR8QfGtz4X1LRNO07Rjqt9q32nyY/tQgVfJi8w5YqeCAfy79KAPGdU+E3i+TRNGgg0+Cae3W4MVrPdRXFnZLJMXWIpIM5RcDzIzu6gDA5+lbNHjs4I5tnmLGqt5eduQOcZ5x9a85+HfxTPi3WbayutDfS4bvSBrFtO92su+MSCNwwAG3DHjk5HJC9K6zxn4ps/CmjLqF5DcXCySLBEkC5DO5woZzhI1JwNzkLz16CgCpeHzfirpATk2ui3pl9vNntdn5+TJ+VdXXN+D9HvLSS/1fW3ifWtTZGmETFo7eJAfLgQnqq7mJbA3M7HAyAOkoAKKKKAPMPEOv6tP4l8cLZXz2ll4a0XfHCiqfOupYpJBIxIzhFRQB0ySTXNaX8Y9Q0PwrBJ4q0pbm5Tw1aa1FPa3O9roSNHD+8Hljy2LyBuAwAJxnFen3fhG1uPFVzrIlZY7+x/s/ULMqDHdoCdhPcMu5xnuGI9KTSfAXhXSLS9tdP0DT4re9jENxGYQwlQdEbdnK+3SgDzm8+IviK/bw5HNpd1oUz+J7OwmcwzLFe20sUrHZ58Ub4ymD8o5Xg4NX9E+Lt9qgs54/DkZttXs7670dUvSZZjanBSZfLxGX7EFsdDXbad4B8K6akKWOh2cAhuY7yPapys0YZUfOeqhmA7DJq1pHhHw/o+rXOp6Xo9laahcZ8yeKIKx3HLfTJ5OOp5NAHmEHx7tbwxR6dob3E12lotgDd7FubmUw+bAG2HBiFwmTznB4FdvpGqX9p8VNY8P3d093Y3FhHqtnvADW37wxSRZA5XIVhnpkitCz8C+F7L+zvsmh2UX9nTvc2m2P/Uyvjcy+hOB+Q9Km0jw3HY+KNY164uXur/UFjgUsoC28EeSsSD03MzE9yfYUAb9FFFABRRRQBxfjGIx6pHL/DJGPzFeJ6pD9k1a6hAwEkOB/snkfoRXv/jWAvp0cyjmJ+fof8ivFfG9v5epQ3CjiaPB/wB5f/rEV5tVctV+Z7+V1LrlL2jNG/hnU7Zj+9u0dYh6siF8/oKu6dL5+nq4OcqCw9eOtc5YX8dvdafLGCYrZctkYyzHL/phfwrW0UrbmSKNw8UbsgIORgEgEe2K4cJGUK03L7Wv3aflY6qkdWzn9ci8q53D7pNaFg++OJe2cn8P8ijxFBgMQPlP3fb2qvocgIOewru6nRfmp3OjJDWsrn02j+Z/pWbpDBZI5OgPBq0rZttvqMfn/wDrqlZkpNtYcOT/AD/wpmMNE0aGsOMMo6EZFc5pQzccfdDH+dbOrE+QCfvKcH6VjaWcFcdWpPc0gvcZ19uN8LE9BwPr3rN1tzF4LuZx1XUInH5gVoW/zQCNOCeB7VX8RqD4E1UAYC3MBH/fxRXLjnaMP8UfzOVOz+aEaZmjgniI3bQVJGRkf/rqv4ZH2PV4GLF5C7l3bq7Z3En64qLSJPN0qId4zsP8v8KW3Pl6lCf+mo/VcVpiIKVOXdpo1cbXR1N4Nt1Kg6K7D9TXpmiKV0eyB4Pkr/KvN79f+JjcD/bJ/M5r1G2G22iA6BAP0qsqfNTUvJHh4x6IkrE8Ypu0OQ/3XU/rj+tbdZ+vxedpM6dc4/mK9Kqrwa8jkpu00zhLQYUVpQ1DFasoxg1aijIPSvG5Wmes5JliOpRUaKfSpgprRIybCgUu2lCn0p2JuOSpRUaqalCmtIohsY1RtU5Q0wxmhpgmQGql7aGdo5EleGWPIV1APB6jB+g/KtIQk9qd9nJ7VPs2yudI5x9MC2lvCk8oMDF0c4JJwRzxz941Rn0be4kW4cS7y7kgYc8cFRgY+Uf49c9ebMntSpp+TyKX1dsr2yRzdvZGGJgCzu7F3c9WP+cD6Cuu8Nw+Tpig9WYt/T+lEenqByK0YUEcSovAArsw9B03zM5q9bnVkPooorrOUKKKKACs/X9G0/xBpU2m6xbLdWMxRniYkBijh15BB4ZQfwrQooA5vVvA3hrVta/ta/0mGTUTt3zKzIZNv3d4UgPjAxuBqS38GeH7e9iu4dNjW4ivptSR97cXEoxJJ16sD06egroKKAOPm+Gng6bTtPsJdBtmtbBGit0Jb5Y2bcyE5yyludrZHtWrJ4U0SRtaZtPizrNulrf4LATxKjIqEA8AKzDjHWtuigDlX+HvhV7+1vJNHhee2WJYtzuVHlALGSmdrFQowSCeBWxqehabqeo6ffX9qs13Yeb9mkLEGPzE2PjBwcqSOa0qKAOWT4feFktRbJpEQgGnNpITzH/49Wbe0X3uhbnPX3roPsFodN/s9reJ7LyvIMEi70MeNu0g9RjjmrNFAHF+GEl8M+JH8LvK8ulTW7XekmQ5aFEZVlt8k5KpvjKZ52sR0Su0rk/Go8jXPB9+oOYtUMD47pLBKmP++/LP/Aa6ygAooooAKK+eviZqPiHw74+1rwzpdzfMvjeG3XS5t7MtjNvEdxt5yo8sl+OhxUmt/EXWNC+KOneHdL1EnTYNVsdIksr6JBK0UiopkU8yPySfMJAyQMHqQD6Bor5Y1n4jeMNZ0rxhZxay63NvZT3Ub6PCjRQokqgDzFYTQttz/rBnr0xXW6v8VLzw/EyS65a31tN4Slv9OvhanbdX6vINoxkcBVyM9snrQB71RXz5pfxO8R3PxB8P6ddX0L2d8LEfZrCCOSQGSFXkMyMRIq5JPmJlFXGcng/QdABRRRQAUUUUAUdch8/SLtAMnyyR+HP9K8Z8Ywebo/mgZMLhvwPB/mK9zIDAg8g9a8u1qwUy3ti/CNuT6A9K4cWrNSPRy+pyS9Dy+0Izg4KmtrTX8h1XGEzwe30rBRWilaKQYZSVI9COtbOnS/wtg+oPeskfQ1VdGnqiK9sUI+U9Pb2rmLEmK4dD3OPzrrCge32nlG6c8g1yd2rQakufX86bIo6pxOkDDzEz05b8qk1G3Ed58gwQFcD8P/rVWgO/J9gtb3iKERyQyqOuUJ+nT+taRV4tnHUqclWEe9zntdcG2DA8MuD/AErM0tSCParWrtiB0bp1FQacCSAO/Ws+p2x+A6bTeULeowPp60muJv8AA+tdl82HB+jqam08ZUKMAn9BVjxH5aeENVtkx5qRRTMPZnwP/Qa87M6vJGnHq5R/BnFJ+99xyugNskvrc9jvH+fwqxMfLuo39HRvycVTtD5GuLGOkkZQ571a1LiPeOuwn+v9K9Fq6sdcl73qdtOvn6tt/vlBx7qteoAYGB0rxeTwxFP4ljudMv77S76V4iZraTcrHauC0Thkb/vnPvXcfbPGGjf8f2n2fiG0H/LbTmFrcge8MjFGPuJF9l7DPJkvq0WuyPncY9UjsKjuE3wsvrj+dYGkeNNE1O8Wx+1NZao3Swv42trg/wC6jgFx7rke9dGa9ZnGZb2SntTPsIBrWK03aKxdGLNVVaMwWeKd9lrR20ban2KH7Vmf9m9qPs1aG2jbT9ig9oyittipBBVsLS4qlSRLqMqeRR5Aq3j2ox7U/ZoXOyssIHapBEB2qXFLTUEhOTIxGKcFA7U6iqshXEPSloopiCiiigAooooAKKKKACiiigAooooAKKKKACiiigDlPiSMaLps2ATFrWmEAj+9eQp/7Pn8K6uuV+JnHhdJDz5Wp6dNj12XsDY/SuqoA53xJ4oTQ9f8NaW9q0za1cyWyyB9oi2Rl8kY5ztx2rFvPiz4Pg0XVdSh1M3SadbC7lhiiZZXjLBVZFcLuBZlAIOMkc1peMPCR8R6z4dv11B7M6RPLMBHHuaTfE0fDZ+UjdnOD06V5/o/wNktW1ZtQ8Sfa3v9En0Z5VsSkreY6v50jtKxdxtwemfbFAHbt8T/AAfFpunX1zrdvbw38PnxCQHcE3bCzgA7VDAruOBkHmr1x488LW+p3enTa5ZLf2sbyzW+/LoiR+YzEDnATnNcJrHwbuNUksLu5160m1CLTl0y6M+ml4LiJGYoREJgVYBsH5mBxnFb1l8OJLPT/GFva65PbS+IFjVLi2h8p7QpAsQKkNz93PG3rgetAEl98UtBEWnvo8o1JrnV7XSZoxuhe3ackK7K6g44J6DOOtWo/iNoUGnm61i9trMtez2cMcUjXDymI4YhUXdkDlhg7c8muM0X4Ivp98buXX4HkOp6ZqTLDpxiUmzMny8yscv5nLEnBBODnibWPgu1/o6WUeuW6OuoXt+s72DF4zcMGwjJMrKVxjO7Dd14FAHpOoeJtF07w9Frt9qNvb6RKkciXchwhWTGw59DkfnWRo/xL8HazqNnYaZ4gs7i9u2dIYRuDFlzlSCPlPBwDgntmo/Engdta8B6f4bfV7gvavaub64TzpJTC6tluRktt5Oe+eayIPhd5Wrpff2xnb4ml8R7Ps39+IR+Tnf2xnf+G2gD0qisKw0F7jwwuk+L7i28SMzMZ5LmyjSOYeYXQGLlflGwe5UHrVL/AIVx4H/6E3w3/wCCuD/4mgDqqK5X/hXHgf8A6E3w3/4K4P8A4mj/AIVx4H/6E3w3/wCCuD/4mgDqq4vxlAItSjmA4lTn6jj/AAq1/wAK48D/APQm+G//AAVwf/E1jeKfhx4OXTDNb+E/D8TRMCdmmwrkHjsv0rDEQ5qbNsPLlmjzDxZbC21t2XhZwJR9eh/UZ/Go7JtwAzhx3qXxf4J8OppyXFroGkxGJ/n8uzjXKnjnA9cVzVp4b0FiM6JpZI7G0j5/SuKDTR9NSnOdNaL7/wDgHf2T7gY3GDjkf4VgeI4ikwY/eU9fUVd8N6VpVg7Np2n2dk74DNBAsZOOxwBkc1J4mg3xk4wwFW9hUm1PUbojeYkK9y4/nXX+IEMmnbsfMkhauM8InzLuBT2bNehXKBwqOODMQa6aEbwZ5eZT5K8Wump5vrnMceO5FJp2FGTUviaI21ysJ6BiV915xTNMXcQT26VytWdmevCSlTUlszo7CeG1hee7bbEg3Oep9lHqSePqaqhLmXwn4lvb7IuLtVlKf881Bwqj6Dj65q7YRLL8rAEDk+3/ANerOrp/xTOvjoPsw6dgDXn4+iuR1Xv7qXl7yv8Af+iOOT1+44q8JS6gnPVZFH+P861NVQiEjtyPwIP+NUNYjP2NQPvferVv8S6Vbzj+ONTXoHY38LOy8NMJtX09+oKxH/xwV6VXmXg35rvSSOrRRn/xwV6bSylcuHSPnsd/EKWr6Tp+s2bWmr2NrfWzdYriJZF/Iiuc/wCEPutL+bwpr19pyj7tndk3tr04G1zvUeySKPauwor0ziOP/wCEi1/SOPEnh2WeFc5vtFY3SY9WhIEq/RRJ9apfEz4gr4S8JafrdlZm6t764ihFxOskcNqjgnzZgELhRjptzk44rvaxvE+hNrttBGmrappckMnmLNp8qozcEFWDKysvPQg8gGgDibb4r2ll4Qh1zWo7e8gkmkjW40OX7RAVQKcsZNhRvmxsPzZBxkVbv/i94ZtIFnRdTuoP7Ph1R5La0Z1itpCQJH9AMcjr7GqUnwR8NG1tY4LvVre4hluZ5LqOWMyXD3AUSlw0ZUEhVGVVcY4xWcfgtHJrTW76vfQ+GBottpPkwTqs9ysTsSsx8vGwgj7hUnnoKALkPxgs7XxTrWn6vaXP9nW1/bWdtf2ls8kIE0aMrTP0GWbAx+Vatv8AF3wrPr8mkxzXRdWnjS48n9zK8KlpEVs5yArYJABxwTU178L9DuoNZh86+ii1S8tb2VYnQCNrcIEVPk4X92uQcnrgiq9p8JtEstUu7qxvdTt7e5kmlayRojEryqwcqTGZAPmJC79ue3agCKy+M3hS4inmn/tOxto9OOqJNeWTxJPACFLR5+8cso988Zq/b/E/QXgna6i1GxuYLy2sprS6tik0b3H+pJXJG1vXPY5qrP8ACLw5c6fYWN49/cWtnpDaKiPKvzQllbexCj5wUUgjA9qJ/hNo11pWqW17qWtXN9qM9vcTapJcKLoPB/qdrBAo284+XuScnmgCTW/ix4a0i5ntZmvJbyK+bTvIihG55VRXbBYhcBWHJI68Zrc1nxhpui+DP+En1OO8g04JE7I0B85fMdUUFOucuOK5O4+DOjXGn3tpNrOuyre3bXly88kExlkZFQ7g8TL0Xg4yMnBAOK6LUvAOj33w9i8Gb7uDSIkgjRopAZQIpFkX5mBHJQZ46E4xxgAseDvGWneK5tUt7KC/tLvTZViuba+tzBKm5dyNtPZhyO/tXS1yMngSzPiLUdat9U1i0u9QvrO+uFtrhY0c2ybFiIC5MbD76knPqK66gAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDlPidk+FVRcbpdS06IZ6AvewKD+tdXXK/Ev/kXLP/sNaT/6cbeuqoAKKKxvGPiK18KeGr7XNQhuZrOzUPKtsgd9pYAkAkcDOTz0BoA2aK5afx5oEGsLYS3YVf7NGrSXbYWCK3LBVZ3JGCxPA71IPHnhM6KdXHiTSP7MEvkm5+1ps8zGdmc/exzjrjmgDpaK5CH4k+EZvEK6PHr2ntcvZC/SQXCeU0fPR84LAKWI7Lz0rabxHoiIrtrOmhGtPt4Y3SYNtx++6/6vkfP05HNAGrRWX4e8Q6P4jtHutA1Sz1G3R/LeS1mWQK3XBweDgjg1qUAFFFFABRRRQAVDeQC5tJoW6SKVqaik1fQE7ankt9bCaC4tZhgMGjb27V5rAjxzsj8SIxVh7g8ivY/FEHka1PtGFfDj8ev65rzLxLZta60ZFHyT/vF+v8Q/r+NeTFcknE+lwNXmVu5asG8wKycSDj6+xq7q6iaw3AfOox/9as+yAaMNH/rB1HTd/wDXrWmIksG/vgYIPf61sjWWkkzN8DwbppZu0Z24+pru7gkzIf8Apqa5LwOAI9QHowauuZcyJ/10b+VdlFWgjw8xlzYiRxHjoD7XZ4HOxv51QsTgBV+8f0q742YnUrdfSL+tVLDCrk8DvXLV+NnsYTTDR/rqdJpS+WAFySf1NWtc+Xwtryg8i1JJ9TmqmmNj524yMAeg/wAasa9lfCeujHzG1Ofz6Vx4/wD3d+sf/SkZT+I5q6UPDI56bcD6CpLImbwzGv8AEjMlLdJhEiHTaCfpUeggtYTQn/nsB+Yrpvbc6vs3O4+HIMlxprY+5Bz+CYr0yvPfAChdRCqMBRIoHphiK9CrXAW9imtjwMc71WFFFFdpxhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHJ/E87PCizcbYNS064bP92O9gc/oprrKzPFGjxa/wCHNS0mdzGl5bvB5i9ULDAYe4OCPpWL4W8YW9yYNJ8Qyw6b4ojAjnspm2ec44MkGceZG3UFc4zg4IIoA62quq2FvqmmXen3sYktbqF4JUP8SMCCPyJrjviT4j1zSdX8LaV4cOnJc61dS2zTXsLyLEFiZwwCsvPHevNtB+MXit9Hi1TULDTLuO68O3OrW9taxyI6SwSCM7iWOVPLEADA4ycZIBu+FfhDrOheBvEOmp4nJ1/UEgtrbUliI+z28AURRAZyOAwJByNwI5Gazh8FtYWC+kXUtMF/PfrfRSq94r27CHy8pN53mbs92ZgfQcYqWXxe8T/8I9dz3P8AYLNLc2ENtf8AmQmO2S4Yq8k8UVxKVRCOCWXOeQMEVT8FeLbyPXYW1DUotYil8YajEbyGWYRiJLNHzEiSlSuc4Rt4GeOeaAOztvhVqkOpWs8+u2995vh99Cv7i5tj5z5Z2EyENjd8+PmycDkkmsu1+EGvS2wh1vVNDvoofDi+H4IvscqoY0mjdWkxJuJxHglSpBII6c8Xf/FrX/EPhfxXZSXlo0TeHm1W2u7JBbzQsJo49pCTylfv5G4q/HIGa6zVvHer6He+NTpUeni6trjSrdJb26bDLLah3YJLMsZcAHCqY93fceoB6J8L/Cmq+FNLvYNa1mTVJbi482MMzuLdNoUIryMzsOP4jx0Hv2lea+H/AB5eah8F9V8WxPDc3tlZ3kyF7RoEd4Q5UMgkfjKjO1yDzgjtwV18VfHFjZ6jeXI8PyQ2NtpeoyRx20ql4rt1TylJkOCN2dxz9KAPoeisd/Euli31KWGeW6/s2YW91HZ28lxLHIdvy+XGrMT8wPAOByeAazf+E80j/nz8Sf8AhOaj/wDGKAOqorlf+E80j/nz8Sf+E5qP/wAYo/4TzSP+fPxJ/wCE5qP/AMYoA6qiuV/4TzSP+fPxJ/4Tmo//ABij/hPNI/58/En/AITmo/8AxigCDxtERf20vZo9v5H/AOvXG+JrA3elmRB+9gPmD3Hcfl/Ktvxd4y0q4s4WS08Qhkf+Pw/fqMEephHoK56DxfpZXDWuuEEYI/sO9P8A7SrzK8GqraR6eFq8sU+xgWa7lyh2v0IPT8a1FfzbRgcrIvHP8jXPXmu2EF3J5dvrOA2CG0e7U47HmKpP+EnsWg3Lb6xvHDY0i75Hr/q615Gj0I4iFRc1zY8Gttv9Qj6bow2PcZrsUb94hJ43Mf0ry7w74lsYdalZoNXIeJhhdJumPUdhHmuvj8XabiI/Ztc6n/mB3vp/1xrpo/AeVmNnXbXWxj+NCDqkOD/yyH8zVawXcAW6DkCsrxR4lsZr+Blg1bAiA+fSrpT1PYx0uk61a3lxHbxxaipfjMmn3Ea/izIAPxNc1RPnZ6+FnH6vBXO1007yGH3R09z61L4kZh4R1tl/54BR/wB9DNQ2jbVVV4J/QVL4injHhXU4v+WjQhtvom8AE/U5/I15+Y1VCik+sor8URL4jMuE2pvY8lQT7DHSqnh4K0s0cpAQzIXycDBPNaGofNhfXk/SqPhswnUrhboqIcqW3dMZPWuiu+WnJ+T232OiPwM9C+HUUaX0yx42RiUJg548zA/SvQK4L4bJH9ou2t8eSvmKm05G3zDjH4Cu9rqwH8CNz5/G/wAZhRRRXYcoUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVHNBFM0ZmijkMbbkLKDtPqPQ1JRQBHLbwyyRSSxRvJES0bMoJQ4xkHtxUVvYWdsYjb2lvEYlKRlI1XYpOSBgcDPOKs0UAU49K0+KGaGOwtEhn5lRYVCyf7wxz+NLDplhAUMNlaxlHMi7IlG1iMFhgcHHGfSrdFAFBdG0xBIF02yUSKVfECjcCckHjkEgH8Kkl02xmWZZbK2cTbfNDRKfM2jC7uOcDpnpVuigCIW0H2U23kRfZinl+VsGzbjG3HTGO1Qtplg6urWVqVdVRgYlIZV+6DxyB2HardFAEcNvDC0rQxRxtK2+QooBdumT6n3qSiigAooooAKKKKAMzxLEZtGuAOqgP+RrhLd9r4r0q4jE0EkZ6OpX8xXmcqmOQg8EHBrz8ZG0lI7sK9Ginr0GbmKUYAkXaT7jp/Oq9tZhCsiHKkfMn8xWhrKl9L3j/lm6t/T+tNsCGTrjd+hH/wBat8PadNX6EVJypTfK9zOg04WniG3ljJ2TRyD9M/0reGQtsP8AZZqgY7r+wBHKGT8tpq06bZLb02V0JJbHPUqSqO8mef8Ai1c31oe3lY/X/wCvUdowRR69APWrnilD5to3X5WH8qqWQC/Mx59fSuKr8bPo8I74eP8AXU27UiKIyS5PGTtGT9AKhvreT/hHtXuLrH2q5EYZQciNd4Cxj6D8yTU1m+VDkYx90H+dLqUhOkSKP47i3X/yKpP8q4MbSUoJ+cf/AEpXJluRXnCHP3iMn/Cs/wAHzQxa3cyXRAi28lhkc5q1qknBXu2f/r1W8MXENvLqk0p5MWxBjPJ6VWOTlQnFJu6tpvrobRX7tno3wp2vp1zLjBZuPYFmNd3XDfCZSNEkbsSP5sf613Nephlamkj57Gfx5eoUUUVucwUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXnmrxKl/cqvQSMB+deh1wmvoU1W6B7tu/MZrkxi91M6sK/eaKAjE9lPD13IQPrWTpJ3QYOc4z+I4rXs32y4rLXFrqEyNhU8xsfjyKnBy3iVio7Mu2mZtSfjiKMtn0JFaUigC1Jz02mqmjxlbOWZ/wDWXDfKP9gdKt3j4JiQfNGoNdpxnFeK4wsFsT/C5Q/rWTbLuILdOwrrfEFr9q0qV4xuYYkH1HX9K5C3cnAXr/KuOurSue/l8+ahbsbEZJwq9e/sKkvE32kCDOFuEc+wUMf54/OmWxRI+vPcnvUF3dBhhT8o/WsJwU1Z+T+53N7Xdilfyl5CR1bgewq3p5itdC1JAw+0SugIx2HP+NRWtsZpBI/fpWlqcsH/AAj8MULq0isTJjqCcnB/OsMXDmjCLTd5L5W9678roh1r1VSj03O4+FQK6IwPoh/Su2rjvhmMaOw/2Y//AEGuxr1MP/DR4mK/jSCiiitjnCiiigAooooAKKKKACiiigAooooAKKKKACig0UAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXCa6xfV7ok5w2PyGK7uuDu8SXlw+c7pGOfxrkxb91I6sLu2ZsZxKDUOoWX2rVIwx2xFQ7H1xxirEq4cYq/Db+cE3dB19x6Vy4eahO7OivHnjZBbR+YxZVxGMKg9FFSfZZPtjTlgQwwVrTig+UADA9KsJAMciuh1pyehgqUFuc0sD2s8ilN8D5I9vauI1rTm0u6bC/6O53RkenpXrUtqCvTisi9tI3Uxzxh4TxgjpT5vae7Lc1oVPq75o6rqjyzzmYYPC+nrVnT7SW+m4H7teWNdHqPhqBZC9ryv9wmn2Sraho2jMfy4AxVRoO/vHTVzKPL+7WpWWBUEIJCgggn0ql4ouI5TMYdpiUBVK98D/wCvW5bbBdxGUrtjjLYPeue1K3M2kiZB8zyNlR9a5asFVxWifuR+XvP80o/ic2DqqE+ab3PSfh0uzTZV9Ng/8drra5fwGMWt0OwZR+ldRXdh/wCGjmxGtVhRRRWxgFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFGaKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigBGOFJ9BXn8RyufWu+nOIJCeMKf5VwCDCCuLGbo7MLsyCXmUVs2o2otYo5nFbsQwgFccTqZdjfipPN4quvSnVqpMxcUT+d8uKqTAOjA96fUUx+U0OTYKKRh3B+cqx2sP1qrMc8P8A41dugruyPx3BqmUO8LnmvRhLmimcM1yyaGTRIlncSMAWOFUntxWP93RLdu/mk/8Aj1aWqxeSoYEkuCSO1ZdwpXRrXPd8/wDj1cmCtOM6qlzKUn8re7b8PmVPRpdj0bwN/wAg+4P/AE1/oK6Sud8ELjTJm9ZT/IV0VdGH/hodf+IwooorYyCiiigAooooAKKKKACiiigAooooAKKKKAEPUUtFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBDe/8ec//AFzb+VcKPuiu7uji2lOM4Q/yrhFGUFcOL3R2YXZlYf8AHwK3ITlFNYiY+0AGtaPcijHIrkidLLg6ClpkcgIGRzUuKszG5qC4fC+5qSVwKpzbm5PSk2NIzrtgd+44BIwfeopRIJAqIruEyAWwCfc9qddDeSB6gUA4uT6nCCu+M/Z0ed9Fc4qivNoxL/UJXvLiyuYlSeCNWJjfehDdBkgHP4UuqpstbSHuCox+NQxxG68Z6s5/1aSoD6ALGv8AUmn30ouL+Ijp5gx9BWWBf+yQk1a6vppvqKSvUt5no3goY0hz6yn+QrfrG8IxGPRIif42Zv1x/StmuiirU0FZ3mwooorUzCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAbIMxsPY1wcZzHiu+rgHDJPKp6hiP1rixi2OvC9SmxxOPrW5AwMYrCuARICK1LJsxiuOO51yWhoIRT81WaQRqWY4UdT6VBPOEeK4R90TfI+DkYPQ/n/OpqVYw3IsXJCDVG7mAGBUk8uBxVBsyPgVXNfYqKIkOZB7HNVbq+hsXtpJ8mS4mWGGMdXYnBP0AOSamurmDT4nmut2M7ERBl5G/uqPWs3TbKSfUYtU1dUF1kJbwr0gTPAHqfU96vEv29CVGm9Evefy2Xm+vZeZw7T5mQW8ix3mvBf8AWS3zrn0AAFQ2ih74EfdRSf6UxsJf6uR96S9kH4cVpaPaltpA+aVgB9K3g+XCQS7JfgOlG9X0PT9Gj8vSrRMYxGv8quU2NQiKo6KMCnV3RVlYwbu7hRRRTEFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVyF5albyfI6uf5119Urm1EkhbHWsa1PnRrSnyM5KW1J7U+2QpxiuiayB7VAthtfOK5HQaOpVkykENVbiwifJClGPUpxn69j+Nbf2Y1Ult7wkhRCB2OSayq0rqzjzfd+oKou5hSwXKcJOjD/AKaR5P6EVFbrdyztFA8LsOGZYyFjPuSTk+w/GtwaPJMQbmdyO6RjYD/X9a0YbNYYxHEgRF4AAwK41lsZ6OPLHtf9Nl8inWS2OElsjbXrv+8lm6ea/J/D0HsKfbo7XMRYMfnHX613BskY5Kg1Ddac7W8gthGs2PkLgkA++K9SomqEqdOPRpL5HKopyu2cFbaTJPfXzsCEe6kbPqNx6V0+kWGb+ABcKrA/QCtfTtLeG2Vbgo0pJZygOMk5OM1o2lqsTlgOcUqFKbhBT6JFucYX5S5RRRXecoUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAJtFIUFOopWC5GUHpTfLHpU1FHKh3ItgpdgqSijlQXGbKXbTqKLBcTbSgYoopiCiiigAooooAKKKKACiiigAooooAKKKKACiiigAooxRQAUUUUAFFFFABRRRQAUUUUAf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The femoral nerve (L2-L4) emerges at the lower border between the psoas and iliacus muscles, and passes beneath the inguinal ligament. The femoral nerve provides motor branches to thigh extensors, sensation to the anterior thigh, femur, knee joint, and medial leg. The saphenous nerve is the extension of the femoral nerve below the knee and is purely sensory.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 513px\">",
"   <div class=\"ttl\">",
"    Saphenous nerve block",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 493px; height: 289px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Medial view of the extremity: For saphenous nerve block,&nbsp;the tibial tuberosity is first marked. A subcutaneous ring of local anesthestic is administered posterior to the medial tibial condyle, or alternatively, around the saphenous vein if it is easily visualized with ultrasound.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10520=[""].join("\n");
var outline_f10_17_10520=null;
var title_f10_17_10521="Ceftriaxone: Drug information";
var content_f10_17_10521=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Ceftriaxone: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?23/39/24180?source=see_link\">",
"    see \"Ceftriaxone: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"    see \"Ceftriaxone: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F148198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Rocephin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F148199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Ceftriaxone for Injection;",
"     </li>",
"     <li>",
"      Ceftriaxone Sodium for Injection BP;",
"     </li>",
"     <li>",
"      Rocephin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F148250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibiotic, Cephalosporin (Third Generation)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F148203\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage range:",
"     </b>",
"     Usual dose: 1-2 g every 12-24 hours, depending on the type and severity of infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Acute bacterial rhinosinusitis, severe infection requiring hospitalization (unlabeled use):",
"     </b>",
"     I.V.: 1-2 g  every 12-24 hours for 5-7 days  (Chow, 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Arthritis, septic (unlabeled use):",
"     </b>",
"     I.V.: 1-2 g once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Brain abscess (unlabeled use):",
"     </b>",
"     I.V.: 2 g every 12 hours with metronidazole",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Cavernous sinus thrombosis (unlabeled use):",
"     </b>",
"     I.V.: 2 g once daily with vancomycin or linezolid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Chancroid (unlabeled use):",
"     </b>",
"     I.M.: 250 mg as single dose (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chemoprophylaxis for high-risk contacts (close exposure to patients with invasive meningococcal disease) (unlabeled use):",
"     </b>",
"     I.M.: 250 mg in a single dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Cholecystitis, mild-to-moderate:",
"     </b>",
"     1-2 g every 12-24 hours for  4-7 days (provided source controlled)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Gonococcal infections:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Uncomplicated gonorrhea of the cervix, pharynx, urethra, or rectum  (unlabeled regimen):",
"     </i>",
"     I.M.: 250 mg in a single dose with  oral azithromycin (preferred) or oral doxycycline (alternative to preferred) (CDC, 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Conjunctivitis, complicated (unlabeled use):",
"     </i>",
"     I.M.: 1 g in a single dose (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Disseminated (unlabeled use):",
"     </i>",
"     I.M., I.V.: 1 g once daily for 24-48 hours may switch to cefixime (after improvement noted) to complete a total of 7 days of therapy (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Endocarditis (unlabeled use):",
"     </i>",
"     I.V.: 1-2 g every 12 hours for at least 28 days (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Epididymitis, acute (unlabeled use):",
"     </i>",
"     I.M.: 250 mg in a single dose with doxycycline (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Meningitis:",
"     </i>",
"     I.V.: 1-2 g every 12 hours for 10-14 days (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Infective endocarditis:",
"     </b>",
"     I.M., I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Native valve:",
"     </i>",
"     2 g once daily for 2-4 weeks;",
"     <b>",
"      Note:",
"     </b>",
"     If using 2-week regimen, concurrent gentamicin is recommended",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Prosthetic valve:",
"     </i>",
"     I.M., I.V.: 2 g once daily for 6 weeks (with or without 2 weeks of gentamicin [dependent on penicillin MIC]);",
"     <b>",
"      Note:",
"     </b>",
"     For HACEK organisms, duration of therapy is 4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Enterococcus faecalis (resistant to penicillin, aminoglycoside, and vancomycin), native or prosthetic valve:",
"     </i>",
"     2 g twice daily for &ge;8 weeks administered concurrently with ampicillin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Prophylaxis:",
"     </i>",
"     I.M., I.V.: 1 g 30-60 minutes before procedure. Intramuscular injections should be avoided in patients who are receiving anticoagulant therapy. In these circumstances, orally administered regimens should be given whenever possible. Intravenously administered antibiotics should be used for patients who are unable to tolerate or absorb oral medications.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Note:",
"     </b>",
"     American Heart Association (AHA) guidelines now recommend prophylaxis only in patients undergoing invasive procedures and in whom underlying cardiac conditions may predispose to a higher risk of adverse outcomes should infection occur. As of April 2007, routine prophylaxis for GI/GU procedures is no longer recommended by the AHA.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Intra-abdominal infection, complicated, community-acquired, mild-to-moderate (in combination with metronidazole):",
"     </b>",
"     1-2 g every 12-24 hours for 4-7 days (provided source controlled)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Lyme disease (unlabeled use):",
"     </b>",
"     I.V.: 2 g once daily for 14-28 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Mastoiditis (hospitalized; unlabeled use):",
"     </b>",
"     I.V.: 2 g once daily; &gt;60 years old: 1 g once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Meningitis (empiric treatment):",
"     </b>",
"     I.V.: 2 g every 12 hours for 7-14 days (longer courses may be necessary for selected organisms)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Orbital cellulitis (unlabeled use) and endophthalmitis:",
"     </b>",
"     I.V.: 2 g once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Pelvic inflammatory disease:",
"     </b>",
"     I.M.: 250 mg in a single dose plus doxycycline (with or without metronidazole) (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Pneumonia, community-acquired:",
"     </b>",
"     I.V.: 1 g once daily, usually in combination with a macrolide; consider 2 g/day for patients at risk for more severe infection and/or resistant organisms (ICU status, age &gt;65 years, disseminated infection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Prophylaxis against sexually-transmitted diseases following sexual assault:",
"     </b>",
"     I.M.:  250 mg as a single dose (in combination with azithromycin and metronidazole) (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Prosthetic joint infection:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Staphylococci, oxacillin-susceptible:",
"     </i>",
"     1-2 g every 24 hours for 2-6 weeks (in combination with rifampin) followed by oral antibiotic treatment and suppressive regimens (Osmon, 2013)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Streptococci, beta-hemolytic:",
"     </i>",
"     2 g every 24 hours for 4-6 weeks (Osmon, 2013)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Pyelonephritis (acute, uncomplicated):",
"     </b>",
"     Females: I.V.: 1-2 g once daily (Stamm, 1993). Many physicians administer a single parenteral dose before initiating oral therapy (Warren, 1999).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Septic/toxic shock/necrotizing fasciitis (unlabeled use):",
"     </b>",
"     I.V.: 2 g once daily; with clindamycin for toxic shock",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Surgical prophylaxis:",
"     </b>",
"     I.V.: 1 g 30 minutes to 2 hours before surgery",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Cholecystectomy:",
"     </i>",
"     1-2 g every 12-24 hours, discontinue within 24 hours unless infection outside gallbladder suspected",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Syphilis (unlabeled use):",
"     </b>",
"     I.M., I.V.: 1 g once daily for 10-14 days;",
"     <b>",
"      Note:",
"     </b>",
"     Alternative treatment for early syphilis, optimal dose, and duration have not been defined  (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Typhoid fever (unlabeled use):",
"     </b>",
"     I.V.: 2 g once daily for 14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Whipple&rsquo;s disease (unlabeled use):",
"     </b>",
"     Initial: 2 g once daily for 10-14 days, then oral therapy for ~1 year.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F148227\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"      see \"Ceftriaxone: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage range:",
"     </b>",
"     Infants and Children: Usual dose: I.M., I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Mild-to-moderate infections:",
"     </i>",
"     50-75 mg/kg/day in 1-2 divided doses every 12-24 hours (maximum: 2 g/day); continue until at least 2 days after signs and symptoms of infection have resolved",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Serious infections:",
"     </i>",
"     80-100 mg/kg/day in 1-2 divided doses (maximum: 4 g/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Acute bacterial rhinosinusitis, severe infection requiring hospitalization (unlabeled use):",
"     </b>",
"     I.V.: 50 mg/kg/day divided every 12 hours for 10-14 days (Chow, 2012)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Community-acquired pneumonia (CAP) (IDSA/PIDS, 2011):",
"     </b>",
"     Infants &gt;3 months and Children: I.V.: 50-100 mg/kg/day once daily or divided every 12 hours.",
"     <b>",
"      Note:",
"     </b>",
"     May consider addition of vancomycin or clindamycin to empiric therapy if community-acquired MRSA suspected. Use the higher end of the range for penicillin-resistant",
"     <i>",
"      S. pneumoniae",
"     </i>",
"     ; in children &ge;5 years, a macrolide antibiotic should be added if atypical pneumonia cannot be ruled out; preferred in patients not fully immunized for",
"     <i>",
"      H. influenzae",
"     </i>",
"     type b and",
"     <i>",
"      S. pneumoniae",
"     </i>",
"     , or significant local resistance to penicillin in invasive pneumococcal strains",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Chemoprophylaxis for high-risk contacts (close exposure to patients with invasive meningococcal disease) (unlabeled use):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &lt;15 years: I.M.: 125 mg in a single dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &ge;15 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Epididymitis, acute:",
"     </b>",
"     Children &gt;8 years (&ge;45 kg) and Adolescents (unlabeled use): I.M.: 125 mg in a single dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Epiglottis (unlabeled use):",
"     </b>",
"     I.M., I.V.: 50-100 mg/kg once daily; reported duration of treatment ranged from 2-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Gonococcal infections:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Arthritis (CDC, 2010):",
"     </i>",
"     I.M., I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &le;45 kg: 50 mg/kg/dose once daily (maximum: 1 g) for 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &gt;45 kg: 50 mg/kg/dose once daily (maximum: 2 g) for 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Bacteremia (CDC, 2010):",
"     </i>",
"     I.M., I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &le;45 kg: 50 mg/kg/dose once daily (maximum: 1 g) for 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &gt;45 kg: 50 mg/kg/dose once daily (maximum: 2 g) for 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Conjunctivitis, complicated (unlabeled use):",
"     </i>",
"     I.M., I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &lt;45 kg: 50 mg/kg in a single dose (maximum: 1 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &ge;45 kg: 1 g in a single dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Disseminated (unlabeled use):",
"     </i>",
"     I.M., I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Infants: 25-50 mg/kg/dose once daily for 7 days (10-14 days for meningitis) (CDC, 2010);",
"     <b>",
"      Note",
"     </b>",
"     : Use contraindicated in hyperbilirubinemic neonates.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Children &lt;45 kg: 25-50 mg/k dose once daily (maximum: 1 g) for 7 days (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Children &gt;45 kg: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Endocarditis (unlabeled use):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &le;45 kg: I.M., I.V.: 50 mg/kg/day every 12 hours (maximum: 2 g daily) for at least 28 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &gt;45 kg: I.V.: 1-2 g every 12 hours, for at least 28 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Meningitis:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &le;45 kg: I.V.: 50 mg/kg/day given every 12 hours (maximum: 2 g daily); usual duration of treatment is 10-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &gt;45 kg: I.V.: 1-2 g every 12 hours; usual duration of treatment is 10-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Prophylaxis (due to maternal gonococcal infection):",
"     </i>",
"     I.M., I.V.: 25-50 mg/kg as a single dose (maximum: 125 mg) (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      Uncomplicated cervicitis, pharyngitis, proctitis, urethritis, vulvovaginitis (unlabeled use) (CDC, 2010):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &le;45 kg: I.M.: 125 mg as a single dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     &gt;45 kg: Refer to adult dosing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Infective endocarditis:",
"     </b>",
"     I.M., I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Native valve:",
"     </i>",
"     100 mg/kg once daily for 2-4 weeks;",
"     <b>",
"      Note:",
"     </b>",
"     If using 2-week regimen, concurrent gentamicin is recommended",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Prosthetic valve:",
"     </i>",
"     100 mg/kg once daily for 6 weeks (with or without 2 weeks of gentamicin [dependent on penicillin MIC]);",
"     <b>",
"      Note:",
"     </b>",
"     For HACEK organisms, duration of therapy is 4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Enterococcus faecalis (resistant to penicillin, aminoglycoside, and vancomycin), native or prosthetic valve:",
"     </i>",
"     100 mg/kg once daily for &ge;8 weeks administered concurrently with ampicillin",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Prophylaxis:",
"     </i>",
"     50 mg/kg 30-60 minutes before procedure; maximum dose: 1 g. Intramuscular injections should be avoided in patients who are receiving anticoagulant therapy. In these circumstances, orally administered regimens should be given whenever possible. Intravenously administered antibiotics should be used for patients who are unable to tolerate or absorb oral medications.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     American Heart Association (AHA) guidelines now recommend prophylaxis only in patients undergoing invasive procedures and in whom underlying cardiac conditions may predispose to a higher risk of adverse outcomes should infection occur. As of April 2007, routine prophylaxis for GI/GU procedures is no longer recommended by the AHA.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Lyme disease, persistent arthritis (unlabeled use):",
"     </b>",
"     I.M., I.V.: 75-100 mg/kg (maximum: 2 g) for 2-4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Meningitis (empiric treatment):",
"     </b>",
"     I.M., I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Uncomplicated:",
"     </i>",
"     Loading dose of 100 mg/kg (maximum: 4 g), followed by 100 mg/kg/day divided every 12-24 hours (maximum: 4 g/day); usual duration of treatment is 7-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Gonococcal, complicated:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &le;45 kg: 50 mg/kg/day given every 12 hours (maximum: 2 g/day); usual duration of treatment is 10-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;45 kg: I.V.: 1-2 g every 12 hours; usual duration of treatment is 10-14 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Ophthalmia neonatorum (unlabeled use):",
"     </b>",
"     Infants: I.M., I.V.: 25-50 mg/kg as a single dose (maximum: 125 mg) (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Otitis media:",
"     </b>",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Acute:",
"     </i>",
"     50 mg/kg in a single dose (maximum: 1 g)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Persistent or relapsing (unlabeled use):",
"     </i>",
"     50 mg/kg once daily for 3 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Pneumonia:",
"     </b>",
"     I.V.: 50-75 mg/kg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Prophylaxis against sexually-transmitted diseases following sexual assault (unlabeled use):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &le;45 kg: I.M.: 125 mg in a single dose (in combination with azithromycin and metronidazole) (CDC, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &gt;45 kg: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Skin/skin structure infections:",
"     </b>",
"     I.M., I.V.: 50-75 mg/kg/day in 1-2 divided doses (maximum: 2 g/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Typhoid fever (unlabeled use):",
"     </b>",
"     I.V.: 75-80  mg/kg once daily for 5-14 days",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F148204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F148205\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     No dosage adjustment is generally necessary in renal impairment;",
"     <b>",
"      Note:",
"     </b>",
"     Concurrent renal and hepatic dysfunction: Maximum dose: &le;2 g/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Poorly dialyzed; no supplemental dose or dosage adjustment necessary, including patients on intermittent hemodialysis, peritoneal dialysis, or continuous renal replacement therapy (eg, CVVHD).",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F148206\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No adjustment necessary unless there is concurrent renal dysfunction (see dosage adjustment in renal impairment).",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F148175\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed in D",
"     <sub>",
"      5",
"     </sub>",
"     W: 1 g (50 mL); 2 g (50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution: 250 mg, 500 mg, 1 g, 2 g, 10 g",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Rocephin&reg;: 500 mg, 1 g [contains sodium ~83 mg (3.6 mEq) per ceftriaxone 1 g]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F148159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F148179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not admix with aminoglycosides in same bottle/bag. Do not reconstitute, admix, or coadminister with calcium-containing solutions. Infuse intermittent infusion over 30 minutes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     I.M.: Inject deep I.M. into large muscle mass; a concentration of 250 mg/mL or 350 mg/mL is recommended for all vial sizes except the 250 mg size (250 mg/mL is suggested); can be diluted with 1:1 water and 1% lidocaine for I.M. administration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Infuse intermittent infusion over 30 minutes.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F148255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W with KCl 10 mEq, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     NS with KCl 20 mEq, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W, NS, mannitol 5%, mannitol 10%, sodium bicarbonate 5%, bacteriostatic water, sterile water for injection.",
"     <b>",
"      Incompatible",
"     </b>",
"     with calcium-containing solutions (eg, LR, Hartmann&rsquo;s solution, parenteral nutrition solutions).",
"     <b>",
"      Variable stability (consult detailed reference)",
"     </b>",
"     in peritoneal dialysis solutions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Daptomycin, diltiazem, famotidine, methotrexate, sodium bicarbonate, theophylline, tigecycline.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Amphotericin B cholesteryl sulfate complex, amsacrine, azithromycin, caspofungin, filgrastim, fluconazole, labetalol, pentamidine, vinorelbine.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Acyclovir, allopurinol, amifostine, amiodarone, anakinra, anidulafungin, aztreonam, bivalirudin, cisatracurium, , dexmedetomidine, docetaxel, doxorubicin liposome, drotrecogin alfa, etoposide phosphate, fenoldopam, fludarabine, foscarnet, gallium nitrate, gemcitabine, granisetron, heparin, hetastarch in lactate electrolyte injection (Hextend&reg;), linezolid, melphalan, meperidine, morphine, paclitaxel, pantoprazole, pemetrexed, propofol, remifentanil, sargramostim, tacrolimus, telavancin, teniposide, thiotepa, vancomycin, warfarin, zidovudine.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Incompatible:",
"     </b>",
"     Acyclovir, allopurinol, amifostine, aminophylline, amiodarone, amphotericin B cholesteryl sulfate complex, amsacrine, anakinra, aninulafungin, azithromycin, aztreonam, bivalirudin, calcium chloride, calcium gluconate, caspofungin, cisatracurium, clindamycin, daptomycin, dexmedetomidine, docetaxel, doxorubicin liposome, drotrecogin alfa, etoposide phosphate, famotidine, fenoldopam, filgrastim, fluconazole, fludarabine, gallium nitrate, gemcitabine, granisetron, hetastarch in lactate electrolyte injection (Hextend&reg;), labetalol, leucovorin, linezolid, melphalan, meperidine, morphine, paclitaxel, pantoprazole, pemetrexed, pentamidine, promethazine, propofol, remifentanil, sargramostim, tacrolimus, telavancin, teniposide, theophylline, thiotepa, vancomycin, warfarin, zidovudine.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Foscarnet, heparin, lidocaine, metronidazole.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F148178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of lower respiratory tract infections, acute bacterial otitis media, skin and skin structure infections, bone and joint infections, intra-abdominal and urinary tract infections, pelvic inflammatory disease (PID), uncomplicated gonorrhea, bacterial septicemia, and meningitis; used in surgical prophylaxis",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F148246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of chancroid, epididymitis, complicated gonococcal infections; sexually-transmitted diseases (STD); periorbital or buccal cellulitis; salmonellosis or shigellosis; atypical community-acquired pneumonia; acute bacterial rhinosinusitis (ABRS); epiglottitis, Lyme disease; used in chemoprophylaxis for high-risk contacts (close exposure to patients with invasive meningococcal disease); sexual assault; typhoid fever, Whipple&rsquo;s disease",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F148257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       CefTRIAXone may be confused with CeFAZolin, cefoTEtan, cefOXitin, cefTAZidime, Cetraxal&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Rocephin&reg; may be confused with Roferon&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F148248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Local: Induration (I.M. 5% to 17%), warmth (I.M.), tightness (I.M.)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Eosinophilia (6%), thrombocytosis (5%), leukopenia (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Transaminases increased (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Tenderness at injection site (I.V. 1%), pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal: BUN increased (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Abdominal pain, agranulocytosis, alkaline phosphatase increased, allergic dermatitis, allergic pneumonitis, anaphylaxis, anemia, basophilia, biliary lithiasis, bilirubin increased, bronchospasm, chills, colitis, creatinine increased, diaphoresis, dizziness, dysgeusia, dyspepsia, edema, epistaxis, erythema multiforme, exanthema, fever, flatulence, flushing, gallbladder sludge, gallstones, glossitis, glycosuria, headache, hematuria, hemolytic anemia,  jaundice, leukocytosis, Lyell&rsquo;s syndrome, lymphocytosis, lymphopenia, moniliasis, monocytosis, nausea, nephrolithiasis, neutropenia, oliguria, palpitation, pancreatitis, phlebitis, prolonged or decreased PT, pruritus, pseudomembranous colitis, renal and pulmonary ceftriaxone-calcium precipitations (neonates including some fatalities), seizure, serum sickness Stevens-Johnson syndrome, stomatitis, thrombocytopenia , toxic epidermal necrolysis, urinary casts, urticaria, vaginitis, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Reactions reported with other cephalosporins: Angioedema, allergic reaction, aplastic anemia, asterixis, cholestasis, encephalopathy, hemorrhage, hepatic dysfunction, hyperactivity (reversible), hypertonia, interstitial nephritis, LDH increased, neuromuscular excitability, pancytopenia, paresthesia, renal dysfunction, superinfection, toxic nephropathy",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F148182\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to ceftriaxone sodium, any component of the formulation, or other cephalosporins;",
"     <b>",
"      do not use in hyperbilirubinemic neonates",
"     </b>",
"     , particularly those who are premature since ceftriaxone is reported to displace bilirubin from albumin binding sites; concomitant use with intravenous calcium-containing solutions/products in neonates (&le;28 days)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F148163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elevated INR: May be associated with increased INR (rarely), especially in nutritionally-deficient patients, prolonged treatment, hepatic or renal disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull;  Hemolytic anemia: Severe  cases (including some fatalities) of immune-related hemolytic anemia have been reported in patients receiving cephalosporins, including ceftriaxone.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pancreatitis: Secondary to biliary obstruction, pancreatitis has been reported rarely.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Penicillin allergy: Use with caution in patients with a history of penicillin allergy, especially IgE-mediated reactions (eg, anaphylaxis, angioedema, urticaria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Superinfection: Prolonged use may result in fungal or bacterial superinfection, including",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gallbladder disease: Abnormal gallbladder sonograms have been reported, possibly due to ceftriaxone-calcium precipitates; discontinue in patients who develop signs and symptoms of gallbladder disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal disease: Use with caution in patients with a history of GI disease, especially colitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal/hepatic impairment (concurrent) Use with caution in patients with concurrent hepatic dysfunction and significant renal disease; dosage should not exceed 2 g/day.",
"    </p>",
"    <p style=\"text-indent:-4em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neonates: Use extreme caution in neonates due to risk of hyperbilirubinemia, particularly in premature infants (contraindicated in hyperbilirubinemic neonates). Fatal precipitation reactions in neonates due to coadministration of calcium-containing solutions have been reported; concurrent use in neonates is contraindicated.",
"    </p>",
"    <p style=\"text-indent:-4em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Precipitation: Ceftriaxone may complex with calcium causing precipitation. Fatal lung and kidney damage associated with calcium-ceftriaxone precipitates has been observed in premature and term neonates. Due to reports of precipitation reaction in neonates, do not reconstitute, admix, or coadminister with calcium-containing solutions (eg, LR, Hartmann&rsquo;s solution, parenteral nutrition), even via separate infusion lines/sites or at different times in any neonate. Ceftriaxone should not be diluted or administered simultaneously with any calcium-containing solution via a Y-site in any patient. However, ceftriaxone and calcium-containing solutions may be administered sequentially of one another for use in patients",
"     <b>",
"      other than neonates",
"     </b>",
"     if infusion lines are thoroughly flushed (with a compatible fluid) between infusions.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298998\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F148168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglycosides: Cephalosporins (3rd Generation) may enhance the nephrotoxic effect of Aminoglycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Salts (Intravenous): May enhance the adverse/toxic effect of CefTRIAXone. Ceftriaxone binds to calcium forming an insoluble precipitate. Management: Use of ceftriaxone with calcium-containing solutions within 48 hours of one another is contraindicated in neonates (28 days of age or younger).  In older patients, flush lines with compatible fluid between administration.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Cephalosporins.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ringer's Injection (Lactated): May enhance the adverse/toxic effect of CefTRIAXone. Ceftriaxone binds to calcium in the Lactated Ringer's forming an insoluble precipitate. Management: Use of ceftriaxone with calcium-containing solutions (including LR) within 48 hours of one another is contraindicated in neonates (28 days of age or younger).  In older patients, flush lines with compatible fluid between administration.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Cephalosporins may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F148171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F5952824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects have not been observed in animal reproduction studies. Ceftriaxone crosses the placenta and distributes to amniotic fluid. An increase in most types of birth defects was not found following first trimester exposure to cephalosporins. Pregnancy was found to influence the single dose pharmacokinetics of ceftriaxone when administered prior to delivery. The pharmacokinetics of ceftriaxone following multiple doses in the third trimester are similar to those of nonpregnant patients. Ceftriaxone is recommended for use in pregnant women for the treatment of gonococcal infections, Lyme disease, and may be used in certain situations prior to vaginal delivery in women at high risk for endocarditis (consult current guidelines).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F148212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/use caution (AAP rates &ldquo;compatible&rdquo;; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F148184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Low concentrations of ceftriaxone are excreted in breast milk. The manufacturer recommends that caution be exercised when administering ceftriaxone to nursing women. Nondose-related effects could include modification of bowel flora.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F148185\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Some products may contain sodium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323052\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (CefTRIAXone Sodium in Dextrose Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     20 mg/mL (50 mL): $17.03",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     40 mg/mL (50 mL): $40.33",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (CefTRIAXone Sodium Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 g (1): $4.80",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2 g (1): $91.72",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg (1): $1.90",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (1): $1.92",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (CefTRIAXone Sodium Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 g (1): $4.68",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2 g (1): $91.72",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 g (1): $41.75",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (CefTRIAXone Sodium-Dextrose Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 g 3.74% (1): $13.92",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     2 g 2.22% (1): $22.25",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (Rocephin Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1 g (1): $75.44",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (1): $44.88",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F148173\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prothrombin time. Observe for signs and symptoms of anaphylaxis.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F148186\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Acantex (AR, CN, PY);",
"     </li>",
"     <li>",
"      Amcef (MX);",
"     </li>",
"     <li>",
"      Aurofox (MX);",
"     </li>",
"     <li>",
"      Axone (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Axtar (MX);",
"     </li>",
"     <li>",
"      Benaxona (MX);",
"     </li>",
"     <li>",
"      Biotriax (ID);",
"     </li>",
"     <li>",
"      Broadced (ID);",
"     </li>",
"     <li>",
"      Brospec (ID);",
"     </li>",
"     <li>",
"      Cafalogen (PE);",
"     </li>",
"     <li>",
"      Cef-S (PH);",
"     </li>",
"     <li>",
"      Cef-Zone (TH);",
"     </li>",
"     <li>",
"      Cefacrol (PE);",
"     </li>",
"     <li>",
"      Cefaxona (MX);",
"     </li>",
"     <li>",
"      Cefaxone (KP, MY, SG);",
"     </li>",
"     <li>",
"      Cefin (CL, SG);",
"     </li>",
"     <li>",
"      Cefkizon (KP);",
"     </li>",
"     <li>",
"      Cefraden (MX);",
"     </li>",
"     <li>",
"      Cefriex (ID);",
"     </li>",
"     <li>",
"      Ceftrex (MX, TH);",
"     </li>",
"     <li>",
"      Ceftrian (EC);",
"     </li>",
"     <li>",
"      Ceftrianol (MX);",
"     </li>",
"     <li>",
"      Ceftrilem (MX);",
"     </li>",
"     <li>",
"      Cefxon (ID);",
"     </li>",
"     <li>",
"      Celltriaxon (MY);",
"     </li>",
"     <li>",
"      Cerixon (KP);",
"     </li>",
"     <li>",
"      Cetriaf (DO);",
"     </li>",
"     <li>",
"      Chef (TW);",
"     </li>",
"     <li>",
"      Cikedrix (PH);",
"     </li>",
"     <li>",
"      Ecotrixon (ID);",
"     </li>",
"     <li>",
"      Elpicef (ID);",
"     </li>",
"     <li>",
"      Eroxet (PH);",
"     </li>",
"     <li>",
"      Erphacef (ID);",
"     </li>",
"     <li>",
"      Exempla (AR);",
"     </li>",
"     <li>",
"      Ferfacef (ID);",
"     </li>",
"     <li>",
"      Forgram (PH);",
"     </li>",
"     <li>",
"      Glicocef (BR);",
"     </li>",
"     <li>",
"      Gomcephin (KP);",
"     </li>",
"     <li>",
"      Keftriaxone (IL);",
"     </li>",
"     <li>",
"      Keptrix (PH);",
"     </li>",
"     <li>",
"      Lendacin (HR, HU);",
"     </li>",
"     <li>",
"      Longacef (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Lyceft (IN);",
"     </li>",
"     <li>",
"      Megion (CR, GT, HN, MX, NI, PA, PH, SV);",
"     </li>",
"     <li>",
"      Mesporin (AE, BF, BH, BJ, CI, CY, EE, EG, ET, GH, GM, GN, IQ, IR, JO, KE, KW, LB, LR, LY, MA, ML, MR, MU, MW, MY, NE, NG, OM, QA, SA, SC, SD, SL, SN, SY, TN, TT, TZ, UG, YE, ZM, ZW);",
"     </li>",
"     <li>",
"      Mesporin IM (BB, BM, BS, BZ, GY, HK, JM, PR, SR);",
"     </li>",
"     <li>",
"      Mesporin IV (BB, BM, BS, BZ, GY, HK, JM, PR, SR);",
"     </li>",
"     <li>",
"      Monocef (IN);",
"     </li>",
"     <li>",
"      Newcef (KP);",
"     </li>",
"     <li>",
"      Novosef (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, RU, SA, SY, TR, YE);",
"     </li>",
"     <li>",
"      Oframax (BF, BJ, CI, ET, GH, GM, GN, IN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SG, SL, SN, TH, TN, TZ, UG, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Oncef (PH);",
"     </li>",
"     <li>",
"      Pantrixon (PH);",
"     </li>",
"     <li>",
"      Retrokor (PH);",
"     </li>",
"     <li>",
"      Rocefalin (ES);",
"     </li>",
"     <li>",
"      Rocefin (BR, CO, IT);",
"     </li>",
"     <li>",
"      Rocefort (GT, HN, NI, SV);",
"     </li>",
"     <li>",
"      Rocephalin (DK, FI, NO, SE);",
"     </li>",
"     <li>",
"      Rocephin \"Roche\" (CZ);",
"     </li>",
"     <li>",
"      Rocephin (AE, AT, AU, BH, CH, CL, CY, DE, EC, EG, GB, GH, GR, HK, HR, HU, ID, IE, IL, IQ, IR, JO, JP, KE, KW, LB, LY, MX, NL, OM, PE, PH, PK, PL, PT, QA, SA, SG, SY, TH, TW, TZ, UG, UY, VE, YE, ZM);",
"     </li>",
"     <li>",
"      Rocephin Roche (CZ);",
"     </li>",
"     <li>",
"      Rocephine (BE, FR, LU);",
"     </li>",
"     <li>",
"      Rocidar (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Roxcef (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Roxon (PH);",
"     </li>",
"     <li>",
"      Samixon (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Sintrex (TW);",
"     </li>",
"     <li>",
"      Socef (ID);",
"     </li>",
"     <li>",
"      Tacex (MX);",
"     </li>",
"     <li>",
"      Terbac (MX);",
"     </li>",
"     <li>",
"      Tercef (BG);",
"     </li>",
"     <li>",
"      Trexofin (SG);",
"     </li>",
"     <li>",
"      Triaken (MX);",
"     </li>",
"     <li>",
"      Triax (IL);",
"     </li>",
"     <li>",
"      Triaxone (SG);",
"     </li>",
"     <li>",
"      Tricef (TW);",
"     </li>",
"     <li>",
"      Tricefin (SG);",
"     </li>",
"     <li>",
"      Trijec (ID);",
"     </li>",
"     <li>",
"      Triox (MX);",
"     </li>",
"     <li>",
"      Trixone (MY);",
"     </li>",
"     <li>",
"      U-Ron (TW);",
"     </li>",
"     <li>",
"      Unocef (MY);",
"     </li>",
"     <li>",
"      Veracol (NZ);",
"     </li>",
"     <li>",
"      Xtenda (PH);",
"     </li>",
"     <li>",
"      Zefone 250 (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Zoxon (HK)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F148162\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs) which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F148181\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: I.M.: Well absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 6-14 L; widely throughout the body including gallbladder, lungs, bone, bile, CSF (higher concentrations achieved when meninges are inflamed)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 85% to 95%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Normal renal and hepatic function: 5-9 hours; Renal impairment (mild-to-severe): 12-16 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: I.M.: 2-3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (33% to 67% as unchanged drug); feces (as inactive drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Family Physicians and American Academy of Pediatrics, Clinical Care and Research, &ldquo;Diagnosis and Management of Acute Otitis Media: Clinical Recommendations.&rdquo; Available at file://www.aafp.org/x26481.xml",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, \"Transfer of Drugs and Other Chemicals Into Human Milk,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics. \"Gonococcal Infections,\" In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds.",
"      <i>",
"       Red Book&reg;: 2006 Report of the Committee on Infectious Diseases.",
"      </i>",
"      27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006:306.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Baddour LM, Wilson WR, Bayer AS, et al, &ldquo;Infective Endocarditis. Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association - Executive Summary:",
"      <i>",
"       Endorsed by the Infectious Diseases Society of America",
"      </i>",
"      ,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2005, 111:3167-184.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/15956145/pubmed\" id=\"15956145\" target=\"_blank\">",
"        15956145",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bradley JS, Byington CL, Shah SS, et al.  &ldquo;The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America&rdquo;,",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2011, 53(7):e25-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/21880587/pubmed\" id=\"21880587\" target=\"_blank\">",
"        21880587",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bradley JS, Compogiannis LS, Murray WE, et al, &ldquo;Pharmacokinetics and Safety of Intramuscular Injection of Concentrated Ceftriaxone in Children,&rdquo;",
"      <i>",
"       Clin Pharm",
"      </i>",
"      , 1992, 11(11):961-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/1464221/pubmed\" id=\"1464221\" target=\"_blank\">",
"        1464221",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bratzler DW, Dellinger EP, Olsen KM, et al, &ldquo;Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery,&rdquo;",
"      <i>",
"       Am J Health Syst Pharm",
"      </i>",
"      , 2013, 70(3):195-283.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/23327981/pubmed\" id=\"23327981\" target=\"_blank\">",
"        23327981",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Sexually Transmitted Diseases Treatment Guidelines, 2010,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2010, 59(RR-12):1-110.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/21160459/pubmed\" id=\"21160459\" target=\"_blank\">",
"        21160459",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Update to CDC's Sexually Transmitted Diseases Treatment Guidelines, 2010:  Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections&rdquo;,",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 2012, 61(31):590-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/22874837/pubmed\" id=\"22874837\" target=\"_blank\">",
"        22874837",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chow AW, Benninger MS, Brook I, et al, &ldquo;IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2012, 54(8):e72-112.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/22438350/pubmed\" id=\"22438350\" target=\"_blank\">",
"        22438350",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Committee on Adolescence, AAP, &ldquo;Sexual Assault and the Adolescent,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1994, 94(5):761-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/7936916/pubmed\" id=\"7936916\" target=\"_blank\">",
"        7936916",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Connor BA and Schwartz E, &ldquo;Typhoid and Parathyphoid Fever in Travellers,&rdquo;",
"      <i>",
"       Lancet Infect Dis",
"      </i>",
"      , 2005, 5(10):623-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/16183516/pubmed\" id=\"16183516\" target=\"_blank\">",
"        16183516",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Deeter RG, Weinstein MP, Swanson KA, et al, &ldquo;Crossover Assessment of Serum Bactericidal Activity and Pharmacokinetics of Five Broad-Spectrum Cephalosporins in the Elderly,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 1990, 34(6):1007-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/2393258/pubmed\" id=\"2393258\" target=\"_blank\">",
"        2393258",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dowell SF, Butler JC, Giebink GS, et al, &ldquo;Acute Otitis Media: Management and Surveillance in an Era of Pneumococcal Resistance - A Report From the Drug-Resistant",
"      <i>",
"       Streptococcus pneumoniae",
"      </i>",
"      Therapeutic Working Group,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 1999, 18(1):1-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/9951971/pubmed\" id=\"9951971\" target=\"_blank\">",
"        9951971",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fenollar F, Pu&eacute;chal X, and Raoult D, &ldquo;Whipple's Disease,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      ,  2007, 356(1):55-66.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/17202456/pubmed\" id=\"17202456\" target=\"_blank\">",
"        17202456",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Frenck RW Jr, Nakhla I, Sultan Y, et al, &ldquo;Azithromycin Versus Ceftriaxone for the Treatment of Uncomplicated Typhoid Fever in Children,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2000, 31(5):1134-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/11073741/pubmed\" id=\"11073741\" target=\"_blank\">",
"        11073741",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Frenkel LD, &ldquo;Once-Daily Administration of Ceftriaxone for the Treatment of Selected Serious Bacterial Infections in Children,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1988, 82(3 Pt 2):486-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/3405685/pubmed\" id=\"3405685\" target=\"_blank\">",
"        3405685",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gould FK, Denning DW, Elliott TS, et al, &ldquo;Guidelines for the Diagnosis and Antibiotic Treatment of Endocarditis in Adults:  A Report of the Working Party of the British Society for Antimicrobial Chemotherapy,&rdquo;",
"      <i>",
"       J Antimicrob Chemother",
"      </i>",
"      , 2012, 67(2):269-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/22086858/pubmed\" id=\"22086858\" target=\"_blank\">",
"        22086858",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hayton WL and Stoeckel K, &ldquo;Age-Associated Changes in Ceftriaxone Pharmacokinetics,&rdquo;",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 1986, 11(1):76-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/3948454/pubmed\" id=\"3948454\" target=\"_blank\">",
"        3948454",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kroh UF, Lennartz H, Edwards DJ, et al, &ldquo;Pharmacokinetics of Ceftriaxone in Patients Undergoing Continuous Veno-Venous Hemofiltration,&rdquo;",
"      <i>",
"       J Clin Pharmacol",
"      </i>",
"      , 1996, 36(12):1114-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/9013367/pubmed\" id=\"9013367\" target=\"_blank\">",
"        9013367",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lipsky BA, Berendt AR, Cornia PB, et al, \"2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2012, 54(12):e132-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/22619242/pubmed\" id=\"22619242\" target=\"_blank\">",
"        22619242",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Low YM, Leong JL, and Tan HKK, &ldquo;Paediatric Acute Epiglottitis Re-Visited,&rdquo;",
"      <i>",
"       Singapore Med J",
"      </i>",
"      , 2003, 44(10): 539-41.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/15024460/pubmed\" id=\"15024460\" target=\"_blank\">",
"        15024460",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Marshall WF and Blair JE, &ldquo;The Cephalosporins,&rdquo;",
"      <i>",
"       Mayo Clin Proc",
"      </i>",
"      , 1999, 74(2):187-95.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/10069359/pubmed\" id=\"10069359\" target=\"_blank\">",
"        10069359",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Osmon DR, Berbari EF, Berendt AR, et al, &ldquo;Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guideline by the Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2013, 56(1):e1-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/23223583/pubmed\" id=\"23223583\" target=\"_blank\">",
"        23223583",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sawyer SM, Johnson PD, Hogg GG, et al, &ldquo;Successful Treatment of Epiglottitis With Two Doses of Ceftriaxone,&rdquo;",
"      <i>",
"       Archives of Disease in Childhood",
"      </i>",
"      , 1994, 70(2):129-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/8129435/pubmed\" id=\"8129435\" target=\"_blank\">",
"        8129435",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schaad UB, Suter S, Gianella-Borradori A, et al, &ldquo;A Comparison of Ceftriaxone and Cefuroxime for the Treatment of Bacterial Meningitis in Children,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1990, 322(3):141-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/2403654/pubmed\" id=\"2403654\" target=\"_blank\">",
"        2403654",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Solomkin JS, Mazuski JE, Bradley JS, et al, &ldquo;Diagnosis and Management of Complicated Intra-Abdominal Infections in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      ,  2010, 15;50(2):133-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/20034345/pubmed\" id=\"20034345\" target=\"_blank\">",
"        20034345",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stamm WE, Hooton TM, &ldquo;Management of Urinary Tract Infections in Adults,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1993, 329(18):1328-34.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/8413414/pubmed\" id=\"8413414\" target=\"_blank\">",
"        8413414",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stephens I and Levine MM, &ldquo;Management of Typhoid Fever in Children,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 2002, 21(2): 157-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/11840084/pubmed\" id=\"11840084\" target=\"_blank\">",
"        11840084",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Trotman RL, Williamson JC, Shoemaker DM, et al, \"Antibiotic Dosing in Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005, 41(8):1159-66.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/16163635/pubmed\" id=\"16163635\" target=\"_blank\">",
"        16163635",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tunkel AR, Hartman BJ, Kaplan SL, et al, &ldquo;Practice Guidelines for the Management of Bacterial Meningitis,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2004, 39(9):1267-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/15494903/pubmed\" id=\"15494903\" target=\"_blank\">",
"        15494903",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Warren JW, Abrutyn E, Hebel JR, et al, &ldquo;Guidelines for Antimicrobial Treatment of Uncomplicated Acute Bacterial Cystitis and Acute Pyelonephritis in Women,&rdquo;",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 1999, 29(4):745-58.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/10589881/pubmed\" id=\"10589881\" target=\"_blank\">",
"        10589881",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wilson W, Taubert KA, Gewitz M, et al, &ldquo;Prevention of Infective Endocarditis. Guidelines From the American Heart Association. A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group,&rdquo;",
"      <i>",
"       Circulation",
"      </i>",
"      , 2007, 115.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?10/17/10521/abstract-text/17446442/pubmed\" id=\"17446442\" target=\"_blank\">",
"        17446442",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9229 Version 48.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-79.122.249.114-59E8FFCE15-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10521=[""].join("\n");
var outline_f10_17_10521=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148198\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148199\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148250\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148203\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148227\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148204\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148205\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148206\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148175\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148159\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148179\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148255\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148178\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148246\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148257\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148248\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148182\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148163\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298998\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148168\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148171\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5952824\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148212\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148184\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148185\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323052\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148173\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148186\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148162\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F148181\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9229\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9229|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?23/39/24180?source=related_link\">",
"      Ceftriaxone: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=related_link\">",
"      Ceftriaxone: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f10_17_10522="C3 glomerulonephritis EM";
var content_f10_17_10522=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F50927&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F50927&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 580px\">",
"   <div class=\"ttl\">",
"    Electron microscopy in C3 glomerulonephritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 560px; height: 479px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electron micrograph in C3 glomerulonephritis showing numerous mesangial (white arrows) and capillary wall deposits. Capillary wall deposits are noted in the subendothelial, intramembranous (yellow arrow), and subepithelial (red arrow) locations.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Provided by Dr. Sanjeev Sethi, Department of Laboratory Medicine and Pathology, Mayo Clinic.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10522=[""].join("\n");
var outline_f10_17_10522=null;
var title_f10_17_10523="Severity of illness score PILD";
var content_f10_17_10523=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F51188&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F51188&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Severity-of-illness score for children with chronic interstitial lung disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        1.",
"       </td>",
"       <td>",
"        Asymptomatic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2.",
"       </td>",
"       <td>",
"        Symptomatic, normal room air oxygen saturation under all conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3.",
"       </td>",
"       <td>",
"        Symptomatic, normal resting room air saturation, but abnormal saturation (&lt;90 percent) with sleep or exercise",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4.",
"       </td>",
"       <td>",
"        Symptomatic, abnormal resting room air saturation (&lt;90 percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5.",
"       </td>",
"       <td>",
"        Symptomatic with pulmonary hypertension",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fan LL, Kozinetz CA. Factors influencing survival in children with chronic interstitial lung disease. Am J Respir Crit Care Med 1997; 156:939. Official Journal of the American Thoracic Society. Copyright &copy;1997 American Lung Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10523=[""].join("\n");
var outline_f10_17_10523=null;
var title_f10_17_10524="Rheumatoid pleural effusion";
var content_f10_17_10524=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F77436&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F77436&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Chronic rheumatoid pleural effusion: Typical abnormalities",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_left\">",
"        Size",
"       </td>",
"       <td>",
"        Small to moderate; unilateral",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle1_left\">",
"        Appearance",
"       </td>",
"       <td>",
"        Milky-green, serous, or hemorrhagic",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle1_left\">",
"        Protein",
"       </td>",
"       <td>",
"        &gt;3 g/dL (&gt;30 g/L), consistent with an exudate",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle1_left\">",
"        Glucose",
"       </td>",
"       <td>",
"        &lt;29 mg/dL (&lt;1.6 mmol/L)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle1_left\">",
"        Lactic dehydrogenase (LDH)",
"       </td>",
"       <td>",
"        &gt;700 U/L, consistent with an exudate",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle1_left\">",
"        Cholesterol",
"       </td>",
"       <td>",
"        &gt;200 mg/dL (5.18 mmol/L), cholesterol crystals may be present under polarizing light",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle1_left\">",
"        pH",
"       </td>",
"       <td>",
"        &lt;7.20",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle1_left\">",
"        Rheumatoid factor",
"       </td>",
"       <td>",
"        &gt;240 IU/mL (&gt;1:320)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle1_left\">",
"        Complement",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle1_left\" rowspan=\"4\">",
"        Cytology",
"       </td>",
"       <td class=\"sublist1_start\">",
"        Cell number:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        &lt;5000/mm",
"        <sup>",
"         3",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Cell type:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lymphocytes (neutrophils and eosinophils acutely)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Bouros D, Pneumatikos I, Tzouvelekis A. Pleural involvement in systemic autoimmune disorders. Respiration 2008; 75:361 and Hooper C, Lee YC, Maskell N, BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65:Suppl 2:ii4.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10524=[""].join("\n");
var outline_f10_17_10524=null;
var title_f10_17_10525="ELISA";
var content_f10_17_10525=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F74627&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F74627&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Enzyme-linked immunosorbent assay (ELISA)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 302px; height: 196px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There are many experimental designs possible for the enzyme-linked immunosorbent assay (ELISA). Depicted in this figure is a common antigen-binding assay using two antibodies. Anywhere from one to three antibody reagents may be used, plates may also be coated with antibodies to interact with other molecules in solution. The reaction is measured by determining the absorption due to the chromophore generated by the enzyme linked to the detecting antibody. The solid-phase radioimmunosorbent assay is identical to that depicted here, except the detecting antibody is labeled with a radioactive isotope.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10525=[""].join("\n");
var outline_f10_17_10525=null;
var title_f10_17_10526="Clinical manifestations of early congenital syphilis";
var content_f10_17_10526=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F67809&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F67809&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical manifestations of early congenital syphilis*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Gestational/perinatal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stillbirth",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prematurity",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Birth weight &lt;2500 g",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nonimmune hydrops fetalis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Placenta",
"       </td>",
"       <td>",
"        Large, thick, pale (send for pathologic/histologic evaluation)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Umbilical cord",
"       </td>",
"       <td>",
"        Inflamed with abscess-like foci of necrosis within Wharton's jelly, centered around the umbilical vessels (necrotizing funisitis); barber-pole appearance (send for pathologic/histologic evaluation)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Systemic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fever",
"       </td>",
"       <td>",
"        May be more prominent in infants born to mothers who are affected late in pregnancy and whose serology is negative at delivery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hepatomegaly",
"       </td>",
"       <td>",
"        Splenomegaly occurs in approximately one-half of patients with hepatomegaly&mdash;isolated splenomegaly does not occur",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Generalized lymphadenopathy",
"       </td>",
"       <td>",
"        May be as large as 1 cm; generally nontender and firm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Failure to thrive",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Edema",
"       </td>",
"       <td>",
"        Due to anemia/hydrops fetalis, nephrotic syndrome, malnutrition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Mucocutaneous",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Syphilitic rhinitis (\"snuffles\")",
"       </td>",
"       <td>",
"        Can be an early feature, developing after the first week of life;",
"        <strong>",
"         contains spirochetes and is infectious (use contact precautions)",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maculopapular rash",
"       </td>",
"       <td>",
"        Usually appears one to two weeks after rhinitis. Oval lesions, initially red or pink and then coppery brown; may be associated with superficial desquamation or scaling, particularly on the palms or soles; more common on the buttocks, back, posterior thighs, and soles;",
"        <strong>",
"         contains spirochetes and is infectious (use contact precautions)",
"        </strong>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vesicular rash (pemphigus syphiliticus)",
"       </td>",
"       <td>",
"        May be present at birth, most often develops in first four weeks; widely disseminated; vesicular fluid",
"        <strong>",
"         contains spirochetes and is infectious (use contact precautions)",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Condyloma lata",
"       </td>",
"       <td>",
"        Single or multiple, flat, wartlike, moist lesions around the mouth, nares, and anus and other areas of the skin where there is moisture or friction;",
"        <strong>",
"         lesions contain spirochetes and are infectious (use contact precautions)",
"        </strong>",
"        ; frequently present without other signs of infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Jaundice",
"       </td>",
"       <td>",
"        Hyperbilirubinemia secondary to syphilitic hepatitis and/or hemolysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Hematologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anemia",
"       </td>",
"       <td>",
"        <p>",
"         Newborn period: Hemolytic (Coomb's test [direct antiglobulin test] negative); may persist after effective treatment",
"        </p>",
"        <p>",
"         After one month of age: May be chronic and nonhemolytic",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thrombocytopenia",
"       </td>",
"       <td>",
"        May be associated with bleeding or petechiae; can be the only manifestation of congenital infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leukopenia",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Leukocytosis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Musculoskeletal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pseudoparalysis of Parrot",
"       </td>",
"       <td>",
"        Lack of movement of an extremity because of pain associated with bone lesion; affects upper extremities more often than lower; usually unilateral; rarely present at birth; poorly correlated with radiographic abnormalities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Radiographic abnormalities:",
"       </td>",
"       <td class=\"sublist1_start\">",
"        Most frequent abnormality in untreated early congenital syphilis; not usually clinically discernable; typically multiple and symmetric",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Periostitis",
"       </td>",
"       <td class=\"sublist_other\">",
"        Irregular periosteal thickening; usually present at birth, but may appear in the first few weeks of life",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Wegner sign",
"       </td>",
"       <td class=\"sublist_other\">",
"        Metaphyseal serration or \"sawtooth metaphysis\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Wimberger sign",
"       </td>",
"       <td class=\"sublist_other\">",
"        Demineralization and osseous destruction of the upper medial tibial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Neurologic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CSF abnormalities",
"       </td>",
"       <td>",
"        Reactive CSF VDRL; elevated CSF white blood cell count; elevated CSF protein",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute syphilitic leptomeningitis",
"       </td>",
"       <td>",
"        Onset during the first year of life, usually between 3 and 6 months; presentation similar to bacterial meningitis but CSF findings more consistent with aseptic meningitis (mononuclear predominance); responds to penicillin therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic meningovascular syphilis",
"       </td>",
"       <td>",
"        Onset toward the end of the first year; hydrocephalus; cranial nerve palsies; intellectual/neurodevelopmental deterioration; cerebral infarction; protracted course",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"2\">",
"        Miscellaneous",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pneumonia/pneumonitis/respiratory distress",
"       </td>",
"       <td>",
"        Complete opacification of both lung fields on chest radiograph",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nephrotic syndrome",
"       </td>",
"       <td>",
"        Usually occurs at two to three months of age and manifests with generalized edema and ascites",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CSF: cerebrospinal fluid; VDRL: Venereal Disease Research Laboratory test.",
"     <br>",
"      * All of these findings may occur in other congenital infections; none is specific for congenital syphilis.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Ingall D, Sanchez PJ, Baker CH. Syphilis. In: Infectious Diseases of the Fetus and Newborn infant, 6th edition, Remington JS, Klein JO, Wilson CB, Baker CJ (Eds), Elsevier Saunders, Philadelphia 2006. p.545.",
"       </li>",
"       <li>",
"        Dobson SR, Sanchez PJ. Syphilis. In: Textbook of Pediatric Infectious Diseases, 6th ed, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.1826.",
"       </li>",
"       <li>",
"        Woods CR. Syphilis in children: congenital and acquired. Semin Pediatr Infect Dis 2005; 16:245.",
"       </li>",
"       <li>",
"        Saloojee H, Velaphi S, Goga Y, et al. The prevention and management of congenital syphilis: an overview and recommendations. Bull World Health Organ 2004; 82:424.",
"       </li>",
"       <li>",
"        Chakraborty R, Luck S. Syphilis is on the increase: the implications for child health. Arch Dis Child 2008; 93:105.",
"       </li>",
"       <li>",
"        Rawstron SA. Treponema pallidum (Syphilis). In: Principles and Practice of Pediatric Infectious Diseases, 3rd edition, Long SS, Pickering LK, Prober CG (Eds), Churchill Livingstone Elsevier, Philadelphia 2008. p.930.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10526=[""].join("\n");
var outline_f10_17_10526=null;
var title_f10_17_10527="Antiviral Rx HBeAg positive";
var content_f10_17_10527=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F52919%7EGAST%2F72908%7EGAST%2F68258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F52919%7EGAST%2F72908%7EGAST%2F68258&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Responses to approved antiviral therapies among treatment-naive patients with HBeAg-positive chronic hepatitis B",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       &nbsp;",
"      </td>",
"      <td class=\"subtitle1\">",
"       Placebo/control groups from multiple studies, percent",
"      </td>",
"      <td class=\"subtitle1\">",
"       Standard IFN-&alpha; 5 MU daily or 10 MU three times per week for 12-24 weeks, percent",
"      </td>",
"      <td class=\"subtitle1\">",
"       Lamivudine 100 mg daily for 48-52 weeks, percent",
"      </td>",
"      <td class=\"subtitle1\">",
"       Adefovir 10 mg daily for 48 weeks, percent",
"      </td>",
"      <td class=\"subtitle1\">",
"       Entecavir 0.5 mg daily for 48 weeks, percent",
"      </td>",
"      <td class=\"subtitle1\">",
"       Tenofovir 300 mg daily for 48 weeks, percent",
"      </td>",
"      <td class=\"subtitle1\">",
"       Telbivudine 600 mg daily for 52 weeks, percent",
"      </td>",
"      <td class=\"subtitle1\">",
"       PegIFN&alpha; 180 mcg once weekly for 48 weeks, percent",
"      </td>",
"      <td class=\"subtitle1\">",
"       Peg IFN&alpha; 180 mcg once weekly + Lamivudine 100 mg daily for 48 weeks, percent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Loss of serum HBV DNA*",
"      </td>",
"      <td>",
"       0-17",
"      </td>",
"      <td>",
"       37",
"      </td>",
"      <td>",
"       40-44",
"      </td>",
"      <td>",
"       21",
"      </td>",
"      <td>",
"       67",
"      </td>",
"      <td>",
"       76",
"      </td>",
"      <td>",
"       60",
"      </td>",
"      <td>",
"       25",
"      </td>",
"      <td>",
"       69",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Loss of HBeAg",
"      </td>",
"      <td>",
"       6-12",
"      </td>",
"      <td>",
"       33",
"      </td>",
"      <td>",
"       17-32",
"      </td>",
"      <td>",
"       24",
"      </td>",
"      <td>",
"       22",
"      </td>",
"      <td>",
"       NA",
"      </td>",
"      <td>",
"       26",
"      </td>",
"      <td>",
"       30/34&bull;",
"      </td>",
"      <td>",
"       27/28&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       HBeAg seroconversion",
"      </td>",
"      <td>",
"       4-6",
"      </td>",
"      <td>",
"       Difference of 18",
"      </td>",
"      <td>",
"       16-21",
"      </td>",
"      <td>",
"       12",
"      </td>",
"      <td>",
"       21",
"      </td>",
"      <td>",
"       21",
"      </td>",
"      <td>",
"       22",
"      </td>",
"      <td>",
"       27/32&bull;",
"      </td>",
"      <td>",
"       24/27&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Loss of HBsAg",
"      </td>",
"      <td>",
"       0-1",
"      </td>",
"      <td>",
"       7.80",
"      </td>",
"      <td>",
"       1",
"      </td>",
"      <td>",
"       0",
"      </td>",
"      <td>",
"       2",
"      </td>",
"      <td>",
"       3.2",
"      </td>",
"      <td>",
"       0",
"      </td>",
"      <td>",
"       3",
"      </td>",
"      <td>",
"       3",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Normalization of ALT",
"      </td>",
"      <td>",
"       7-24",
"      </td>",
"      <td>",
"       Difference of 23",
"      </td>",
"      <td>",
"       41-75",
"      </td>",
"      <td>",
"       48",
"      </td>",
"      <td>",
"       68",
"      </td>",
"      <td>",
"       68",
"      </td>",
"      <td>",
"       77",
"      </td>",
"      <td>",
"       39",
"      </td>",
"      <td>",
"       46",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Histologic improvement",
"      </td>",
"      <td>",
"       NA",
"      </td>",
"      <td>",
"       NA",
"      </td>",
"      <td>",
"       49-56",
"      </td>",
"      <td>",
"       53",
"      </td>",
"      <td>",
"       72",
"      </td>",
"      <td>",
"       74",
"      </td>",
"      <td>",
"       65",
"      </td>",
"      <td>",
"       38&Delta;",
"      </td>",
"      <td>",
"       41&Delta;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Durability of response",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       80-90",
"      </td>",
"      <td>",
"       50-80&loz;",
"      </td>",
"      <td>",
"       &sim;90&loz;",
"      </td>",
"      <td>",
"       69&loz;",
"      </td>",
"      <td>",
"       NA",
"      </td>",
"      <td>",
"       &sim;80",
"      </td>",
"      <td>",
"       NA",
"      </td>",
"      <td>",
"       NA",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     NA: not available.",
"     <br>",
"      * Hybridization or branched chain DNA assays (lower limit of detection 20,000-200,000 international units/mL or 5-6 log copies/mL) in standard IFN-&alpha; studies and some lamivudine studies, and PCR assays (lower limit of detection approximately 50 international units/mL or 250 copies/mL) in other studies.",
"      <br>",
"       &bull; Responses at week 48/week 72 (24 weeks after stopping treatment).",
"       <br>",
"        &Delta; Post-treatment biopsies obtained at week 72.",
"        <br>",
"         &loz; Lamivudine and entecavir - no or short duration of consolidation treatment, Adefovir and telbivudine - most patients had consolidation treatment.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Lok ASF, McMahon BJ. Chronic hepatitis B: Update 2009. Hepatology 2009; 50:661. Available online at file://publish.aasld.org/Pages/Default.aspx. Accessed September 8th 2009. Copyright &copy; 2009 American Association for the Study of Liver Diseases.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Responses to approved antiviral therapies among treatment-naive patients with HBeAG-negative chronic hepatitis B",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Control/placebo groups from multiple studies, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Standard IFN-&alpha; 5 MU daily or 10 MU three times per week for 6-12 months, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Lamivudine 100 mg daily for 48-52 weeks, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Adefovir 10 mg daily for 48 weeks, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Entecavir 0.5 mg daily for 48 weeks, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Telbivudine 600 mg daily for 52 weeks, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Tenofovir 300 mg daily for 48 weeks, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        PegIFN&alpha; 180 mcg once weekly for 48 weeks, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Peg IFN&alpha; 180 mcg once weekly + Lamivudine 100 mg daily for 48 weeks, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Loss of serum HBV DNA*",
"       </td>",
"       <td>",
"        0-20",
"       </td>",
"       <td>",
"        60-70",
"       </td>",
"       <td>",
"        60-73",
"       </td>",
"       <td>",
"        51",
"       </td>",
"       <td>",
"        90",
"       </td>",
"       <td>",
"        88",
"       </td>",
"       <td>",
"        93",
"       </td>",
"       <td>",
"        63",
"       </td>",
"       <td>",
"        87",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normalization of ALT",
"       </td>",
"       <td>",
"        10-29",
"       </td>",
"       <td>",
"        60-70",
"       </td>",
"       <td>",
"        60-79",
"       </td>",
"       <td>",
"        72",
"       </td>",
"       <td>",
"        78",
"       </td>",
"       <td>",
"        74",
"       </td>",
"       <td>",
"        76",
"       </td>",
"       <td>",
"        38",
"       </td>",
"       <td>",
"        49",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Histologic improvement",
"       </td>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        60-66",
"       </td>",
"       <td>",
"        64",
"       </td>",
"       <td>",
"        70",
"       </td>",
"       <td>",
"        67",
"       </td>",
"       <td>",
"        72",
"       </td>",
"       <td>",
"        48",
"       </td>",
"       <td>",
"        38&bull;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Durability of response",
"       </td>",
"       <td>",
"        Control",
"       </td>",
"       <td>",
"        10-20",
"       </td>",
"       <td>",
"        &lt;10",
"       </td>",
"       <td>",
"        ~5",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        NA",
"       </td>",
"       <td>",
"        ~20",
"       </td>",
"       <td>",
"        ~20",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     NA: not available.",
"     <br>",
"      * Hybridization or branched chain DNA assays (lower limit of detection 20,000-200,000 international units/mL or 5-6 log copies/mL) in standard IFN-&alpha; studies and some lamivudine studies, and PCR assays (lower limit of detection approximately 50 international units/mL or 250 copies/mL) in other studies.",
"      <br>",
"       <span class=\"bullet\">",
"        &bull;",
"       </span>",
"       Post-treatment biopsies obtained at week 72.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Lok ASF, McMahon BJ. Chronic hepatitis B: Update 2009. Hepatology 2009; 50:661. Available online at file://publish.aasld.org/Pages/Default.aspx. Accessed September 8th 2009. Copyright &copy; 2009 American Association for the Study of Liver Diseases.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Comparison of approved treatments of chronic hepatitis B",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Pegylated IFN&alpha;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Lamivudine",
"       </td>",
"       <td class=\"subtitle1\">",
"        Adefovir",
"       </td>",
"       <td class=\"subtitle1\">",
"        Entecavir",
"       </td>",
"       <td class=\"subtitle1\">",
"        Telbivudine",
"       </td>",
"       <td class=\"subtitle1\">",
"        Tenofovir",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\">",
"        Indications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        HBeAg+, normal ALT",
"       </td>",
"       <td>",
"        Not indicated",
"       </td>",
"       <td>",
"        Not indicated",
"       </td>",
"       <td>",
"        Not indicated",
"       </td>",
"       <td>",
"        Not indicated",
"       </td>",
"       <td>",
"        Not indicated",
"       </td>",
"       <td>",
"        Not indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        HBeAg+ chronic hepatitis",
"       </td>",
"       <td>",
"        Indicated",
"       </td>",
"       <td>",
"        Indicated*",
"       </td>",
"       <td>",
"        Indicated",
"        <sub>",
"         <sup>",
"          &bull;",
"         </sup>",
"        </sub>",
"       </td>",
"       <td>",
"        Indicated",
"       </td>",
"       <td>",
"        Indicated*",
"       </td>",
"       <td>",
"        Indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        HBeAg- chronic hepatitis",
"       </td>",
"       <td>",
"        Indicated",
"       </td>",
"       <td>",
"        Indicated*",
"       </td>",
"       <td>",
"        Indicated",
"        <sub>",
"         <sup>",
"          &bull;",
"         </sup>",
"        </sub>",
"       </td>",
"       <td>",
"        Indicated",
"       </td>",
"       <td>",
"        Indicated*",
"       </td>",
"       <td>",
"        Indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"7\">",
"        Duration of treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        HBeAg+ chronic hepatitis",
"       </td>",
"       <td>",
"        1 year",
"       </td>",
"       <td>",
"        &ge;1 year&Delta;",
"       </td>",
"       <td>",
"        &ge;1 year&Delta;",
"       </td>",
"       <td>",
"        &ge;1 year&Delta;",
"       </td>",
"       <td>",
"        &ge;1 year&Delta;",
"       </td>",
"       <td>",
"        &ge;1 year&Delta;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        HBeAg- chronic hepatitis",
"       </td>",
"       <td>",
"        1 year",
"       </td>",
"       <td>",
"        &gt;1 year&loz;",
"       </td>",
"       <td>",
"        &gt;1 year&loz;",
"       </td>",
"       <td>",
"        &gt;1 year&loz;",
"       </td>",
"       <td>",
"        &gt;1 year&loz;",
"       </td>",
"       <td>",
"        &gt;1 year&loz;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Route",
"       </td>",
"       <td>",
"        Subcutaneous",
"       </td>",
"       <td>",
"        Oral",
"       </td>",
"       <td>",
"        Oral",
"       </td>",
"       <td>",
"        Oral",
"       </td>",
"       <td>",
"        Oral",
"       </td>",
"       <td>",
"        Oral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Side effects",
"       </td>",
"       <td>",
"        Many",
"       </td>",
"       <td>",
"        Negligible",
"       </td>",
"       <td>",
"        Potential nephrotoxicity",
"       </td>",
"       <td>",
"        Negligible",
"       </td>",
"       <td>",
"        Negligible",
"       </td>",
"       <td>",
"        Potential nephrotoxicity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" rowspan=\"2\">",
"        Drug resistance",
"       </td>",
"       <td rowspan=\"2\">",
"        -",
"       </td>",
"       <td>",
"        &sim;20 percent, year 1",
"       </td>",
"       <td>",
"        None, year 1",
"       </td>",
"       <td rowspan=\"2\">",
"        &sim;1 percent up to year 6&sect;",
"       </td>",
"       <td rowspan=\"2\">",
"        &sim;25 percent up to year 2",
"       </td>",
"       <td rowspan=\"2\">",
"        None, up to&nbsp;year 5&yen;",
"        <br/>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &sim;70 percent, year 5",
"       </td>",
"       <td>",
"        29 percent, year 5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Cost������",
"       </td>",
"       <td>",
"        High",
"       </td>",
"       <td>",
"        Low",
"       </td>",
"       <td>",
"        Intermediate",
"       </td>",
"       <td>",
"        High",
"       </td>",
"       <td>",
"        Intermediate",
"       </td>",
"       <td>",
"        Intermediate",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Not preferred drug due to high rate of resistance.",
"     <br>",
"      &bull; Not preferred drug due to weak antiviral activity.",
"      <br>",
"       &Delta; Treatment for at least 12 months after anti-HBe seroconversion.",
"       <br>",
"        &loz; Treatment continued until HBsAg loss.",
"        <br>",
"         &sect; Entecavir resistance 1.2 percent up to six years in nucleoside na&iuml;ve patients but 1.0 mg dose used from&nbsp;year&nbsp;3 onward, resistance&nbsp;~50 percent at&nbsp;year five in patients with prior lamivudine resistance.",
"         <br>",
"          &yen; Patients with detectable HBV DNA at week 72 eligible to receive additional treatment with emtricitabine and ~70% of such patients elected to do so.",
"          <br>",
"           &Dagger; Based on treatment duration of 1 year.",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted&nbsp;with permission from: Lok ASF, McMahon BJ. Chronic hepatitis B: Update 2009. Hepatology 2009; 50:661. Available online at file://publish.aasld.org/Pages/Default.aspx. Accessed September 8th 2009. Copyright &copy; 2009 American Association for the Study of Liver Diseases.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f10_17_10527=[""].join("\n");
var outline_f10_17_10527=null;
